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Abstract 
 
Currently, the most powerful therapy for obesity is bariatric surgery both in terms of 
significant weight loss and long-term efficacy. Most surgeons regard the Roux-en-Y 
gastric bypass (gastric bypass) operation as “gold standard” for obesity treatment. 
However, underlying mechanisms by which gastric bypass induces and sustains 
weight loss are not fully understood, but include reduced hunger, increased satiety, 
increased energy expenditure, altered taste, as well as reduced preference for foods 
with a high fat and sugar content. In fact, gastric patients often report idiosyncratic 
changes in taste perception that involves “sweet” taste and a calorie-dense food. 
I herein aimed to investigate how gastric bypass reduces intake of and preference 
for food high in fat and sugar in rats and humans. I found that the proportion of 
dietary fat in gastric bypass patients was significantly reduced six years after surgery 
compared with patients after vertical-banded gastroplasty. In addition, gastric bypass 
patients had an increased sucrose detection sensitivity compared with before 
surgery and controls, but hedonic taste ratings of sucrose in bypass patients 
remained unchanged. Rats after gastric bypass exhibit a shift away from high to low 
fat food. When compared to sham-operated rats, gastric bypass rats did not prefer 
high sucrose and fat concentrations in a two bottle preference test, but preoperative 
sucrose exposure reduced this effect. There was no difference in appetitive or 
consumatory behaviour in the brief access test between the sham-operated and 
gastric bypass rats. An oral gavage of 1 ml corn oil in gastric bypass rats induced 
conditioned taste aversion which was also demonstrated after exogenous 
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administration of the GLP-1 receptor agonist exendin-4 (2 µg/kg intraperitoneal) in 
unoperated rats.  
These findings suggest that an altered food preference may contribute to long-term 
maintained weight loss after gastric bypass. Postingestive effects resulting in 
conditioned taste aversion may partially explain this observation. 
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Chapter 1: Introduction 
 
 
The obesity epidemic  
 
Obesity is a currently the largest nutrition related condition affecting not only 
developed, but increasingly developing countries (World Health Organisation (WHO) 
2006). It is a chronic and relapsing disease and is becoming more prevalent in 
younger patients. Over 400 million people are currently diagnosed as clinically obese 
with a body mass index (BMI) ≥ 30 kg/m2 and nearly 1.6 billion are overweight (BMI 
25 to 29.9 kg/m2). Obesity is globally responsible for millions of deaths per year and 
a huge economic cost to the world health service economy as a result of its 
associated co-morbidities including type 2 diabetes mellitus, hypertension and 
hyperlipidaemia. The mechanisms that render a person obese have not yet been 
fully elucidated. Evidence implicates multiple factors including poor diet, sedentary 
lifestyle, environmental cues, genetics and disturbed energy balance (James 2008).  
 
 
Non-surgical treatments modalities 
 
Traditional weight loss strategies involving a healthy diet and increased levels of 
physical activity are only effective in the short term and deliver up to 7% of body 
weight loss (Bray 2008). Obesity specialists realized early that the majority of obese 
patients, especially the ones seeking help, go to extreme efforts to overcome their 
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disease. They are fighting an evolutionary imposed metabolic pathophysiological 
process aimed at maintaining weight homeostasis and protecting against the effects 
of famine (Cummings and Schwartz 2003).  The introduction of new anti-obesity 
medications in the last ten years has been a step in the right direction. However, 
even the most effective of these drugs offer only 5-10% body weight loss which re-
accumulates should the drug be discontinued (Bray 2008;Padwal and Majumdar 
2007). Two of the three most successful anti-obesity agents have recently been 
withdrawn from the market due to serious health and safety concerns: Rimonabant 
(Accomplia®), an inverse agonist for the cannabinoid receptor CB1, was withdrawn 
by the European Medicines Agency in January 2009 due to concerns over increased 
suicidality and depression. Sibutramine (Reductil®), a centrally-acting serotonin-
norepinephrine reuptake inhibitor, was also demonetized in Europe secondary to an 
increased cardiovascular risk. Thus, the only drug currently available in Europe for 
obesity treatment is the pancreatic lipase inhibitor orlistat. However, its use is limited 
by the unpleasant adverse effect of anal leakage of oily faeces and the magnitude of 
weight loss achieved may be insufficient to ameliorate the life-threatening 
complications of obesity.      
 
 
Obesity surgery: procedures and weight loss mechanisms 
 
Currently, the most powerful therapeutic modality for obesity is bariatric surgery both 
in terms of significant body weight loss and long term efficacy (Buchwald et al. 
2004;Buchwald et al. 2009). The average weight loss after obesity surgery varies 
from 15% to 35% depending on the procedure employed (Buchwald, Avidor, 
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Braunwald, Jensen, Pories, Fahrbach, & Schoelles 2004). It was in the 1950s that 
these procedures were originally designed and have over the last century undergone 
numerous technical modifications that have improved both safety and efficacy 
profiles. Rather unexpectedly, bariatric surgery has been shown to at least 
ameliorate or even cure Type 2 Diabetes, the metabolic syndrome and have 
profound effects on the cardiovascular system (Ashrafian et al. 2008;Buchwald, 
Estok, Fahrbach, Banel, Jensen, Pories, Bantle, & Sledge 2009;Bueter et al. 2009a). 
These clinically significant changes take place within a few days or weeks post 
operatively and have lead to the concept of “metabolic surgery”. 
The most common obesity surgery operations are gastric banding, Roux-en-Y 
gastric bypass and biliopancreatic diversion. In gastric banding an expandable 
silastic band is placed around the proximal stomach creating a gastric pouch. Other 
variations of this type of surgery include vertical banded gastroplasty in which 
restriction is achieved with stapling and banding and finally the more recently 
developed sleeve gastrectomy where a gastric sleeve tube remains after 85% of 
stomach excision.  
 
The biliopancreatic diversion with or without duodenal switch was designed to limit 
nutrient absorption. However, with time the gastrointestinal tract (in contact with 
food) may undergo hypertrophy (Borg et al. 2006) and calorie malabsorption may 
become less prominent (Pilkington et al. 1976). 
 
The most popular procedure is the Roux-en-Y gastric bypass, an operation some 
regard as the “gold standard” for the treatment of obesity currently. It incorporates a 
partial gastrectomy, anastomosis of the stomach pouch to the jejunum and an 
16 
 
entero-entero anastomosis between the excluded biliary alimentary limbs (Olbers et 
al. 2003).  
 
Patients with a BMI of more than 40 kg/m2 or with a BMI of more than 35 kg/m2 and 
significant co-morbidities may be referred for bariatric surgery based on the most 
recent international societies/institutes guidelines (i.e. National Institute of Clinical 
Excellence, National Institutes of Health, The American College of Surgeons, The 
American Society of Bariatric Surgeons) (The National Institute of Clinical Excellence 
2006). These patients should be assessed by an expert multidisciplinary team after 
behavioral or drug therapies have failed. 
The mechanism of weight loss following obesity surgery is still not fully understood. 
A small stomach may play a role, but changes in eating behavior, decreased 
appetite and meal frequency (Brown et al. 1982;Halmi et al. 1981;Kenler et al. 
1990;Morinigo et al. 2006;Olbers et al. 2006;Sugerman et al. 1987) and paradoxical 
increases in energy expenditure have been implicated (Bueter et al. 
2009b;Stylopoulos et al. 2009). This introduction will concentrate on the most novel 
weight loss mechanism which postulates alterations in food preference due to 
changes in taste.  
 
 
Mechanism of weight loss after bariatric surgery – Gut hormones 
 
Gastric bypass increases postprandial levels of the L-cell hormones glucagon like 
peptide 1 (GLP-1) and peptide YY (PYY) (le Roux et al. 2006a). These gut hormones 
are anorexigenic and their administration either peripherally or centrally reduces 
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hunger and enhances satiation (Baggio and Drucker 2007;Batterham et al. 2003). 
Studies have demonstrated that postprandial PYY and GLP-1 levels start rising early 
after the operation and remain elevated for many months after surgery (le Roux et al. 
2007). In patients with poor weight loss after gastric bypass, the postprandial PYY 
and GLP-1 responses are lower compared with patients who lost more weight after 
gastric bypass (le Roux, Welbourn, Werling, Osborne, Kokkinos, Laurenius, Lonroth, 
Fandriks, Ghatei, Bloom, & Olbers 2007) supporting the idea of an important role of 
GLP-1 and PYY in the weight lowering effects of gastric bypass. Moreover, inhibition 
of the gastrointestinal hormone response with octreotide after gastric bypass 
increased appetite and food intake (le Roux, Welbourn, Werling, Osborne, Kokkinos, 
Laurenius, Lonroth, Fandriks, Ghatei, Bloom, & Olbers 2007). The combined effect 
of having elevated levels of GLP-1 and PYY reduces food intake more than 
predicted by individual hormone infusions alone (Neary et al. 2005). This 
combination of gut hormone responses might contribute to the successful weight 
loss and its maintenance after gastric bypass. Interestingly, recent studies reported 
increased GLP-1 and PYY levels three months after Sleeve Gastrectomy similarly to 
gastric bypass (Peterli et al. 2009), but this procedure requires increased study 
before further insights can be revealed regarding its gut hormonal modulation. In 
contrast, although an optimally inflated gastric banding also reduces hunger and 
induces early satiation, changes in appetite are independent of gut hormone 
changes. Thus, non-hormonal mechanisms have been suggested following gastric 
banding (Dixon et al. 2005). 
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Food preferences after obesity surgery 
 
Changes in appetite behavior after obesity surgery were reported in the 1970s. 
Halmi using structured interviews reported that post gastric bypass patients reached 
satiety much faster compared to before surgery and the reason for reduced food 
intake was lack of “desire” (Halmi, Mason, Falk, & Stunkard 1981). More importantly 
there was a statistically significant reduction in intake for high fat meals and high 
calorie carbohydrates six months after surgery. At the same time patients found 
these foods “no longer enjoyable”. In an attempt to explain the changes in high 
calorie carbohydrate eating, dumping syndrome was implicated even though that 
was not evaluated further (Halmi, Mason, Falk, & Stunkard 1981). 
 
These findings were replicated by Brown who used food diaries to show that both 
total fat and carbohydrate intake was significantly lower after gastric bypass. Patients 
stated that they were “not interested in sweets or deserts after surgery” even though 
again this was not formally quantified (Brown, Settle, & Van Rij 1982).  
Kenler et al were the first to conduct a study comparing gastric bypass and 
horizontal gastroplasty (Kenler, Brolin, & Cody 1990), as it was recognised very early 
that the superior weight loss after gastric bypass may be due to changes in taste 
preference rather than gastric restriction alone (Kenler, Brolin, & Cody 1990). This 
comparative trial using diet interviews showed that gastric bypass patients 
consumed 45% less solid sweets and sweet high calorie beverages and 37% less 
milk or ice cream compared to gastroplasty patients (Kenler, Brolin, & Cody 1990). 
Milk and ice cream consumption increased postoperatively in the gastroplasty group 
as these food substances may have been easier to swallow. Dumping syndrome 
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was suggested (but not proven) to be responsible for the changes in sweet 
consumption (Kenler, Brolin, & Cody 1990). Some patients reported “losing their 
taste” for milk and ice cream even without having unpleasant gastrointestinal 
symptoms. On this basis the authors recommended gastric bypass as a more 
suitable procedure for sweet and ice cream eaters supporting the findings and 
recommendations of the Sugerman group (Sugerman, Starkey, & Birkenhauer 
1987). Olbers compared patients after gastric bypass and vertical banded 
gastroplasty in a randomised controlled trial (Olbers, Bjorkman, Lindroos, Maleckas, 
Lonn, Sjostrom, & Lonroth 2006). The latter group of patients consumed a 
significantly higher proportion of their total calories as fat and carbohydrates in 
contrast to the bypass group (Olbers, Bjorkman, Lindroos, Maleckas, Lonn, 
Sjostrom, & Lonroth 2006). Interestingly post gastric bypass patients preferred fruit 
and vegetables and consciously avoided fat and reported not feeling well after its 
consumption, potentially as a result of a dumping phenomenon (Olbers, Bjorkman, 
Lindroos, Maleckas, Lonn, Sjostrom, & Lonroth 2006). 
 
More recently, Thomas concentrated on the consumption of fatty foods post gastric 
bypass (Thomas and Marcus 2008). High fat foods were avoided compared to low 
fat foods after surgery and patients even reported low fat food “intolerance”. 
Reasons to explain the reduced consumption of high fat foods may include 
compliance with bariatric dietetic advice or learned behaviours due to negative 
postingestive or postabsorptive effects. The authors propose that the unexpected 
low fat food intolerance could potentially be explained by altered intestinal transit and 
digestion due to changes in texture (Thomas & Marcus 2008).  
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Based on these findings and the terminology used in the literature of the time 
(desire, not interested or intolerance) it was realized that obesity surgery and 
specifically gastric bypass doesn’t just reduce the amount that people eat but also 
changes the perception of food and thus eating behaviour, leading to the concept of 
behavioral surgery. Is this altered perception a result of changes in taste or post 
ingestive effects? Can gastric bypass influence fundamental and evolutionary robust 
physiological circuits like the gustatory system, something that behavioral anti-
obesity interventions have not succeeded in achieving? And if so at what level of 
taste transduction does this manipulation take place – the taste bud, the brain or 
both? These questions have raised the interest of obesity and behavior researchers 
in the mid-90s and the last few years and have lead to ground breaking clinical and 
preclinical experimental work. 
 
 
Evidence for fat as a distinct taste modality 
 
Taste encompasses the chemical senses of taste and olfaction as well as the oral 
perception of texture (Drewnowski 1997a). However, it is controversial, whether fat 
generates a distinct taste quality (Spector and Glendinning 2009). Prior work 
indicated that fat detection was based on its ability to both alter the tactile food 
properties and retain food-related odors. There is accumulating evidence, however, 
supporting the specific involvement of the gustatory system. Mechanisms that have 
been identified for the initial events in the taste transduction of free fatty acids 
include the intracellular transport of free fatty acids by the fatty acid transporter CD-
36 (Fukuwatari et al. 1997) and an inhibition of delayed rectifying potassium (DRK) 
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channels (Gilbertson et al. 1997;Gilbertson et al. 1998). The CD36 fatty acid 
translocater is expressed in murine taste cells, and may serve as a receptor. CD36 is 
expressed on the apical surface of taste cells (Abumrad 2005). Following interaction 
of CD36 with fatty acids derived from hydrolysis of triglycerides by lingual lipase, a 
signal is transduced to nerve fibers, which leads to taste perception and release of 
bile acids, preparing the digestive system for fat absorption (Abumrad 2005). CD36 
binds fatty acids with high affinity and facilitates their transfer into the cell in 
interaction with other proteins (Laugerette et al. 2005). The CD36 protein is 
necessary for normal responsiveness to fatty acids at both the cellular and 
behavioral (i.e. 30 min or 24-hour intake) levels (Gaillard et al. 2008;Laugerette, 
Passilly-Degrace, Patris, Niot, Febbraio, Montmayeur, & Besnard 2005;Sclafani et al. 
2007).  
Concomitant with a role for the taste system in nutrient recognition, the specificity of 
DRK channels in the anterior tongue (fungiform taste buds) is limited to the essential 
(cis-polyunsaturated) fatty acids (Gilbertson, Fontenot, Liu, Zhang, & Monroe 1997), 
while the posterior tongue, however, appears to be less specific, and taste cells in 
the foliate and circumvallate taste buds also responded to the monounsaturated fatty 
acids, palmitoleic and oleic acid, in a preliminary study (Gilbertson et al. 2005). In 
one recent study, Gilbertson et al investigated in more detail the role of DRK 
channels in fat chemoreception in two strains of rats (Gilbertson, Liu, York, & Bray 
1998). One strain, the Osborne–Mendel rats may be broadly classified as an obesity-
prone, fat-preferring rat while the other, S5B/Pl rats, is obesity-resistant and 
carbohydrate preferring [16]. Gilbertson et al compared the two strains of rats for 
their electrophysiological responses in fungiform taste receptor cells to a variety of 
fatty acids using patch clamp recording, for the ability of fatty acids to alter taste 
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preference in behavioral assays, and for quantitative expression of DRK channels 
using quantitative real-time polymerase chain reaction (PCR). It was found that 
Osborne – Mendel rats exhibited a greater DRK current density and express 
quantitatively more DRK channels as assayed using quantitative real-time PCR. No 
differences were found when comparing expression of fatty acid activated two pore 
domain potassium channels indicating that differences in DRK expression may 
contribute to the phenotypic differences between Osborne – Mendel and S5B/Pl rats 
and that these channels may play roles in helping to shape dietary preference and 
fat intake. 
There is also other experimental evidence that rodents and humans can detect long 
chain fatty acids through oral mechanisms (Chale-Rush et al. 2007;Pittman et al. 
2007). In addition, rodents will lick for fats in a concentration-dependent manner 
(Glendinning et al. 2008).  
 
 
The sense of Taste – Basic Pathways 
 
Taste encompasses the “chemical senses of taste and olfaction as well as the oral 
perception of texture” (Drewnowski 1997b). Food preference is influenced by taste 
with three categories of taste processing (Spector & Glendinning 2009): Stimulus 
identification (sensory) is the detection or discrimination of sensory signals arising 
from taste cell activation. Ingestive motivation (reward) involves processes that 
promote or discourage ingestion. Digestive preparation (physiological changes) 
refers to feed-forward physiological reflexes that protect oral tissues, aid digestion, 
and facilitate homeostasis. Behavioural responses to taste stimuli can however also 
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be influenced by non-gustatory factors, including olfactory, somatosensory, and 
visceral signals. A comprehensive description of the complex gustatory system in 
primates is beyond the scope of this chapter. However some basic concepts will be 
introduced for better understanding of the studies discussed later on.  
 
Taste signals originate from taste receptors located in the mouth and even the small 
intestine (Jang et al. 2007). The primary taste cortex in the primate anterior insula 
and adjoining frontal operculum contains not only taste neurons tuned to sweet, salt, 
bitter, sour, and umami as exemplified by monosodium glutamate (Baylis and Rolls 
1991;Rolls et al. 1996;Scott et al. 1986;Yaxley et al. 1990), but also other neurons 
that encode oral somatosensory stimuli including viscosity, fat texture, temperature 
and capsaicin (Verhagen et al. 2004). Some neurons in the primary taste cortex 
respond to particular combinations of taste and oral texture stimuli, but do not 
respond to olfactory stimuli or visual stimuli such as the sight of food (Verhagen, 
Kadohisa, & Rolls 2004). Neurons in the primary taste cortex do not represent the 
reward value of taste, that is, the appetite for a food, in that their firing is not 
decreased to zero by feeding the taste to satiety (Rolls, Critchley, Wakeman, & 
Mason 1996;Yaxley et al. 1988). 
A secondary cortical taste area in primates was discovered in the caudolateral 
orbitofrontal cortex (OFC), extending several millimetre in front of the primary taste 
cortex (Rolls et al. 1990). Neurons in this region respond not only to each of the four 
classical prototypical tastes sweet, salt, bitter and sour, (Rolls 1997) but also there 
are many neurons that respond best to umami tastants such as glutamate (which is 
present in many natural foods such as tomatoes, mushrooms and milk) (Baylis & 
Rolls 1991) and inosine monophosphate (which is present in meat and some fish 
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such as tuna) (Rolls, Critchley, Wakeman, & Mason 1996). This evidence, taken 
together with the identification of glutamate taste receptors (Maruyama et al. 
2006;Zhao et al. 2003), leads to the view that there are five prototypical types of 
taste information channels, with umami contributing, often in combination with 
corresponding olfactory inputs (McCabe and Rolls 2007;Rolls et al. 1998;Rolls 
2009), to the flavour of protein. In addition, other neurons respond to water, and 
others to somatosensory stimuli including astringency as exemplified by tannic acid 
(Critchley and Rolls 1996), and capsaicin (Rolls et al. 2003). Taste responses are 
found in a large mediolateral extent of the OFC (Critchley & Rolls 1996;Kadohisa et 
al. 2004;Rolls 2008). Texture of fatty foods activates neurons in the OFC, which also 
receive inputs from the other chemical senses and taste specific neurons. Therefore 
differences in the “sweetness” and odour of an ice cream for example can influence 
the activation of the neurons involved with fat perception (Rolls 2007;Spector 2010).  
These mechanisms have been studied by using advanced techniques such as 
functional magnetic resonance imaging (fMRI) and positron emission tomography. 
Using fMRI, changes in region of interest neuronal activity can be measured through 
alterations in blood oxygen dependent signal which reflects concentrations of 
deoxyhaemoglobin a recognised paramagnetic contrast agent (Tataranni and 
DelParigi 2003). 
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Functional taste domains 
 
Taste function can be experimentally classified into at least three general domains 
(Spector & Glendinning 2009):  
 
Stimulus identification is the detection or discrimination of sensory signals arising 
from taste cell activation in the oral cavity. Stimulus identification involves the 
discrimination between the sensory signals representing different taste stimuli arising 
from the interactions of chemical compounds with taste receptors.  
 
Ingestive motivation refers to processes that promote or discourage ingestion of 
foods and fluids on the basis of taste input. Ingestive motivation can be further 
divided into two functional subclasses: Appetitive behavior (“wanting”) can be 
defined as actions that lead to contact with the taste stimulus (e.g. searching, 
foraging, approach to a drinking spout) and reflects how much the stimulus is 
wanted. Consummatory behavior (“liking”) represents the behavior that is elicited 
during the contact with the taste stimulus (e.g. oral motor responses, swallowing) 
and reflects how much the stimulus is liked.  
 
Digestive preparation refers to physiological reflexes that fall into a general class 
referred to as cephalic phase responses, which are internal physiological events 
triggered by stimulus contact with any sensory receptor of the head (Powley 1977). 
Cephalic phase responses generally prepare to digest, absorb and then store 
nutrients that enter the body through feeding. Cephalic phase reflexes can be both 
intrinsic and learned. For example, most animals readily learn to avoid foods that 
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render them ill through conditioned taste preferences and conditioned taste 
aversions and rats can be conditioned to react aversively to sweet solutions by 
rendering them ill after ingestion. Consequently, they will decrease their intake of the 
sweet solutions when they are exposed to them again. The vagus nerve is thought to 
be an important pathway for cephalic phase responses (Rozin 1976).  
 
 
General procedural requirements in the assessment of taste function  
 
For taste function assessment it is important to circumvent the influence of 
postingestive factors in both animals and humans. Postingestive effects can be 
positive (e.g. satiation, fullness) or negative (nausea, visceral pain) and occur after 
food ingestion. They also include postabsorptive effects. Hence, two important 
methodological features must be considered for the experimental protocols: First, 
only small volumes of taste solutions must be used. Second, immediate responses 
to the taste stimulus should be measured. For animal experiments, the application of 
these methodological features requires the use of a special stimulus delivery system 
and a lickometer (Spector 2003).  
 
 
Procedures for assessing taste function in animals 
 
Animal psychophysical procedures primarily measure sensory and discriminative 
(Stimulus identification) or hedonic (Ingestive motivation) taste functions. Various 
procedures have been designed to assess taste sensitivity and discrimination 
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independent of the motivational properties of the taste stimuli themselves. Most 
techniques are based on the principles of operant conditioning procedures. Here, a 
taste stimulus signals another event independent of its affective valence as the 
motivation to respond is usually provided by an imposed schedule of food or water 
restriction. This motivates the animal to respond correctly to obtain a food or water 
reinforcement. Some investigators have used a two-alternative, forced-choice 
procedure in which two-bottles, one containing a taste solution and the other 
containing water, were presented, and if the water-deprived animal licked from the 
“incorrect” solution, it received an electric shock (HARRIMAN and MACLEOD 1953). 
Others used a yes/no procedure in which a single stimulus is presented on a trial 
and the animal indicates whether the solution contains the relevant taste stimulus 
(Morrison and Norrison 1966). Here, food-deprived rats were trained to press a lever 
if the stimulus was a taste compound and another lever if the stimulus was water; 
correct responses were rewarded with a food pellet.  For my experiments, a two-
response operant taste discrimination procedure was used, in which water-deprived 
rats were trained and tested in a specially designed computer-controlled gustometer 
as decribed below (Eylam and Spector 2002;Spector et al. 1990).  
 
The hedonic taste responsiveness of animals can be effectively evaluated with a 
brief-access test. Here, very small samples of a taste stimulus are presented for very 
brief duration (e.g. 10 sec) and the animal’s unconditioned licking responses are 
measured (Smith 2001;Spector & Glendinning 2009). Using Davis-Rig Lickometers 
(Davis MS-160, DiLog Instruments, Tallahassee, Florida, USA), this test allows 
minimizing any postingestive effects of any substance tested as only small amounts 
are ingested. Several concentrations can be presented in a random order and a 
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concentration-response function can be derived in a single session. The brief access 
test measures both components of the hedonic motivation to ingest a specific 
stimulus: Firstly, the animal’s approach and contact with the stimulus which is known 
as the appetitive component (“Wanting” – e.g. how often does the rat go to the spout 
and starts drinking?) and secondly, the oral motor responses generated once the 
stimulus is ingested which is called the consummatory component (“Liking” – e.g. 
how fast does the rat lick?). 
 
 
Procedures for assessing taste function in humans   
    
So far, most studies in humans have assessed food preference after bariatric 
surgery using either survey or scaling methods. These methods are subject to the 
inaccuracy of verbal report and may not reflect the actual “affective” value of the 
stimulus. To the best of our knowledge, psychophysical methods as described 
previously have not been imposed for human studies yet; at least not in the context 
of bariatric surgery.  
 
Bariatric surgery and taste function 
 
 
Stimulus identification after bariatric surgery  
 
So far, only the effects of bariatric surgery on sweet, but not on fat taste sensitivity 
have been studied. Although different methodologies were used, most studies 
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demonstrated a selectively decreased sweet taste detection threshold after gastric 
bypass (Burge et al. 1995;Scruggs et al. 1994) suggesting an altered sweet taste 
preference after the operation. However, there might also be an increased fat 
detection sensitivity after gastric bypass potentially explaining a reduced preference 
for high fat foods in patients after gastric bypass as it may translate into a more 
intense sensation and result in reduced consumption of high calorie food. However, 
taste detection thresholds are only one basic aspect of taste function in general and 
have been shown to vary as a function of genetics, pharmacological treatment, and 
neural manipulations (Spector 2003) . It also remains unclear how differences in fat 
taste sensitivity correlate with suprathreshold sensitivity and whether they accurately 
reflect the hedonic evaluation of higher concentrations of fat stimuli (Bartoshuk 
1978). 
 
 
Ingestive motivation and obesity 
 
The concepts of taste hedonics and alterations in reward responses have not been 
fully explored as a potential mechanism for the development of obesity. Research 
into eating control has recently focused on the role of dopamine in reward-based 
behaviors. Obese individuals rate fatty food more rewarding and work harder for the 
delivery of more food (Epstein et al. 2007). The reward-related dopamine release in 
mesolimbic brain structures caused by the ingestion of highly palatable foods can 
also be elicited by cues that predict food availability in the absence of actual food 
stimuli (Stoeckel et al. 2008). Furthermore, the central reward pathways of obese 
subjects show greater activation in functional magnetic resonance imaging when 
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presented with pictures of high calorie foods compared to lean controls (Wang et al. 
2001). Remarkably, the density of dopamine type 2 receptors in mesolimbic brain 
areas has been found to be significantly reduced in severly obese patients (Volkow 
et al. 2002). Thus, there might be a decreased reward sensing in obese patients 
leading to a compensatory behavior of increased food and in particular fat intake. In 
other words, some forms of obesity may partly result from overeating in an attempt to 
compensate for reduced dopaminergic activity in the mesolimbic system. This state 
might be similar to that of a reward deficiency syndrome (Corwin and Grigson 2009) 
as the same mesolimbic brain areas are activated by recreational drugs. Some 
authors have suggested obesity as an addiction state (Steele et al. 2010).  
 
 
Ingestive motivation after bariatric surgery  
 
The effect of bariatric surgery on complex central reward circuits has not been fully 
elucidated yet. Two recent studies investigated the dopamine type 2 receptor density 
in reward-processing brain areas after gastric bypass using positron-emission 
computed tomography, but findings were controversial: Steele et al described an 
increased dopamine type 2 receptor availability in the brain following RYGB (Dunn et 
al. 2010), while Dunn et al found the opposite (le Roux, Aylwin, Batterham, Borg, 
Coyle, Prasad, Shurey, Ghatei, Patel, & Bloom 2006a).  
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Digestive preparation after bariatric surgery 
 
The effect of bariatric surgery on cephalic phase reflexes has not been studied. 
 
 
Taste and gut hormones 
 
Metabolic mechanisms may facilitate the effect of gastric bypass on taste pathways. 
As described earlier, GLP-1 and PYY are gut hormones co-secreted by the L cells in 
response to a meal, and their postprandial levels are increased after gastric bypass 
(Baggio & Drucker 2007;Batterham, Cohen, Ellis, le Roux, Withers, Frost, Ghatei, & 
Bloom 2003). In addition to their anorexigenic functions (Batterham et al. 2007), high 
PYY levels activate brain regions related to food reward including the ventral 
striatum, OFC and insular cortex (Grill et al. 2007), and GLP-1 receptors have been 
isolated in brain reward areas (Shin et al. 2008). GLP-1 and its receptor have also 
been isolated from taste cells of taste buds and adjacent intragemnal afferent fibres 
respectively, interacting in a paracrine manner (Shin, Martin, Golden, Dotson, 
Maudsley, Kim, Jang, Mattson, Drucker, Egan, & Munger 2008). Importantly, mice 
lacking the GLP-1 receptor show decreased behavioral responsiveness to sucrose 
(Kokrashvili et al. 2009b). Furthermore, recognition and transduction of sweet-tasting 
compounds has been shown to involve in part α-gustducin and the sugar binding 
receptor subunit T1R3 (Jang, Kokrashvili, Theodorakis, Carlson, Kim, Zhou, Kim, Xu, 
Chan, Juhaszova, Bernier, Mosinger, Margolskee, & Egan 2007). These molecules 
also partly mediate the glucose-dependent GLP-1 secretion from enteroendocrine L 
cells of the gut (Jang, Kokrashvili, Theodorakis, Carlson, Kim, Zhou, Kim, Xu, Chan, 
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Juhaszova, Bernier, Mosinger, Margolskee, & Egan 2007). The molecular similarities 
between enteroendocrine L cells of the gut and taste receptor cells of the oral cavity 
suggest that GLP-1 could play a role in gustatory function (Halmi, Mason, Falk, & 
Stunkard 1981). For example, stimulation of sweet taste receptors might lead to 
GLP-1 release which then in turn may act to enhance or maintain sweet taste 
sensitivity through a positive feedback mechanism. Thus, GLP-1 and PYY input to 
the taste signal pathways at multiple levels and sufficiently high plasma levels of 
both hormones may affect peripheral and central taste signalling after gastric 
bypass. The reductions in preference for sucrose and potentially for high fat food 
reported after gastric bypass are consistent with this possibility. 
 
Rationale for use of a Roux-en-Y gastric bypass rat model  
 
 
It has been previously reported that subjective taste changes occur after gastric 
bypass surgery (Brolin et al. 1994;Brown, Settle, & Van Rij 1982;Olbers, Bjorkman, 
Lindroos, Maleckas, Lonn, Sjostrom, & Lonroth 2006). The proportion to which these 
changes are psychologically versus physiologically based is unknown. The realm of 
psychological issues and pathology contributing to obesity is vast. However, if the 
physiological basis of taste changes could be defined, this could be the target of new 
treatments to pharmacologically alter food taste making it less appealing. 
To study the physiologic aspects of taste change in the absence of individual 
psychological issues requires an animal model. Although little is known about the 
mechanisms underlying taste change after gastric bypass in humans, it is clear that 
an animal model providing uniform eating experiences and removing the 
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environmental background associated with human weight loss could be helpful in 
determining some of these mechanisms. 
It is therefore important that the rat gastric bypass model is physiologically as close 
as possible to human bypass patients. This includes not only technical aspects (e.g. 
size of the gastric pouch), but also physiological (e.g. postprandial levels of 
gastrointestinal hormones such as GLP-1 and PYY) and behavioral aspects (e.g. 
reduced preference of caloric dense food).  
 
 
Surgical technique of Roux-en-Y gastric bypass in rats 
 
Rats were food deprived for 12 hours overnight, but water was available ad libitum. 
Before surgery, rats were weighed, and then anesthetized with isofluorane (4% for 
induction, 3% for maintenance). Preoperatively, gentamicin 8 mg/kg and carprofen 
0.01 ml were administered intraperitoneally (ip) as prophylaxis for postoperative 
infection and pain relief. Surgery was performed on a heating pad to avoid decrease 
of body temperature during the procedure. Prior to a midline laparotomy, the 
abdomen was shaved and disinfected with surgical scrub. In the sham group a 7 mm 
gastrotomy on the anterior wall of the stomach with subsequent closure (interrupted 
prolene 5-0 sutures) and a 7 mm jejunotomy with subsequent closure (running 
prolene 6-0 suture) was performed. In the gastric bypass group, the proximal 
jejunum was divided 15 cm distal to the pylorus to create a biliopancreatic limb. After 
identification of the caecum, the ileum was then followed proximally to create a 
common channel of 25 cm. Here, a 7 mm side-to-side Jejuno-Jejunostomy (running 
prolene 7-0 suture) between the biliopancreatic limb and the common channel was 
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performed.  Figure 1 shows a schematic illustration of the pre- and postoperative 
anatomy. 
 
 
Figure 1: Diagrammatic representation of the gastrointestinal anatomy before (a) and after (b) the 
gastric bypass operation.(A) Biliopancreatic limb (~ 10 cm), (B) Alimentary limb (~50 cm), (C) 
Common channel (~25 cm), (D) Caecum. 
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Chapter 2: Role of the vagus for body weight loss in a rodent model of 
Roux-en-Y Gastric Bypass 
 
Introduction 
 
Traditionally, the vagal nerve is thought to have an important role in the regulation of 
food intake and body weight, but only a few reports examined whether vagal 
preservation is effective or necessary in weight control after bariatric surgery 
(Perathoner et al. 2009;Sundbom et al. 2007;Wang and Liu 2009). There is 
considerable controversy and confusion about the relative importance of the nerve 
as gut hormones released from enteroendocrine cells in the distal ileum like 
Glucagon-like peptide (GLP-1) and peptide tyrosine-tyrosine (PYY) can inform the 
brain either through the circulation or via afferent vagal fibres or both (Berthoud 
2008). Often various routes are described for same physiological effects, particularly 
for food intake (Berthoud 2008).  
In this chapter, I describe variations in the technique for gastric bypass surgery in 
rats in the area of the gastro-jejunostomy. Here, the para-esophageal bundle can be 
found which contains the left gastric vessels and the dorsal vagal trunk that consists 
of about 4/5 right vagal fibres and about 1/5 left vagal fibres (Niederhausern W.v. 
1953). The aim of this study was to assess whether preservation of the vagal fibres 
in the para-oesophageal bundle has an impact on body weight and food intake after 
gastric bypass in rats.  
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Material and Methods 
 
Animals 
 
Male Wistar rats used were individually housed under a 12-hour / 12-hour light-dark 
cycle and at a room temperature of 21 ± 2 ºC. Water and standard chow were 
available ad libitum, unless otherwise stated.  All experiments were approved by the 
Veterinary Office of the Canton Zurich, Switzerland. Experiments were performed at 
the Institute of Veterinary Physiology and Zürich Centre for Integrative Human 
Physiology, Vetsuisse Faculty University of Zurich in Zurich, Switzerland. Body 
weight and food intake were measured daily in study 1 and 2 for a postoperative 
period of 60 days and in study 3 for 75 days. 
 
Surgery  
 
Gastric bypass surgery was performed as described on page 32. Two different 
techniques were used to handle the vagal fibres in the para-oesophageal bundle in 
the area of the gastric pouch. All groups were operated in chronological order. In a 
first group, 25 rats (Body weight 348 ± 3.9g) were randomized for gastric bypass (n = 
17) or sham operation (n = 8). In this group the vagal fibres were not preserved in 
the gastric bypass rats as the para-esophageal neurovascular bundle was 
completely ligated (Study 1). In a subsequent group, 18 rats (332 ± 2.4g) were 
randomized to gastric bypass (n = 10) or sham operation (n = 8). Here, the vagal 
fibres were preserved as the left gastric vessels were separated and selectively 
ligated in all gastric bypass rats (Study 2). Significant differences in body weight and 
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energy intake were observed in these two groups. As it was unclear whether these 
differences were related to the different techniques of vagal preservation, a third 
group (Study 3) of 39 rats (471 ± 4.3g) was randomized for gastric bypass without 
vagal preservation (n = 14) or gastric bypass with vagal preservation (n = 14) or 
sham operation (n = 11). Figure 2 gives a schematic illustration of the different 
techniques used.   
No vagal preservation
(Study 1)
Vagal preservation
(Study 2)
A B
C
D
 
Figure 2: Schematic illustration of the two different techniques to handle the vagal fibres in the para-
oesophageal neurovascular bundle in the area of the gastric pouch with vagal fibres (yellow) and the 
left gastric vessel (red). (A) preoperative anatomy, (B)  magnification, (C) complete ligation of the 
para-oesophageal bundle with  no preservation of the vagal fibres and (D) selective ligation of the left 
gastric vessel with preservation of the vagal fibres.   
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Hormone assay 
 
Animals from study 3 were fasted for 12 hours from the beginning of the light cycle 
on postoperative day 50. At the onset of the dark cycle animals were offered 5g of 
standard chow all of which was consumed within half an hour by the animals. 
Approximately 200 μl of blood was obtained by puncture of a sublingual vein under 
brief isoflurane anesthesia from sham-operated controls, gastric bypass with and 
without vagal preservation (each n=6). Blood was collected into EDTA-rinsed tubes 
and, immediately centrifuged at 3000 rpm for 10 min at 4°C. The supernatant was 
stored at -80°C until further analysis. Concentrations of active GLP-1 and PYY were 
analyzed using a rat endocrine lincoplex kit (RENDO-85K, Labodia SA, Yens, 
Switzerland). 
 
Measurement of size of the gastrojejunostomy 
 
To exclude that the differences in body weight between bypass rats were due to 
different levels of restriction and subsequent differences in food intake, sizes of the 
gastro-jejunostomy were measured during necropsy in all gastric bypass rats of 
study 3.  
 
CRP analysis 
 
Blood was obtained from all animals of study 3 by puncture of a sublingual vein 
under brief isoflurane anesthesia. Blood was collected into EDTA-rinsed tubes and 
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immediately centrifuged at 3000 rpm for 10 min at 4°C. Plasma was stored at -80°C 
before analysis for C-reactive protein (Abbott, UK) to assess inflammation.  
 
Faecal analysis 
 
To evaluate nutrient malabsorption, faeces were collected over 24-hours on 
postoperative days 15 and 59 from all animals in study 3. Faeces were dried in an 
oven and weighed; calorie content was measured using a ballistic bomb calorimeter 
(Jackson et al. 1977). 
 
Statistics 
 
All data were normally distributed and are expressed as mean  SEM. Student’s t-
test for independent samples and one-way ANOVA with repeated measures and 
post-hoc Bonferroni test for each time point were used to test for significant 
differences. P < 0.05 was considered significant. 
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Results 
 
Mortality 
 
Overall surgical mortality was 13.4% (11/82). Gastric bypass-related mortality was 
14.5% (8/55), while mortality after sham-operation was 11.1% (3/27, p=0.67). There 
was no mortality difference between bypass rats with complete ligation and with 
preservation of the para-esophageal bundle. All eight bypass rats showed signs of 
respiratory distress along with hypersalivation and dysphagia within the first two 
postoperative days after the operation and were euthanized immediately after onset 
of symptoms. Necropsy revealed that these symptoms originated at the level of the 
gastro-jejunostomy where food did not pass through and was retained in the 
oesophagus. Whether this was due to inflammatory swelling following anastomotic 
leakage or due to anastomotic constriction remains unclear.  The three sham-
operated rats died without prior noticeable symptoms. Necropsy revealed in two 
cases a small bowel ileus presumably due to a volvulus after inappropriate 
repositioning of the viscera into the abdominal cavity at the end of the operation. In 
one case a leak at the site of the gastrotomy was found.  
     
Energy intake 
 
In study 1 there was no difference in average daily energy intake between gastric 
bypass rats and sham-operated rats over a period of 60 days (sham: 97.4±2.5 kcal 
vs. bypass: 89.3±4.7 kcal, p=0.30). In contrast, gastric bypass rats of study 2 ate 
significantly less than the sham-operated rats (sham: 76.7±2.2 kcal vs. bypass 
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52.5±4.8 kcal, p<0.001). In study 3, there was no difference in average energy intake 
between bypass rats without vagal preservation and sham-operated rats over a 
period of 75 days, while bypass rats with vagal preservation ate significantly less 
than sham-operated rats and rats without vagal preservation (sham: 118.7±3.9 kcal 
vs. Bypass with vagal preservation: 84.4±3.3 kcal vs. Bypass without vagal 
preservation: 102.8±7.5 kcal, p<0.001). The average daily energy intake is shown for 
all three groups in figure 3. 
 
Figure 3: Average daily energy intake during study 1 (A) over 60 days for sham-operated ad libitum 
fed rats (n=7, white column) and for gastric bypass rats (n=14, black column). Average daily energy 
intake during study 2 (B) over 60 days for sham-operated ad libitum fed rats (n=8, white column) and 
for gastric bypass rats (n=8, black column). Average daily energy intake of study 3 (C) over 75 days 
for sham-operated ad libitum fed rats (n=10, white column) and for gastric bypass rats with vagal 
preservation (n=11, dark grey) or without vagal preservation (n=10, light grey). All data are shown as 
mean values ± SEM. Post-hoc differences between the three groups are indicated (*** = p<0.001 and 
* = p<0.05). 
 
Body weight 
 
In all three studies gastric bypass rats had a significant lower body weight than 
sham-operated rats from day 5 after surgery throughout the rest of the observation 
period. After a short period of post surgical weight loss, sham-operated rats in all 
three studies constantly gained weight for the rest of the study. In study 1 gastric 
bypass rats started to regain weight around postoperative day 25 and there was no 
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difference between their body weight before surgery and after surgery at the end of 
the observation period (day 0: 457.0±7.4 g vs. day 60: 468.0±9.3 g, p=0.36). In study 
2, gastric bypass animals lost about 20% of their preoperative weight by 
postoperative day 25 and their body weight then plateaued around 260 g (day 0: 
330.8±5.8 g vs. day 60: 259.1±16.3 g, p=0.001). In study 3, there was no difference 
in body weight between bypass rats without vagal preservation and bypass rats with 
vagal preservation until postoperative day 40 (day 40: bypass with vagal 
preservation: 408.3±11.2 g vs. bypass without vagal preservation: 414.4±11.2 g, 
p=0.70). However, thereafter bypass rats without vagal preservation started to regain 
weight for the rest of the observation period, while bypass rats with preserved vagal 
fibres maintained their low body weight (day 75: bypass with selective ligation: 
365.8±14.6 g vs. bypass with complete ligation: 468.0±9.3 g, p<0.001). The 
development of body weight after surgery is shown for all groups in figures 4.  
 
Figure 4: Body weight change in study 1 (A) for the gastric bypass (-o-) (n=14) and sham-operated 
rats (-■-)(n=7), in study 2 (B) for the gastric bypass (-o-) (n=8) and sham-operated rats (-■-)(n=8) and 
in study 3 (C) for the gastric bypass rats without vagal preservation (-o-) (n=10) and gastric bypass 
rats with vagal preservation (-●-) (n=11) and sham-operated rats (-■-)(n=10). Data are shown as 
mean values ± SEM (* = p<0.05 for sham vs. bypass; # = p<0.05 for bypass without vagal 
preservation vs. bypass with vagal preservation). 
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Postprandial plasma levels of PYY and active GLP-1 
 
One-way ANOVA revealed significant differences for levels of PYY and active GLP-1 
after gastric bypass with and without vagal preservation in comparison to sham-
operated controls of study 3 (PYY: sham: 29.5±7.1 pg/ml vs. bypass with vagal 
preservation: 70.4±8.8 pg/ml vs. bypass without vagal preservation: 83.2±14.3 pg/ml, 
p<0.01; GLP-1:  sham: 85.8±2.1 pg/ml vs. bypass with vagal preservation: 
146.9±23.7 pg/ml vs. bypass without vagal preservation: 155.4±24.1 pg/ml, p<0.05). 
However, post-hoc Bonferroni testing showed no significant difference for PYY and 
GLP-1 levels between gastric bypass rats with or without vagal preservation (figure 
5).  
 
Figure 5: Levels of active GLP-1 (A) and PYY (B) for sham-operated ad libitum fed rats (n=6, white 
column) and for gastric bypass rats with vagal preservation (n=6, dark grey) or without vagal 
preservation (n=6, light grey). Data are shown as mean values ± SEM. Post-hoc differences between 
the three groups are indicated (** = p<0.01 and * = p<0.05). 
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Size of the gastro-jejunostomy 
 
There was no gastrogastric fistula in any of the gastric bypass rats of study 3. The 
overall size of the gastro-jejunostomy in all gastric bypass rats was 15.4±0.4 mm. 
There was no difference in size of the anastomosis between rats in which the 
complete para-esophageal bundle was ligated and rats in which the left gastric 
vessels were separated and selectively ligated (bypass with selective ligation: 
15.2±0.4 mm vs. 15.6±0.7 mm, p=0.69).  
 
CRP analysis 
 
C-reactive protein levels were below 2mg/L in all animals of study 3 indicating that 
there was no postsurgical infection or inflammation 28 days after surgery. 
 
Faecal analysis 
 
There was no increase in either fresh faecal mass (sham: 8.4±0.5 g vs. Bypass with 
vagal preservation: 7.5±0.6 g vs. Bypass without vagal preservation: 7.2±0.6 g, 
p=0.31) or faecal calorie content (sham: 3.56±0.04 kcal vs. Bypass with vagal 
preservation: 3.43±0.05 kcal vs. Bypass without vagal preservation: 3.65±0.06 kcal, 
p=0.24) in the gastric bypass animals compared to the sham-operated rats in study 
3.  
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Discussion 
 
In this study body weight and food intake after gastric bypass were related to 
whether the vagal fibres within the para-oesophageal bundle were preserved or not 
while there were no differences in levels of GLP-1 and PYY between these two 
groups. This finding highlights the important role of the vagal nerve for mediating the 
inhibitory effects of gut hormones such as PYY and GLP-1 on food intake and body 
weight after gastric bypass surgery in rats. It is further supported by previous reports 
describing that ablation of the vagal-brainstem-hypothalamic pathway attenuates the 
inhibitory effects of PYY and GLP-1 on food intake (Abbott et al. 2005). This is an 
important observation as only a few reports examined whether vagal preservation is 
effective or necessary in weight control after bariatric surgery (Perathoner, Weiss, 
Santner, Brandacher, Laimer, Holler, Aigner, & Klaus 2009;Sundbom, Holdstock, 
Engstrom, & Karlsson 2007;Wang & Liu 2009).  
The size of the gastric pouch and the lengths of the different limbs used in this study 
have been proven to effectively induce weight loss (Bueter et al. 2009c). An 
increasing body of evidence in humans indicates that up to certain limits the size of 
the gastric pouch and length of the different limbs is of less importance for the 
outcome of gastric bypass (Muller et al. 2008). In support of this observation, I 
demonstrated that the level of restriction measured by the size of the gastro-
jejunostomy has no impact on different levels of weight loss and food intake after 
gastric bypass in rats.  
In conclusion, my gastric bypass technique induces reliable weight loss in rats with 
an acceptable mortality. I propose that vagal nerve fibres should be preserved during 
gastric bypass in rats. Restriction at the gastro-jejunal anastomosis does not seem to 
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be critical for the weight loss. Although the mechanisms have not yet been fully 
elucidated, vagal preservation may play an important role in inducing and 
maintaining weight loss after gastric bypass in humans and rats.  
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Chapter 3: Changes in energy expenditure after Roux-en-Y Gastric 
Bypass in rats 
 
Introduction  
 
One of the proposed mechanisms for reduced food intake after bypass surgery is the 
secretory stimulus to L-cells in the distal gut, resulting in increased levels of 
gastrointestinal satiation hormones such as peptide YY (PYY) and peptides of the 
enteroglucagon family (Borg, le Roux, Ghatei, Bloom, Patel, & Aylwin 2006;Korner et 
al. 2005;le Roux, Welbourn, Werling, Osborne, Kokkinos, Laurenius, Lonroth, 
Fandriks, Ghatei, Bloom, & Olbers 2007;Nadreau et al. 2006;Rubino 2008). These 
hormones stimulate anorectic pathways in the hypothalamus and brainstem leading 
to reduced food intake (Murphy and Bloom 2006) and may also influence energy 
expenditure (Badman and Flier 2005).  
Gastric bypass surgery has been successfully modeled in rat experiments. The body 
weight loss after gastric bypass in rats is not only due to decreased food intake, as 
sham-operated pair-fed controls weigh more than gastric bypass rats (Guijarro et al. 
2008;le Roux, Aylwin, Batterham, Borg, Coyle, Prasad, Shurey, Ghatei, Patel, & 
Bloom 2006a;Nadreau, Baraboi, Samson, Blouin, Hould, Marceau, Biron, & Richard 
2006;Sclafani et al. 1978;Sclafani 1987). Possible explanations such as 
malabsorption and inflammation have been excluded (le Roux, Aylwin, Batterham, 
Borg, Coyle, Prasad, Shurey, Ghatei, Patel, & Bloom 2006a), thus the weight 
difference despite similar food intake raises the possibility of enhanced energy 
expenditure (le Roux, Aylwin, Batterham, Borg, Coyle, Prasad, Shurey, Ghatei, 
Patel, & Bloom 2006a) as previously speculated (de Castro et al. 2008;Furnes et al. 
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2008). I therefore tested the hypothesis that energy expenditure would be higher 
after bypass surgery.  
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Material and Methods 
 
Animals and housing 
 
Thirty adult diet-induced obese male Wistar rats weighing 480 – 500 g were used for 
energy expenditure experiments, and sixteen adult male Wistar rats weighing 330-
350 g were used for morphometric gut analysis. All animals were individually housed 
under artificial 12 hour / 12 hour light-dark cycle and at a room temperature of 
21±2ºC unless otherwise stated. Water and standard chow were available ad libitum. 
All experiments were approved by the Veterinary Office of the Canton Zurich, 
Switzerland.  Experiments were performed at the Institute of Veterinary Physiology 
and Zürich Centre for Integrative Human Physiology, Vetsuisse Faculty University of 
Zurich in Zurich, Switzerland.  
 
Surgery 
 
Surgery was performed according to an established protocol with preservation of the 
vagal fibres in the para-oesophageal bundle as previously described (page 35).  
 
Indirect calorimetry 
 
Rats were individually housed in Plexiglas air-tight metabolic cages (41x41x31 cm) 
on a layer of wood shavings under the same light and temperature conditions as 
described above. Water and standard powder chow (GLP3433, Provimi Kliba Ag, 
Switzerland) were available ad libitum, unless otherwise stated. Food intake and 
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water intake were measured continuously. Physical activity was monitored by a 3-
dimensional array of infrared light beams and sensors. Thus, the activity data 
provided represent a relative measure of locomotor activity of the rats. The activity 
data do not relate to an absolute measurement of distance moved or to a spatial 
position. Measurements were conducted in an open circuit calorimetry system 
(AccuScan Inc., USA) (Wielinga et al. 2007). Energy expenditure was calculated for 
each 2 min sample according to Weir (WEIR 1949) using the following equitation: 
total energy expenditure (kcal/h) = 3.9xV(O2)L/h+1.1xV(CO2)L/h. The respiratory 
quotient was defined as the quotient of CO2 production and O2 consumption. 
 
Experimental design 
 
The thirty diet-induced obese rats used in the energy expenditure experiments were 
randomized to gastric bypass (n=14) or sham operation (n=16). After a recovery 
period of 7 days sham-operated animals were randomly divided into two groups of 8 
rats each: shams with no dietary manipulation (ad libitum fed shams weighing  
488.8±3.9 g) and food-restricted shams whose postoperative weight was matched to 
the weight of bypass animals (body weight-matched shams weighing 474.34.2 g). 
Starting on day 7 after gastric bypass surgery, the body weight-matched shams 
received as much food daily as was necessary for them to maintain a similar body 
weight to the bypass rats. Based on experiences from previous studies, rats were 
given 10 g of standard chow in the beginning of food restriction. This amount of food 
was offered at dark onset and readjusted every third day depending on the body 
weight. Sixteen metabolic cages were used and measurements were conducted in 
the following order on three consecutive days: bypass (n=8) vs. sham ad libitum fed 
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(n=8) (40 days after surgery) and bypass (n=6) vs. shams body weight-matched 
(n=8) (75 days after surgery). Diet-induced thermogenesis was measured in rats that 
were fasted for 12 hour from the beginning of the light cycle and received a 5 g meal 
at subsequent dark onset. Diet-induced thermogenesis was calculated as the 
cumulative increase in energy expenditure after a 5 g test meal compared to fasting 
values before the test meal (expressed as percentage of the energy content of the 
test meal: 17.6 kcal).   
 
Faecal analysis 
 
To evaluate nutrient absorption, faeces were collected over 24 h on postoperative 
days 15 and 59 from all animals. Faeces were dried in an oven and weighed; calorie 
content was measured using a ballistic bomb calorimeter (Jackson, Davis, & 
Macdonald 1977). 
 
Blood analysis 
 
Blood was obtained by puncture of a sublingual vein under brief isoflurane 
anesthesia on postoperative day 80. Approximately 200 μl blood was collected into 
EDTA-rinsed tubes and immediately centrifuged at 3000 rpm for 10 min at 4°C. 
Plasma was stored at -80°C before analysis. Measurements of C-reactive protein 
(Abbott, UK) were made to assess inflammation. 
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Measurement of Body composition 
 
Adipose tissue mass was measured using a rodent CT scanner (Latheta, Aloka, 
Japan). Rats were anesthetized with isoflurane and the area between vertebrae L1 
and L5 was scanned using an X-ray source tube voltage of 50 kV, current of 1 mA, 
pitch size of 2 mm, and a speed of 4.5 sec per image (roughly 25 images per rat). 
Aloka© software was used to estimate volumes of adipose tissue and non-adipose 
tissue using differences in X-ray density. Adipose tissue weights were computed 
using the density factor of 0.92 g/cm3. Scanning was undertaken seventy days after 
surgery. 
 
Gut morphometry 
 
For the study of gut morphometry 16 male Wistar rats were randomized to gastric 
bypass (n=8) or sham operation (n=8). All rats were ad libitum fed throughout the 
complete observation period of 60 days. Rats were fasted for 24 hours before being 
killed to ensure the small bowel was free of chow residue. The entire small bowel 
from the duodenum to the ileocaecal valve was collected. Total wet weight and 
length of the small bowel were measured in the sham-operated rats, whilst in gastric 
bypass rats the weight and length of the three limbs (alimentary, biliopancreatic and 
common channel) were measured separately and then added.  
For analysis of gut morphometry, two centimeter segments of the alimentary, 
biliopancreatic limb and common channel from bypass operated rats and 
corresponding segments of jejunum, duodenum, and ileum of sham-operated rats 
were opened on the mesenteric border and fixed overnight at 4°C in Zamboni’s 
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fixative (2% paraformaldehyde, 15% picric acid, pH 7.4). Transverse segments from 
each segment were incubated in 20% sucrose in phosphate-buffered saline (PBS) 
overnight at 4°C and then embedded in OCT compound. Sections of intestine (12 
μm) were cut on a cryostat, thaw-mounted onto slides coated with poly-D-lysine and 
stored at −20°C until use. Sections were then processed for hematoxylin and eosin 
staining. Sections were washed 3 times at 10 minute intervals in PBS containing 
0.1% Triton X-100 and then rinsed in distilled water. Sections were immersed in 
Ehrlich’s Alum Hematoxylin for 4 minutes and then rinsed in distilled water. Sections 
were then dipped 2-3 times in 0.5% acid alcohol and rinsed in distilled water. 
Sections were soaked in Scott’s Blueing for 30 seconds before being rinsed in 
distilled water for 30 seconds. Next, the sections were dipped once in Eosin Y acid 
washed stain and again rinsed in distilled water. Slides were then coverslipped with 
bicarbonate-buffered glycerol and sections were examined for morphometric 
analysis. Muscle thickness (circular + longitudinal muscle), mucosal height (villus 
height + crypt depth), villus height and crypt depth were measured in well-orientated 
sections under a Zeiss Axioplan microscope fitted with an eyepiece graticule by an 
observer blinded to the group. Three measurements per tissue were taken and an 
average was obtained. 
 
Statistical analysis 
 
All data were normally distributed and are expressed as mean  SEM. Student’s t-
test for independent samples and one-way ANOVA with repeated measures and 
post-hoc Bonferroni test for each time point were used to test for significant 
differences. P<0.05 was considered significant. For all analyses data from the two 
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gastric bypass groups were pooled, because data did not differ between the two time 
points (day 40 and day 75 after surgery). 
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Results 
 
Body weight 
 
Figure 6 shows the body weight changes for both groups. For the energy 
expenditure experiments (figure 6a), body weight was significantly lower in gastric 
bypass rats compared to the sham-operated ad libitum fed group from day 5 after 
surgery. On postoperative day 70, the difference in weight was almost 200 g (sham 
ad lib: 603.2±6.6 g vs. bypass: 414.3±13.8 g, p<0.001). After a short period of post 
surgical weight loss, shams ad libitum fed constantly gained weight for the rest of the 
study. In contrast, gastric bypass animals lost 11.2±1.4% of their preoperative weight 
by postoperative day 10; body weight then plateaued around 415 g.  
Food restriction started one week after surgery for the body weight-matched shams 
(n=8). There was no significant difference in body weight between the gastric bypass 
group and the food restricted body weight-matched rats on and after day 55 (sham 
body weight-matched: 412.2±3.0 g vs. bypass: 408.7±9.4 g, p=0.78).  
There was no increase in either fresh faecal mass (sham ad lib: 8.4±0.5 g vs. sham 
body weight-matched: 6.6±0.6 g vs. bypass: 7.3±0.4 g, p=n.s.) or faecal calorie 
content (sham ad lib: 3.56±0.04 kcal/g vs. sham body weight-matched: 3.51±0.04 
kcal/g vs. bypass: 3.65 ± 0.04 kcal/g, p=n.s.) in the gastric bypass animals compared 
to the control groups. C-reactive protein levels were below the detection limit of the 
assay (<2mg/L) in all animals suggesting no postsurgical infection or inflammation 28 
days after surgery.   
In the gut morphometry experiments, body weight was significantly lower in gastric 
bypass rats compared to the sham-operated group from day 5 after surgery (figure 
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6b); sham-operated rats gained weight for the rest of the study, while gastric bypass 
animals lost 15.4±1.1% of their preoperative weight by postoperative day 10 and 
then plateaued around 260 g. The difference in body weight on day 60 was 164 g 
(sham ad lib: 423.6±10.2 g vs. bypass: 259.1±16.3 g, p<0.001).  
 
 
Figure 6: Body weight change for the gastric bypass (-o-) (n=14) and sham-operated rats ad libitum 
fed (-■-)(n=8) and sham-operated body weight-matched (-●-)(n=8) used for energy expenditure 
measurements (a) and for gastric bypass (-o-) (n=8) and sham- operated rats ad libitum fed (-■-)(n=8) 
used for gut morphometry analysis (b). Data are shown as mean values ± SEM. 
 
Body Composition 
 
Adipose tissue mass between vertebrae L1 and L5 in gastric bypass was lower than 
in sham-operated ad libitum fed rats, but similar to body weight-matched shams 
(sham ad lib: 27.6±2.7 g vs. sham body weight-matched: 5.3±0.9 g vs. bypass: 
11.6±1.3 g, p<0.001). Non-adipose tissue in gastric bypass was lower than in sham 
ad libitum fed rats, but higher than in body weight-matched shams (sham ad lib: 
107.1±2.9 g vs. sham body weight-matched: 71.0±1.1 g vs. bypass: 80.9±2.4 g, 
p<0.001).  
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Food intake outside metabolic cages 
 
Food intake followed similar patterns as body weight. Figure 7a shows the average 
daily food intake for rats of the energy expenditure experiments (postoperative day 
1-70). Daily food intake was consistently lower after gastric bypass (sham ad lib: 
34.0±1.2 g vs. bypass: 27.5±0.8 g, p<0.001). Body weight-matched shams required 
significantly less food than gastric bypass animals to maintain the same level of body 
weight (sham body weight-matched: 16.2±0.5 g vs. bypass: 27.5±0.8 g, p<0.001). 
Gastric bypass rats used for the analysis of gut morphometry also ate significantly 
less than their sham-operated counterparts (sham: 32.5±0.4 g vs. bypass: 26.0±0.5 
g, p<0.001).  
 
Food intake in metabolic cages 
 
Meal patterns were different between the three groups in the energy expenditure 
experiment. In the dark phase gastric bypass and sham-operated ad libitum fed rats 
ate more than in the light phase. Dark phase food intake in gastric bypass rats was 
lower than in sham ad libitum fed rats (sham ad lib: 26.6±1.1 g vs. bypass: 17.0±1.5 
g, p<0.001), while they ate more during the light phase (sham ad lib: 2.7±0.5 g vs. 
bypass: 4.5±0.7 g, p<0.05, Figure 7b). Sham-operated body weight-matched rats 
consumed all their food during the first half of the dark phase and are therefore not 
represented in figure 7b. 
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 Figure 7: (A) Average daily food intake over 70 days for sham-operated ad libitum fed rats (n=8, 
white column), for sham-operated body weight-matched rats (n=8, grey column) and for gastric 
bypass rats (n=14, black column). Data are shown as mean values ± SEM (*** = p<0.001). (B) 
Average food intake during dark and light phase for sham-operated ad libitum fed (n=8, white 
columns) and gastric bypass rats (n=8, black columns). Data are shown as mean values ± SEM (* = 
p<0.05, *** = p<0.001).  
 
Energy Expenditure   
 
Twenty four hour energy expenditure was increased after gastric bypass compared 
to sham-operated ad libitum fed rats and sham-operated body weight-matched 
controls (sham ad lib: 4.29±0.08 kcal/kg/h vs. sham body weight-matched: 3.98±0.10 
kcal/kg/h vs. bypass: 4.50±0.04 kcal/kg/h, p<0.001). Sham body weight-matched rats 
had lower total energy expenditure than sham-operated ad libitum fed rats (p<0.05). 
When analyzing the two phases of the light dark-cycle separately, it was obvious that 
during the light phase, when overall activity is typically low, energy expenditure in 
gastric bypass rats was significantly higher than in sham-operated ad libitum fed 
animals and body weight-matched shams (sham ad lib: 3.63±0.04 kcal/kg/h vs. 
sham body weight-matched: 3.42±0.05 kcal/kg/h vs. bypass: 4.12±0.03 kcal/kg/h, 
p<0.001). In the dark phase, when overall activity is typically higher, there was no 
59 
 
difference in energy expenditure between gastric bypass and sham-operated ad 
libitum fed rats, but energy expenditure in bypass rats was higher than in body 
weight-matched shams (sham ad lib: 4.81±0.06 kcal/kg/h vs. sham body weight-
matched: 4.46±0.15 kcal/kg/h vs. bypass: 4.81±0.04 kcal/kg/h, p<0.01). Figure 8a 
shows average 24 hour, light phase and dark phase energy expenditure for all 
groups.    
 
 
Figure 8: Differences in maintenance energy expenditure (A), respiratory quotients (B), average body
temperature (C), activity (D) and diet-induced thermogenesis (E) for sham-operated ad libitum fed 
 
(n=8, white columns), for sham-operated body weight-matched (n=8, grey columns) and for gastric 
bypass rats (n=14, black columns). While data for energy expenditure, body temperature and activity 
are shown during 24 hour, the light and dark phase, respiratory quotients are shown during 12 hour 
fasting and within the first six hours after a 5g test meal. Data for diet-induced thermogenesis are 
expressed as a percentage of the energy content of a 5g test meal and shown at 1h, 2h and 3h after 
re-feeding with the test meal after a 12 hour fasting period. All data are shown as mean values ± SEM 
(* = p<0.05, ** = p<0.01, *** = p<0.001). 
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Respiratory Quotient 
 
Respiratory quotients were examined during 12 hours of fasting and for the 
subsequent 6 hours after offering a fixed test meal of 5 g. Respiratory Quotients as 
measured during the light and dark phase are shown in Figure 8b. During fasting 
gastric bypass rats had a lower respiratory quotient than sham-operated ad libitum 
fed rats, but there was no difference to sham-operated body weight-matched rats. 
The pattern was similar for the 0-3 hour observation period after the test meal for 
gastric bypass, sham ad libitum fed and sham body weight-matched rats (sham ad 
lib: 0.89±0.01 vs. sham body weight-matched: 0.78±0.01 vs. bypass: 0.77±0.01, 
p<0.001) and the 3–6 hour observation period after the test meal (sham ad lib: 
0.95±0.01 vs. sham body weight-matched 0.73±0.01 vs. bypass: 0.74±0.01, 
p<0.001). Respiratory quotient between gastric bypass and sham body weight-
matched rats was not different during fasting or the six hours after the test meal.   
 
Body Temperature  
 
Body temperature as measured during the light and dark phase is shown in Figure 
8c. Body temperature in gastric bypass rats was lower than in sham-operated ad 
libitum fed rats, but higher compared to body weight-matched sham rats during the 
light phase (sham ad lib: 36.8±0.02°C vs. sham body weight-matched: 36.3±0.06°C 
vs. bypass: 36.5±0.03°C, p<0.001). During the dark phase, average body 
temperature in gastric bypass rats was lower than in sham-operated ad libitum fed 
rats, but no different compared to body weight-matched sham rats (sham ad lib: 
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37.7±0.02°C vs. sham body weight-matched: 37.3±0.09°C vs. bypass: 37.3±0.03°C, 
p<0.001).  
 
Physical activity 
 
A dissociation between total energy expenditure and body temperature was 
observed and thus, physical activity was analyzed (Figure 8d). No difference in 
activity over 24 hour or during the light phase was seen among all three groups. 
During the dark phase, however, gastric bypass rats were less active than sham-
operated ad libitum fed rats and sham-operated body weight-matched rats (sham ad 
lib: 7.19±0.4 activity counts vs. sham body weight-matched: 6.70±0.8 activity counts 
vs. bypass: 5.04±0.2 activity counts, p<0.001).  
 
Diet-Induced Thermogenesis   
 
Diet-induced thermogenesis was measured over three hours after a 5 g standard 
test meal after a 12h fast. The sham-operated ad libitum fed and the sham-operated 
body weight-matched groups consumed all 5 g within 20 minutes, the gastric bypass 
animals required 30 minutes. Figure 8e shows the diet-induced thermogenesis for all 
groups for the first three hours after the test meal. Three hours after the 5 g test 
meal, gastric bypass rats had a significantly greater diet-induced thermogenesis than 
the body weight-matched controls, but bypass was not different from the sham-
operated ad libitum fed rats (sham ad lib: 5.2±4.4% vs. sham-body weight-matched: 
0.41±1.9% vs. bypass: 10.5±2.0%, p<0.05). 
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Gut morphometry 
 
Differences in gut morphometry are summarized in figure 9. There was no difference 
in total length of the complete small bowel between sham-operated and gastric 
bypass rats (sham ad lib: 108.6±1.7 cm vs. bypass: 110±2.2 cm, p=0.82). In 
contrast, the wet weight of the small bowel was 72.1% higher after gastric bypass 
than after sham-operations (sham ad lib: 12.2±0.6 g vs. bypass: 21.0±1.2 g, 
p<0.001). Average weight of the alimentary limb was 10.6±0.8 g, of the 
biliopancreatic limb 2.7±0.2 g and of the common channel 7.8±0.6 g.  Muscle 
thickness (sham ad lib: 95.0±8.7 µm vs. bypass: 247.9±32.5 µm, p<0.001), mucosal 
height (sham ad lib: 530.8±19.1 µm vs. bypass: 969±58.2 µm, p<0.001), villus height 
(sham ad lib: 390.4±21.7 µm vs. bypass: 673.6±63.8 µm, p<0.001) and crypt depth 
(sham ad lib: 140.4±8.0 µm vs. bypass: 295.4±20.6 µm, p<0.001) were significantly 
increased in the alimentary limb after gastric bypass in comparison to the 
corresponding section of the jejunum of the sham-operated controls. Gastric bypass 
rats had a significantly greater villus height of the common channel than sham-
operated animals (sham ad lib: 287.1±18.1 µm vs. bypass: 464.6±73.9 µm, p<0.05). 
There was a trend towards an increase in mucosal height (sham ad lib: 490.4±29.6 
µm vs. bypass: 673.8±99.7 µm, p=0.09) and muscle thickness (sham ad lib: 
490.4±29.6 µm vs. bypass: 673.8±99.8 µm, p=0.09) in the common channel.    
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 Figure 9: Length (A) and weight (B) of the entire small bowel and differences in gut morphometry in 
rats 60 days after gastric bypass (n=8) and sham operation (n=8). Differences in muscle thickness 
(C), mucosal height (D), villus height (E) and crypt depth (F) are shown for the alimentary limb, the 
biliopancreatic limb and the common channel after gastric bypass in comparison to the corresponding 
parts of jejunum, duodenum and ileum after sham-operation. Data are shown as mean values ± SEM 
(*** = p<0.001, * = p<0.05).     
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Discussion 
 
I demonstrate a higher total energy expenditure in rats after gastric bypass 
compared to ad libitum fed and body weight-matched sham groups which is in 
accordance with some, but not all previous reports of energy expenditure in humans 
(Carrasco et al. 2007;Das et al. 2003;Flancbaum et al. 1997).   Differences in energy 
expenditure were mainly due to changes during the light phase when physical 
activity is typically low. Gastric bypass surgery did not only prevent the expected 
decrease in energy expenditure subsequent to body weight loss, but actually 
increased 24 hour and in particular light phase energy expenditure in comparison to 
the control groups.  
My data suggest that gastric bypass induces profound changes in food intake, 
energy expenditure and the mechanisms by which the body controls energy 
expenditure. Gastric bypass increases postprandial levels of PYY and GLP-1 
(Korner, Bessler, Cirilo, Conwell, Daud, Restuccia, & Wardlaw 2005;le Roux, Aylwin, 
Batterham, Borg, Coyle, Prasad, Shurey, Ghatei, Patel, & Bloom 2006a), which are 
satiating inducing gut hormones and hence favour an anorectic state and facilitate 
body weight loss through modulation of the hypothalamus and brainstem (Abbott, 
Monteiro, Small, Sajedi, Smith, Parkinson, Ghatei, & Bloom 2005;Larsen et al. 
1997), also being involved in the control of energy expenditure (Murphy & Bloom 
2006). In fact, PYY has been shown to activate anorectic POMC expressing neurons 
in the ARC (Batterham et al. 2002) and to inhibit NPY neurons (cuna-Goycolea and 
van den Pol 2005), suggesting a potential to increase energy expenditure.   
In summary, not only did gastric bypass surgery prevent the expected decrease in 
energy expenditure subsequent to body weight loss in this diet-induced obese rat 
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model, but 24 hour and in particular light phase energy expenditure were higher than 
in sham controls. Diet-induced thermogenesis was also higher after gastric bypass 
surgery compared to body weight-matched controls. Increased energy expenditure 
may offer an additional explanation why gastric bypass surgery is superior to dieting 
for successfully maintaining long-term body weight loss.  
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Chapter 4: Sodium and water handling after Roux-en-Y Gastric Bypass 
in rats 
 
Introduction 
 
Hypertension is associated with central adiposity and insulin resistance (Chen et al. 
2009;Kannel et al. 1967;Stamler et al. 1978), but the pathophysiological mechanism 
remains unclear. There are several plausible hypotheses, including insulin resistance 
(DeFronzo et al. 1975;Natali et al. 1993), aldosterone and so-called aldosterone 
releasing factors (Connell and Davies 2005;Laragh 2001), as well as 
hyperleptinemia (Galletti et al. 2008;Rahmouni et al. 2005), leading to sodium 
retention, increased blood volume and finally elevated blood pressure. Alternatively, 
it has been suggested that increased aldosterone levels might be secondary to 
increased intra-abdominal pressure (Sugerman et al. 1997;Sugerman et al. 1998). A 
proposed mechanism is that increased intra-abdominal pressure raises the 
diaphragm, which increases pleural pressure, decreasing venous return to the heart. 
Increased intra-abdominal pressure would also increase inferior vena cava pressure, 
resulting in increased renal venous pressure and a decrease renal perfusion. Both 
mechanisms would activate the renin-angiotensin-aldosterone system, leading to 
increased renal sodium and water retention (Sugerman, Windsor, Bessos, & Wolfe 
1997;Sugerman, Windsor, Bessos, Kellum, Reines, & DeMaria 1998). However, 
reduction of visceral fat mass and decrease in sympathetic nerve activity and/or 
sodium retention do not occur immediately after gastric bypass surgery, and they do 
not explain the early reductions in blood pressure reported by Ahmed at al (Ahmed 
et al. 2008). Therefore, I hypothesized that renal sodium and water handling may be 
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altered by bypass surgery, and that this might contribute to the early improvement in 
blood pressure control that occurs.  
Thus, the aim in this study was to evaluate water intake, urine output, and renal 
sodium excretion in rats before and shortly after gastric bypass surgery in response 
to an acute oral sodium challenge. 
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Material and Methods 
 
Animals 
 
Twenty one male wistar rats (body weight 348±19g) were randomized to have either 
a gastric bypass (n=14) or sham operation (n=7). The work was performed under UK 
Home Office licence (PL 70-5569), and all animals were kept in identical 
environmental conditions (temperature 24ºC, humidity 60%, light cycle 7.00 – 19.00) 
with normal chow (RM1 diet, Special Diet Services Ltd, UK) and tap water ad libitum 
unless otherwise stated. Body weight was measured daily.  
 
Metabolic cage experiments 
 
Urine output, water intake and sodium excretion were measured at three different 
time points. Firstly, before surgery and following a previous oral sodium load; 
secondly, after surgery, but without an oral sodium load (baseline measurements); 
thirdly, after surgery and following an oral sodium load. Prior to each experiment, 
animals were maintained on a low sodium diet and given deionized water ad libitum 
for one week to establish a stable urinary excretion rate for sodium, and to enhance 
endogenous mechanisms for sodium retention (Mu et al. 1995). The low sodium diet 
was identical to normal chow, except for its sodium content (D02051701, Research 
Diets Inc., New Brunswick, NJ, USA; sodium content 102.6 ppm). For measurements 
after an oral sodium load, sodium (1.5 mmol Na/ kg body weight) was given 
intragastrically by oral gavage over 10s as hyperosmolar NaCl solution (616 mM) at 
the beginning of the light phase (7.00 am). Animals were then placed in individual 
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metabolic cages for urine collection, and to record water intake over 8 hours. For 
baseline measurements animals were placed in metabolic cages without having 
received oral sodium load. In all experiments urine was collected in pre-weighed 
plastic tubes. Water was given in pre-weighed plastic bottles that were also re-
weighed at the end of the experiment.  The cages were cleaned and rinsed with 
deionized water after each experiment. 
 
Surgery 
 
Surgery was performed according to an established protocol with preservation of the 
vagal fibres in the para-oesophageal bundle as previously described (page 35).  
 
Measurement of urinary sodium  
 
Urine sodium concentration was measured by Integrated Chip Technology (ICT) 
using the Architect ci16200  (Abbott, Illinois, USA). It obtains millivolt readings, and 
then converts them to assay-specific analyte conversion units. The measurement of 
ICT reference solution and ICT samples are used to calculate the assay results.  
 
Statistical analysis 
 
Data is presented as mean ± SEM. Data were compared with the use of 2-tailed, 
paired Student t tests (Graphpad Prism, USA). P<0.05 was considered significant. 
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Results 
 
Body weight  
 
Body weight was significantly lower in gastric bypass rats compared to the sham-
operated group from day 5 after surgery (sham: 349.9 ± 6.1 g vs. bypass: 313.6 ± 
6.4 g, p<0.01); sham-operated rats gained weight for the rest of the study. The 
difference in body weight on day 60 was 165 g (sham: 501 ± 8 g vs. bypass: 346 ± 
21 g, p<0.001). Figure 10 shows the percentage of initial body weight for all bypass 
(n=14) and sham-operated rats (n=7).  
 
 
Figure 10: Body weight change in gastric bypass (-o-) (n=14) and sham-operated rats (-■-) (n=7). 
Data are shown as mean values ± SEM (* = p<0.05).  
 
Urine output (volume) 
 
In gastric bypass rats, sodium loading after surgery led to a greater increase in urine 
output when compared with urine output following the same sodium load before 
surgery (pre-op: 0.015 ± 0.002 ml/g body weight vs. post-op: 0.034 ± 0.007 ml/g 
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body weight, p= 0.03). There was no change in urine output in the sham-operated 
group after the sodium load when compared with their pre-operative response after 
sodium loading (pre-op: 0.011 ± 0.001 ml/g body weight vs. post-op: 0.010 ± 0.002 
ml/g body weight, p= 0.44). Gastric bypass rats produced significantly more urine 
than sham-operated rats after sodium loading (sham: 0.010 ± 0.002 vs. bypass: 
0.034 ± 0.007 ml/g body weight, p= 0.04). There was no difference in baseline urine 
production between these groups after surgery (sham: 0.011 ± 0.001 ml/g body 
weight vs. bypass: 0.015 ± 0.002 ml/g body weight, p= 0.12). Figure 11 summarizes 
data for urine output.  
 
 
Figure 11: Urine production of bypass-operated (black columns, n=14) and sham-operated rats 
(white columns, n=7) after oral sodium loading (1.5 mmol Na/ kg body weight of a 616 mM NaCl 
solution) pre-operatively and on post-operative day 30. Baseline urine output was measured without 
oral sodium loading. Data are shown as mean values ± SEM. p>0.05 was considered significant (*). 
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Water intake 
 
Data for water intake are summarized in Figure 12. Gastric bypass rats consumed 
significantly more water after the sodium load compared with before surgery (pre-op: 
0.033 ± 0.006 ml/g body weight vs. postop: 0.065 ± 0.012 ml/g body weight, p= 
0.02). No changes were observed for water intake pre- and post-sham surgery after 
the sodium load (pre-op: 0.029 ± 0.006 ml/g body weight vs. post-op: 0.021 ± 0.002 
ml/g body weight, p=0.31). Bypass rats also drank significantly more water than 
sham-operated rats (sham: 0.021 ± 0.002 ml/g body weight vs. bypass: 0.065 ± 
0.012 ml/g body weight, p= 0.02) after the sodium load. There was no difference in 
baseline water intake between the groups (sham: 0.029 ± 0.006 ml/g body weight vs. 
bypass: 0.033 ± 0.006 ml/g body weight, p=0.68).  
 
 
Figure 12: Water intake of bypass-operated (black columns, n=14) and sham-operated rats (white 
columns, n=7) after oral sodium loading (1.5 mmol Na/ kg body weight of a 616 mM NaCl solution) 
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pre-operatively and on post-operative day 30. Baseline water intake was measured without oral 
sodium loading. Data are shown as mean values ± SEM. p>0.05 was considered significant (*). 
 
 
Sodium excretion 
 
Post-operative sodium loading led to a greater increase in cumulative sodium 
excretion in the gastric bypass rats compared with their pre-operative response (pre-
op: 31.7 ± 8.7 µmol vs. post-op: 65.9 ± 10.7 µmol, p= 0.02). No changes in sodium 
excretion were observed pre- or post-sham surgery after oral salt loading (pre-op: 
40.9 ± 16.0 µmol vs. post-op: 36.2 ± 10.7 µmol, p= 0.81). Gastric bypass rats had a 
greater sodium excretion in bypass rats compared with their sham-operated 
counterparts after salt loading (sham: 36.2 ± 10.7 µmol vs. bypass: 80.9 ± 14.4 µmol, 
p=0.03). There was no significant difference between baseline sodium excretion 
between gastric bypass rats and sham-operated rats (sham: 40.9 ± 16.0 µmol vs. 
bypass: 31.7 ± 8.7 µmol, p= 0.59).  Data are summarized in Figure 13.  
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 Figure 13: Cumulative sodium excretion of bypass-operated (black columns, n=14) and sham-
operated rats (white columns, n=7) after oral sodium loading (1.5 mmol Na/ kg body weight of a 616 
mM NaCl solution) preoperatively and on postoperative day 30. Baseline sodium excretion was 
measured without oral sodium loading. Data are shown as mean values ± SEM. p>0.05 was 
considered significant (*). 
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Discussion 
 
The beneficial effect of gastric bypass surgery on arterial hypertension is well 
documented (Adams et al. 2007;Buchwald 2005). The reduction of visceral fat mass, 
and subsequent decrease in sympathetic activation and sodium retention, is not 
immediate and does not explain the early reduction in blood pressure observed after 
gastric bypass described by Ahmed at al (Ahmed, Rickards, Coniglio, Xia, Johnson, 
Boss, & O'Malley 2008). Thus, I reasoned that other mechanisms might be involved 
in the early resolution of hypertension after gastric bypass, and that alteration of 
renal sodium and water handling could be one of them.  
I have demonstrated a significant increase in urine output, water intake and sodium 
excretion after gastric bypass surgery compared with pre-operative measurements. 
Sham-operated animals show no changes in water intake, urine production or 
sodium excretion after surgery.  
My data suggest that gastric bypass induces profound changes in sodium and water 
handling. As gastric bypass significantly rearranges the gastrointestinal anatomy, I 
suggest that gastrointestinal and central neuroendocrine signaling contribute to 
increased sodium and water excretion (Lowell and Spiegelman 2000). Potential 
mediators between the gut and the kidney include both, Peptide YY (PYY) (Playford 
et al. 1995) and glucagon-like peptide (GLP)-1, which have been shown to have 
diuretic and natriuretic properties (Michell et al. 2008). Thus, it is reasonable to 
speculate that GLP-1 and PYY could mediate a link between the gastrointestinal 
tract and kidney in terms of sodium and water excretion (Gutzwiller et al. 
2004;Gutzwiller et al. 2006;Michell, Debnam, & Unwin 2008). 
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In conclusion, gastric bypass surgery in humans, and in the rat, provides us with a 
valuable model in which to explore the role of the gastrointestinal tract in sodium and 
water homeostasis, and other electrolytes, and perhaps also in salt-sensitive 
hypertension.  
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Chapter 5: Analysis of Fat Preference after Roux-en-Y Gastric Bypass in 
humans  
 
Introduction 
 
Patients reach satiety earlier after gastric bypass surgery (Brolin, Robertson, Kenler, 
& Cody 1994;Brown, Settle, & Van Rij 1982;Halmi, Mason, Falk, & Stunkard 1981) 
and report a reduced desire to consume fatty food as they no longer found it 
enjoyable (Brolin, Robertson, Kenler, & Cody 1994;Brown, Settle, & Van Rij 
1982;Halmi, Mason, Falk, & Stunkard 1981). Total fat intake is lower after gastric 
bypass partly because of a reported disinterest in desserts and ice cream (Brolin, 
Robertson, Kenler, & Cody 1994;Brown, Settle, & Van Rij 1982). A randomised 
controlled trial comparing gastric bypass and vertical-banded gastroplasty confirmed 
a reduced intake of high fat foods one year after gastric bypass (Olbers et al. 2005).  
In this study, we tested how gastric bypass changes fat preference and intake of fat 
in humans. We used data from a randomised controlled trial between gastric bypass 
and vertical-banded gastroplasty (Olbers, Fagevik-Olsen, Maleckas, & Lonroth 2005) 
to establish the importance of the phenomenon in humans. It was the aim of this 
study to evaluate human patients six years after being randomised to gastric bypass 
or vertical-banded gastroplasty.  
78 
 
Material and Methods 
 
In this study, 16 patients (11 female) were included from a prospective clinical trial 
which randomized patients to gastric bypass and vertical-banded gastroplasty during 
2000-2001 (Olbers, Fagevik-Olsen, Maleckas, & Lonroth 2005). I was involved in the 
design and analysis of this study. Between 12/2006 and 06/2007, nine gastric 
bypass and seven vertical-banded gastroplasty patients were included at an average 
of six years after surgery (range 5.8-6.8 years). The study protocol was approved by 
the local ethics committee (Reference number 359-09) and the study was conducted 
according to the principles of the Helsinki declaration.  
 
Both operations were performed laparoscopically as described previously (Olbers, 
Fagevik-Olsen, Maleckas, & Lonroth 2005). The validated Swedish Obese Subjects 
study questionnaire was used for dietary assessment (Lindroos et al. 1993). The 
questionnaires included 49 questions on ordinary food consumption patterns during 
the past 3 months, with the emphasis on portion size and day of week. Amounts of 
snacks and sweets were quantified using sizes for preconfectioned packages as sold 
in Sweden. Bread-type, thickness, and contents of sandwiches were described in 
detail, owing to the large contribution of sandwiches in the Swedish diet. The 
amounts of food reported by the subjects were converted into grams, from which 
daily intake of energy and 29 different nutrients were computed. In addition, a short 
questionnaire was used to explore whether the patient avoided certain foods. 
Included were direct questions (e.g., Do you eat whole meat?) and an open question 
(e.g., Do you avoid eating any foods? Why?). 
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Results 
 
Gastric bypass patients and vertical gastroplasty patients reduced their body mass 
index by 26.5±2.9 % and 17.8±2.5 % respectively six years after surgery. There 
were however no statistically significant changes in reported energy intake six years 
after surgery (preop: gastroplasty: 3050.0±354.5 kcal vs. bypass: 2552.3±219.5 kcal, 
p=0.26 and postop: gastroplasty 2854.6±258.4 kcal vs. bypass:  2322.9±183.6 kcal, 
p=0.11). Proportions of total energy intake from protein, fat, and carbohydrates six 
years after surgery are shown in Figure 14A. Bypass patients reported lower 
proportion of calories ingested as fat compared to patients after vertical-banded 
gastroplasty (p=0.046). There was no difference in the proportion of calories from 
carbohydrates (p=0.09) or proteins (p=0.48) as compared with vertical-banded 
gastroplasty patients. As shown in Figure 14B, gastroplasty patients reported a 
higher proportion of their total energy intake from foods high in fat, e.g. cheese and 
sausages (p=0.041) and desserts (p=0.007) than bypass patients, who instead 
reported a higher relative intake from fruits and vegetables (p=0.004).   
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Figure 14: The proportion of total energy intake from protein, fat, and carbohydrates (A) and from 
various food groups (B) 6 years after laparoscopic gastric bypass (black columns) and laparoscopic 
vertical-banded gastroplasty (white columns). Data are shown as mean values ± SEM (* = p<0.05, ** 
= p<0.01). 
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Discussion 
 
Patients randomised to gastric bypass six years earlier decreased their liking for fat 
compared to pre surgery, but the same is not the case after vertical-banded 
gastroplasty. This long-term reduction in dietary fat following gastric bypass was 
found to be the single most pronounced differing factor in the dietary composition 
between the two groups six years after the operation. As part of general lifestyle 
advice (Blundell and MacDiarmid 1997) to achieve adequate and sustained weight 
loss a reduction in total energy intake by reducing dietary fat is recommended.  
My findings add to previous reports in humans which have shown a reduced dietary 
fat intake one year after gastric bypass surgery (Olbers, Bjorkman, Lindroos, 
Maleckas, Lonn, Sjostrom, & Lonroth 2006). Interestingly, the reduced preference for 
fat was absent or at least less pronounced in patients six years after vertical-banded 
gastroplasty in which the anatomical rearrangement of the small bowel is not part of 
the operation and which is known not to induce changes in postprandial gut hormone 
levels (Valverde et al. 2005). Thus, changes in fat preference might be at least partly 
mediated by alterations in gastrointestinal and central neuroendocrine signalling 
(Korner, Bessler, Cirilo, Conwell, Daud, Restuccia, & Wardlaw 2005;le Roux, Aylwin, 
Batterham, Borg, Coyle, Prasad, Shurey, Ghatei, Patel, & Bloom 2006a;Stylopoulos, 
Hoppin, & Kaplan 2009). Indeed, gastric bypass increases postprandial levels of 
PYY and GLP-1 (Korner, Bessler, Cirilo, Conwell, Daud, Restuccia, & Wardlaw 
2005;le Roux, Aylwin, Batterham, Borg, Coyle, Prasad, Shurey, Ghatei, Patel, & 
Bloom 2006a), which are satiating inducing gut hormones and hence favour an 
anorectic state and facilitate body weight loss through modulation of the 
hypothalamus and brainstem (Abbott, Monteiro, Small, Sajedi, Smith, Parkinson, 
82 
 
Ghatei, & Bloom 2005;Larsen, Tang-Christensen, & Jessop 1997), In addition, GLP-
1 or PYY may also influence fatty acid detection or perception and there may be 
parallels with the recognition of sweet stimuli. Mice lacking the GLP-1 receptor show 
decreased behavioural responsiveness to sucrose.  This receptor has been shown to 
be expressed on taste afferent fibers, and GLP-1 is expressed in taste buds cells 
(Feng et al. 2008;Shin, Martin, Golden, Dotson, Maudsley, Kim, Jang, Mattson, 
Drucker, Egan, & Munger 2008).  
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Chapter 6: Analysis of Fat Preference after Roux-en-Y Gastric Bypass in 
rats  
 
Introduction 
 
A limitation of human studies investigating changes in fat preference after gastric 
bypass surgery includes the use of survey or scaling. Complementary use of an 
animal model can add new insights as it circumvents some of the problems of verbal 
report that may interfere with the assessment of the actual “affective” value of the 
stimulus. As food preference is influenced by taste, the gustatory system is a prime 
candidate to explain the effects outlined above.  
In this study, I tested how gastric bypass changes fat preference and intake of fat in 
rats. I used my rat model to assess fat preference because it allows greater latitude 
in behavioural, endocrine, and molecular measurements while providing a logical 
bridge with reports of changes in human taste preference following surgery. Thus, 
the aims of this study were to use a rat model to further investigate the underlying 
mechanisms of : a) preference for solid high fat versus low fat chow, b) preference 
for increasing fat concentrations in a liquid preparation early and late after gastric 
bypass, c) licking responses to increasing fat concentrations in a liquid preparation in 
a brief access test that minimises postingestive consequences and d) whether 
reduced preference for fat may be due to induction of conditioned taste aversion 
perhaps mediated through increased endogenous levels of GLP-1. 
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Material and Methods 
 
Animals 
 
Obese male Wistar rats were individually housed under a 12 hour /12 hour light-dark 
cycle at a room temperature of 21±2 ºC. Water and standard chow were available ad 
libitum, unless otherwise stated.  All experiments were performed under a license 
issued by the Home Office UK (PL70-6669) or approved by the Veterinary Office of 
the Canton Zurich, Switzerland.  
 
Surgery  
 
After 1 week of acclimatization, the obese rats were randomized to gastric bypass or 
sham operation. Surgery was performed according to an established protocol with 
preservation of the vagal fibres in the para-oesophageal bundle as previously 
described (page 35).  
 
Hormone assay 
 
Rats used in the late two bottle preference test were fasted for 12 hours from the 
beginning of the light cycle. At the onset of the dark cycle animals were offered 5g of 
standard chow all of which was consumed within half an hour by the animals. Blood 
was then obtained by puncture of a sublingual vein under brief isoflurane anesthesia 
from sham-operated controls (n=9) and gastric bypass rats (n=9). Blood was 
collected into EDTA-rinsed tubes and immediately centrifuged at 3000 rpm for 10 
min at 4°C. The supernatant was stored at -80°C until further analysis. 
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Concentrations of active GLP-1 and PYY were analyzed using a rat endocrine 
lincoplex kit (RENDO-85K, Labodia SA, Yens, Switzerland). 
 
Food preference  
 
A food preference test was presurgically conducted with 26 obese male Wistar rats. 
Food was offered in three equal compartments which were filled with 30 g of the 
following three food choices:  60% fat diet (Research Diets, D12492, energy content: 
23.9 kilojoule per gram (kJ/g)), a 60% fat diet with added Bisto® (gravy type flavour) 
and normal chow with 2% fat (RM1 diet, Special Diet Services Ltd, UK, 14.7 kJ/g). 
Bisto® was added to one section of the high fat chow for the rats to differentiate it 
from the other high fat chow in the next section. The three diet options thus 
contained three distinct flavours and two different calorie densities. Food intake was 
recorded after 24-hour intervals over two days by weighing the food at the end of the 
dark cycle. Rats were then randomised to bypass (n=13) or sham operations (n=13) 
for baseline measurements; the effect of surgery on high fat versus low fat intake 
was tested about ten days after surgery in the same animals.  
 
Two bottle preference test  
 
Intralipid® (Fresenius Kabi, UK) is a fat emulsion used for parenteral nutrition in 
malnourished patients. The emulsion consists of soy bean oil, egg phospholipids, 
glycerin, omega-6 essential fatty acids, alpha-linoleic acid and linolenic acid. We 
diluted the standard 20% Intralipid® solution with distilled water to provide seven 
concentrations (0.005%, 0.01%, 0.05%, 0.1%, 0.5%, 1%, 5%) for this study.  
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The obese rats were presented with two pre-weighed bottles, one of which contained 
distilled water and the other of which contained Intralipid® solution in ascending 
concentrations. The volume of the bottles containing distilled water or Intralipid® was 
made up to 200 ml every day. Readings were recorded at the start of the light phase 
by re-weighing the bottles. The positions of the bottles were switched each day to 
preclude the development of a side preference. To control for spillage during the 
manipulation of the bottles, two additional bottles were placed in cages without 
animals, and daily measurements were obtained. The average amount of spillage 
(0.69±0.04 ml) was subtracted from measured volumes of distilled water and 
Intralipid® intake before further analysis.  
 
Each animal was tested for 14 days (7 x 2-day periods). Intralipid® preference for 
each 24-h period was defined as: [Intake of Intralipid (in ml)  ⁄  Total Fluid Intake (ml)] 
x 100.  With this type of preference experiment, a score of 50% conventionally 
represents neutrality, equality of preference, indifference, or inability to distinguish; 
0% to 49% indicates rejection, aversion, or refusal; and 51% to 100% represents 
varying degrees of preference and avidity.   
 
Two bottle preference tests were performed early after surgery (10 days) and late 
after surgery (200 days). In the early experiment 10 days after surgery, three groups 
of fat taste naive rats were used. Twelve sham-operated controls, eighteen gastric 
bypass rats and six unoperated controls were subjected to the two bottle preference 
test as described above. Preference (%), acceptance (Intralipid® intake in ml), food 
(chow) intake (g) and total energy intake (Intralipid plus chow; kJ) were measured 
daily. In the late experiment 200 days after surgery, ten sham-operated controls and 
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ten gastric bypass rats were subjected to the same two bottle preference test as 
described above.  
 
Brief Access Tests  
 
Sixteen obese male Wistar rats aged 10 weeks that were naive to the taste of 
Intralipid® were tested in a lickometer (Davis MS-160, DiLog Instruments, 
Tallahassee, FL) after being randomized to sham- or gastric bypass operation (each 
n=8). The brief access test procedure was conducted as previously described (Smith 
2001).  Briefly, a rat was placed in the test chamber of the apparatus. A motorized 
shutter opened allowing the rat access to a single sipper tube containing Intralipid®. 
A small fan, positioned above the sample slot directed a current of air past the 
drinking spout to minimize potential olfactory cues from the Intralipid®. Rats initiated 
a trial by licking the spout. Each trial was 10 s, followed by a 7.5-s intertrial interval 
during which time the tube was changed via a motorized block for the next trial. A 
concentration-response/ licking function was derived in three test sessions of 30 
minutes each during which rats were able to initiate as many trials as possible. The 
briefness of the test as suggested by its name minimises any postingestive effects of 
the substance tested as only small amounts are ingested. Before being tested for 
Intralipid® all rats underwent 4 days of water training as described previously 
(Spector & Glendinning 2009). The same seven Intralipid® concentrations as in the 
two bottle preference tests (0.005%, 0.01%, 0.05%, 0.1%, 0.5%, 1%, 5%) as well as 
distilled water were used and presented in randomized order (without replacement) 
in blocks of trials. Rats were tested on a 23-h restricted water-access schedule as 
88 
 
well as with water available ad libitum for three daily sessions every other day in two 
subsequent weeks. 
Conditioned taste aversion for corn oil 
 
Fat taste naive obese male Wistar rats were used. Sixteen gastric bypass and 22 
sham-operated rats were individually housed for one week with ad libitum access to 
food and water before they underwent the conditioned taste aversion experiment. 
Rats were slightly sedated by brief exposure to isoflurane before the oral gavage 
with corn oil or saline. The five groups included gastric bypass rats receiving saline 
(n=8), gastric bypass rats receiving corn oil (n=8), sham-operated rats receiving 
saline (n=8), sham-operated rats receiving corn oil (n=8) and sham-operated rats 
receiving intraperitoneal lithium chloride as a positive control (i.p. LiCl, 76.2 mg/kg 
body weight) (n=6). Lithium chloride has been previously shown to induce visceral 
malaise when injected intraperitoneally and is therefore commonly used as an 
illness-inducing control in a conditioned taste aversion paradigm (Gu et al. 
1993;Lamprecht and Dudai 1995;Yamamoto et al. 1992). 
At the beginning of the experiment water was withdrawn from all animals at the start 
of the dark phase (day 0). In order to acclimatise rats to weighing and timing of 
distilled water presentation, animals were presented with two water bottles (volume 
100 ml) at the onset of the light phase from day one until day four for 30-min and four 
hours later for another 45-min period. At the end of presentation, water bottles and 
rats were weighed. Individual water consumption from each bottle was measured for 
each rat every day. On day 5 each rat was given 30 min access to the conditioned 
stimulus (novel flavour of 0.3% solution of saccharine sodium salt hydrate) contained 
in both bottles at the onset of the light phase. Immediately following the access to 
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that novel flavour, rats were weighed and received either an oral gavage of 1 ml corn 
oil, 1 ml sterile isotonic saline or an intraperitoneal injection of LiCl. The small volume 
of 1ml for oral gavage was chosen to minimize potential side effects by the 
administered volume per se, considering the altered anatomy of the stomach in 
gastric bypass rats. Rats were offered water four hours after light onset for a 45-min 
period. 
 
The same protocol was repeated on day 8 and day 11. On all other days rats were 
given access to water for 30 min at the onset of the light phase and four hours later 
for another 45 min as described above (wash-out period). On day 14 each rat was 
presented with two bottles, one containing water and the other containing 0.3% 
saccharine solution in counterbalanced fashion and the respective consumption was 
measured for 30 minutes at light onset.  
 
Conditioned taste aversion against GLP-1 receptor agonist exendin-4 
 
Unoperated obese rats (400±15 g) received one hour daily access to water for 7 
days to ensure stable fluid intake during the one hour period. On day 8, rats were 
given one hour access to a novel flavour of 0.3% solution of saccharine sodium salt 
hydrate solution (rather than water) followed immediately by treatment. As positive 
control for the formation of a conditioned taste aversion, one group of rats (n=7) was 
given 76.2 mg/kg lithium chloride intraperitoneally. Another group (n=7) received 
intraperitoneal sterile isotonic saline as control. To test the ability of exendin-4 to 
induce a conditioned taste aversion, another group of rats (n=7) received 2 µg/kg 
body weight exendin-4 intraperitoneally. To serve as further control for the anorexic 
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effects of exendin-4, another group of seven rats received intraperitoneal amylin 
(20µg/kg). This dose of amylin produces a similar reduction in one hour food intake 
tests as exendin-4, but amylin does not induce conditioned taste aversion (Lutz et al. 
1995;Mack et al. 2007a). 
 
All groups consumed similar amounts of saccharin solution (12-13 ml) during the one 
hour access prior to the various treatments. After 2 intervening days of one hour 
access to water, rats were tested for the acquisition of a conditioned taste aversion. 
In a two-bottle intake test, rats were first given 5 seconds access to water and 
saccharin separately (in counterbalanced order) to ensure that each rat sampled 
both solutions. The rats were then simultaneously presented with water and 
saccharin for one hour. The same test was repeated on the following day. 
 
Tissue dopamine assay 
 
Sixty days after surgery and after one week of ad libitum access to normal chow 
(RM1 diet, Special Diet Services Ltd, UK), nine gastric bypass rats and six sham-
operated controls were briefly anesthetized with 4% isofluorane and then 
decapitated. Brains were removed, snap-frozen and immediately stored at -80°C.  
For further analysis, a three mm portion of the striatum was measured by utilizing a 
flexible measuring tape and then dissected. The caudate nucleus, putamen and 
nucleus accumbens were extracted from the striatum section by using tailored hole 
punches referring to exact coordinates according to the Paxinos rat brain atlas. The 
individual tissue samples were then weighed and placed in ice-cold phosphate buffer 
solution (PBS) and homogenized. All homegenates were split into two equal 
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portions, with one half of each treated with 0.2 M perchloric acid (1:10, w/v) 
containing ascorbic acid (0.2 μM) and EDTA (0.2 μM), to precipitate cell debris. 
These were centrifuged at 9000 × g for 15 minutes at 4°C, supernatants passed 
through a syringe filter (10 μm pore size) and whole tissue dopamine levels 
estimated using HPLC with electrochemical detection (Biggs et al. 1992). Dopamine 
peak areas were converted to dopamine amounts using an external standard 
method and expressed as amount of dopamine in picograms (pgs) per gram of 
striatal cortical tissue. 
  
Statistical analysis 
 
All data were normally distributed and expressed as mean  SEM. Student’s t-test 
for independent samples was used to test for significant differences. Preference, 
acceptance, food intake and energy intake in the two bottle preference tests were 
analyzed with a two-way group (between subjects) x concentration (within subjects) 
analysis of variance (ANOVA). A one-way ANOVA followed by Bonferroni post hoc 
tests for each concentration was applied when there was a significant group x 
concentration interaction. In the brief access test, the mean number of licks at each 
concentration per trial was collapsed across the three test sessions. For each rat, the 
mean number of licks to water was subtracted from the mean number of licks at 
each concentration, yielding a Licks-to-Intralipid® / Licks-to-Water value. This 
measure has also been successfully used in previous studies (Jiang et al. 
2008;Spector et al. 1996b) to produce concentration-response curves that are 
relative to a water baseline. The lick response (adjusted for water) for each 
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concentration of a stimulus was compared using ANOVAs. The statistical rejection 
criterion of 0.05 was used for all analyses. 
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Results 
 
Food preference  
 
Average body weight of the obese rats before surgery was 385±7.8 g. After a short 
period of post surgical weight loss, body weight increased in sham-operated rats to 
427.8±12.1 g on postoperative day 10 and it increased further for the rest of the 
observation period. In contrast, gastric bypass animals lost 13.8±3.0% of their 
preoperative weight by postoperative day 10 (318.7±8.2 g); body weight then leveled 
off around 320 g. Figure 15 shows intake of the three types of diet before and after 
surgery. There was no difference in total 48 hour energy intake before and after 
sham-operation (1277±115 kJ vs. 1318±102 kJ, p=0.35); gastric bypass rats 
significantly reduced their 48h energy intake after surgery (1297±92 kJ vs. 813±202 
kJ, p<0.001). Sham-operated rats consumed similar proportions of the three food 
choices before and after surgery (high fat: 609±82 kJ before vs. 621±89 kJ after 
surgery, p=0.72; high fat plus Bisto®: 633±91 kJ vs. 658±93 kJ, p=0.48; normal 
chow: 36±27 g vs. 39±26 kJ, p=0.75). Gastric bypass rats significantly reduced their 
energy intake of the two high fat diets (high fat: 607.4±62.1 kJ vs. 344±89 kJ, 
p<0.001; high fat plus Bisto®: 649±105 kJ vs. 352±108 kJ, p<0.001), while they 
significantly increased their intake of the normal chow (normal chow: 41±26 kJ vs. 
117±63 kJ, p<0.001). In view of the 40% reduction of total energy intake after 
surgery, gastric bypass increased normal chow intake from 3.2±2.1 % to 14.0±6.6 % 
(p<0.001) of total energy intake.   
94 
 
 Figure 15: Energy (kJ) from 60% high fat (HF) diet, of 60% HF diet plus Bisto® (gravy type flavour) 
and normal chow (LF) in gastric bypass rats (n=13) and sham-operated rats (n=13) before and after 
surgery over a 48 hour period. Data are shown as mean values ± SEM (*** = p<0.001: total energy 
intake preoperative vs. postoperative after gastric bypass). 
  
Two bottle preference test  
 
Body weight 
 
The average presurgical body weight of the obese rats used for the early weight 
stabilisation phase experiment was 368.3±2.0 g. Ten days after surgery the sham-
operated controls weighed 403.5±6.4 g and the gastric bypass rats weighed 
352.8±6.4 g (p<0.001). The average presurgical body weight of the rats used for the 
late weight stabilisation phase was 476.8±4.1 g; body weight 200 days after surgery 
increased to 712.5±10.8 g in the sham-operated rats and was 455.9±14.3 g in the 
gastric bypass rats (p<0.001). Figure 16 shows the body weight changes for both 
groups.  
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 Figure 16: Body weight change for the gastric bypass (-o-) and sham-operated rats ad libitum fed (-■-
) used for the two bottle preference test in the early phase (A) and in the late phase (B) after surgery. 
Data are shown as mean values ± SEM. 
 
 
Postprandial plasma levels of PYY and active GLP-1 
 
Gastric bypass rats had significantly higher plasma active GLP-1 and PYY levels 
compared to sham-operated controls measured 30 minutes after the 5g test meal 
(Figure 17).  
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 Figure 17: PYY- and GLP-1 level for the gastric bypass (n=9, black) and sham-operated rats ad 
libitum fed (n=10, white used for the two bottle preference test in the late phase after surgery. Data 
are shown as mean values ± SEM (*** = p<0.001). 
 
 
Preference 
 
Two-way ANOVA revealed a significant main effect of Intralipid® concentration 
(F(6,482)=33.3; p<0.001), but not of surgical group (F(2,482)=2.11; p=0.12). 
However, the group x concentration interaction was also significant (F(12,482)=4.48; 
p<0.001). Ten days after surgery both unoperated and sham-operated rats showed a 
similar increase in preference (Intralipid versus total intake) for Intralipid® at 
concentrations above 0.1%. In contrast, gastric bypass rats did not show a clear 
preference for the Intralipid® solutions (Figure 18A, 0.5% Intralipid®: unoperated: 
92.8±0.9 % vs. sham: 82.4±3.8 % vs. bypass: 66.5±5.5 %, p<0.01; 1% Intralipid®: 
unoperated: 96.2±0.6 % vs. sham: 90.7±2.8 % vs. bypass: 74.1±4.5 %, p<0.01; 5% 
Intralipid®: unoperated: 96.4±0.5 % vs. sham: 92.8±1.7 % vs. bypass: 63.2±5.5 %, 
p<0.001).  
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Observations were similar in the late phase of weight stabilisation study. The two-
way ANOVA showed a significant main effect of Intralipid® concentration 
(F(6,266)=7.73; p<0.001), but not of surgical group (F(1,266)=2.80; p=0.12), while 
the group x concentration interaction was also significant (F(6,266)=9.93; p<0.001). 
On postoperative day 200 sham-operated rats had a higher preference for Intralipid® 
concentrations above 0.1%, while gastric bypass rats showed no preference for 
Intralipid® (Figure 19A). 
 
Acceptance 
 
A significant main effect of Intralipid® concentration (F(6,482)=90.17; p<0.001) and of 
surgical group (F(2,482)=107.0; p<0.001) was found in the two-way ANOVA. The 
group x concentration interaction was also significant (F(12,482)=21.35; p<0.001). 
During the early weight stabilisation phase unoperated rats and sham-operated rats 
showed increased acceptance of Intralipid® intake (in ml) at concentrations above 
0.1%, whilst acceptance did not increase in gastric bypass rats with higher 
concentrations (Figure 18B, 0.5% Intralipid®: unoperated: 83.8±8.6 ml vs. sham: 
58.2±4.6 ml vs. bypass: 28.1±2.9 ml, p<0.001; 1% Intralipid®: unoperated: 96.3±10.6 
ml vs. sham: 60.2±6.1 ml vs. bypass: 30.0±2.4 ml, p<0.001; 5% Intralipid®: 
unoperated: 112.9±10.5 ml vs. sham: 81.5±7.7 ml vs. bypass: 21.5±2.0 ml, p<0.001). 
In the late phase of weight stabilisation two-way ANOVA revealed a significant main 
effect of Intralipid® concentration (F(6,266)=36.31; p<0.001) and of surgical group 
(F(1,266)=158.89; p<0.001). The interaction was also significant (F(6,266)=41.60; 
p<0.001). Gastric bypass rats also had a lower acceptance for Intralipid® 
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concentrations above 0.1 % compared to their sham-operated counterparts (Figure 
19B). 
 
Food intake 
 
Two-way ANOVA revealed a significant main effect of surgical group (F(2,482)=9.45; 
p<0.001), but not of Intralipid® concentration (F(6,482)=1.34; p=0.24). There was no 
group x concentration interaction (F(12,482)=0.88; p=0.56). Average daily food 
intake for all three groups of the early weight stabilisation phase throughout the two 
bottle experiment was 29.3±0.3 g for unoperated rats, 31.3±0.3 g for sham-operated 
rats and 29.9±0.3 g for gastric bypass rats (p<0.001). In this group, food intake did 
not change with increasing Intralipid® concentrations throughout the two bottle 
experiment (Figure 18C). In the late phase of weight stabilisation, the main effects of 
Intralipid® concentration (F(6,266)=4.91; p<0.001) and of surgical group 
(F(1,266)=30.89; p<0.001) were significant in the two-way ANOVA. However, there 
was no significant group x concentration interaction (F(6,266)=0.43; p=0.85). Gastric 
bypass rats ate significantly less per day than the sham-operated controls 
throughout the two bottle experiment (sham: 34.0±1.2 g vs. bypass: 27.5±0.8 g, 
p<0.001). As seen during the early phase experiment, food intake did not change 
with increasing Intralipid® concentrations (Figure 19C).    
 
Calorie intake 
 
Total calorie intake was the sum of calories consumed as food (14.74 kJ/g) and 
Intralipid® (energy content of the standard 20% solution: 42.0 kJ/ml). There was a 
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significant main effect of Intralipid® concentration (F(6,482)=24.75; p<0.001), but not 
of surgical group (F(2,482)=1.04; p=0.3549) in the two-way ANOVA. The group x 
concentration interaction was also significant (F(12,482)=5.94; p<0.001). During the 
early weight stabilisation phase both unoperated and sham-operated rats increased 
their calorie intake when exposed to the 5% Intralipid® solution, but gastric bypass 
rats did not (Figure 18D, unoperated: 668.1±28.1 kJ vs. sham: 633.0±16.5 kJ vs. 
bypass: 507.1±12.2 kJ, p<0.001). During the late weight stabilisation phase, the 
main effects of Intralipid® concentration (F(6,266)=5.79; p<0.001) and of surgical 
group (F(1,266)=75.53; p<0.001) were significant in the two-way ANOVA. The group 
x concentration interaction was also significant (F(6,266)=5.91; p<0.001).  Sham-
operated rats increased their energy intake when exposed to the 0.5%, 1% and 5% 
Intralipid® solutions compared to gastric bypass rats, which showed no increase in 
energy intake even with the highest Intralipid® concentration (5%) (Figure 19D, 0.5% 
Intralipid®: sham: 400.5±11.3 kJ vs. bypass: 326.0±14.9 kJ, p<0.001, 1% Intralipid®: 
sham: 419.8±8.6 kJ vs. bypass: 356.3±17.2 kJ, p<0.01, 5% Intralipid®: sham: 
478.1±12.2 kJ vs. bypass: 321.4±13.9 kJ, p<0.001). 
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 Figure 18: Two bottle preference test in gastric bypass rats (n=18, -O-), in sham-operated rats (n=12, 
-■-) and unoperated rats (n=6, -X-) during the early weight stabilisation phase; Seven Intralipid® 
concentrations were used in ascending order: 0.005%, 0.01%, 0.05%, 0.1%, 0.5%, 1%, 5%; A 
Preference; B Acceptance; C Food intake; D Total calorie intake. Data are shown as mean values ± 
SEM (** = p<0.01, *** = p<0.001 using one-way ANOVA for concentration to concentration analysis 
between all three groups indicate difference between gastric bypass rats from sham and unoperated 
rats). X-axes are displayed on a log10 scale. 
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 Figure 19: Two bottle preference test in gastric bypass (n=10, -O-) and sham-operated rats (n=10, -■-
) during the late weight stabilisation phase (postoperative day 200); Seven Intralipid® concentrations 
were used in ascending order: 0.005%, 0.01%, 0.05%, 0.1%, 0.5%, 1%, 5%; A Preference; B 
Acceptance; C Food intake; D Total calorie intake. Data are shown as mean values ± SEM (** = 
p<0.01, *** = p<0.001 using one-way ANOVA for concentration to concentration analysis between the 
two groups indicate difference between gastric bypass rats and sham-operated rats). X-axes are 
displayed on a log10 scale. 
 
Brief Access Tests 
 
Body weight 
 
The average presurgical body weight of the obese rats used for the brief access test 
was 434±6 g. From postoperative day 5 the sham-operated controls weighed 
significantly more compared to the gastric bypass rats (postop day 5: sham: 430±8 g 
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vs. bypass: 377±7 g, p<0.001). Body weight changes for both groups are shown in 
figure 20A. 
 
Licking response 
 
Two-way ANOVA revealed no significant difference between the licking response of 
sham-operated and gastric bypass operated rats after surgery with or without water 
restriction. When water was available ad libitum prior to the test, there was a 
significant main effect of Intralipid® concentration (F(6,54)=15.16; p<0.001), but not 
of surgical group (F(1,54)=1.52; p=0.25) in the two-way ANOVA. The group x 
concentration interaction was also not significant (F(6,54)=1.20; p=0.32). When 
water was restricted, there was a significant main effect of Intralipid® concentration 
(F(6,60)=5.16; p<0.001), but not of surgical group (F(1,60)=0.00; p=0.99) in the two-
way ANOVA. The group x concentration interaction was also not significant 
(F(6,60)=0.61; p=0.72). The Intralipid® concentration-response functions (i.e. the 
number of licks to Intralipid adjusted to water baseline) for the two test conditions are 
shown in figure 20B and C.  
 
Number of trials  
 
Two-way ANOVA revealed no differences between gastric bypass rats and sham-
operated controls in the absolute number of trails initiated to the Intralipid® 
concentrations with or without water restriction. When water was available ad libitum 
prior to the test, there was a significant main effect of Intralipid® concentration 
(F(6,54)=5.85; p<0.001), but not of surgical group (F(1,54)=4.86; p=0.055) in the 
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two-way ANOVA. The group x concentration interaction was also not significant 
(F(6,54)=2.04; p=0.076). When water was restricted, there was a significant main 
effect of Intralipid® concentration (F(6,60)=6.08; p<0.001), but not of surgical group 
(F(1,60)=0.41; p=0.54) in the two-way ANOVA. The group x concentration interaction 
was also not significant (F(6,60)=1.73; p=0.13). The number of initiated trials for 
each Intralipid® concentration during the two test conditions is shown in figure 20D 
and E.  
 
 
 
Figure 20: Body weight changes for the gastric bypass (n=8, -o-) and sham-operated rats ad libitum 
fed (n=8, -■-) used for the brief access test (A). Postoperative Intralipid® concentration-response 
functions relative to a water baseline are shown without (B) and with 23h water restriction (C). The 
absolute number of initiated trials for each Intralipid® concentration are shown without (D) and with 
(E) water restriction. Data are shown as mean values ± SEM (*** = p<0.001). X-axes are displayed on 
a log10 scale. 
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Conditioned taste aversion for corn oil 
 
Mean saccharine and water intake were significantly different between all groups 
(p<0.001). There was no difference in saccharine intake between sham-operated 
rats that were exposed to gavage with sterile isotonic saline or corn oil on the final 
test day (saline: 13.8±1.5 ml vs. corn oil: 10.1±1.8 ml, p=0.13); both groups showed 
a significantly higher saccharine intake when compared to water intake (saline 
gavage: saccharine: 13.8±1.5 ml vs. water: 1.0±0.5 ml, p<0.001 and corn oil gavage: 
saccharine: 10.1±1.8 ml vs. water: 1.2±0.6 ml, p<0.001). Saccharine intake of sham-
operated rats was significantly reduced after intraperitoneal injection of the positive 
control LiCl when compared to rats that received oral saline or corn oil gavage 
(saline: 13.8±1.5 ml vs. corn oil: 10.1±1.8 ml vs. LiCl: 0.32±0.1 ml, p<0.001). In 
contrast to sham operated rats, gastric bypass rats reduced their saccharine intake 
significantly after corn oil gavage when compared to saline gavage (saline: 10.8±1.5 
ml vs. corn oil: 4.1±1.5 ml, p<0.01). Gastric bypass rats preferred saccharine over 
water after saline gavage (saccharine: 10.8±1.5 ml vs. water: 1.1±0.6 ml, p<0.001), 
but there was no preference after corn oil gavage (saccharine: 4.1±1.5 ml vs. water: 
4.9±1.4 ml, p=0.68). Saccharine and water intake for all groups are shown in Figure 
21A. Apart from the positive control group, saccharine intake expressed as 
percentage of total fluid intake was significantly reduced in gastric bypass rats after 
corn oil gavage in comparison to all other groups (Figure 21B, sham saline: 93.1±3.6 
% vs. sham corn oil: 87.8±6.1 % vs. bypass saline: 90.1±4.0 % vs. bypass corn oil: 
43.6±14.5 %, p<0.001).  
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Conditioned taste aversion for the GLP-1 receptor agonist exendin-4 
 
Saccharine intake was significantly reduced in rats that had received the positive 
control lithium chloride when compared to rats that received saline or amylin (saline: 
47.7±7.8 ml vs. amylin: 37.4±6.9 ml vs. lithium chloride: 12.4±4.9 ml, p<0.001). 
There was no difference in saccharine intake between rats that were exposed to 
sterile isotonic saline or amylin on the final test day (p=0.58); both groups showed a 
significantly higher saccharine intake when compared to water intake (saline: 
saccharine: 47.7±7.8 ml vs. water: 3.4±0.5 ml, p<0.001 and amylin: saccharine: 
37.4±6.9 ml vs. water: 3.5±1.0 ml, p<0.01). Furthermore, rats reduced their 
saccharine intake significantly after receiving exendine-4 when compared to saline 
administration (saline: 47.7±7.8 ml vs. exendine-4: 18.2±8.5 ml, p<0.01). The rats 
showed no preference after exendine-4 injection for saccharine (saccharine: 
18.2±8.5 ml vs. water: 10.0±2.0 ml, p=0.32). Saccharine and water intake for all 
groups are shown in figure 21C. 
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Figure 21: Conditioned taste aversion; A Saccharine (S) and water (W) intake in sham-operated rats 
after oral gavage with 1ml of sterile isotonic saline (n=8, white), 1ml of corn oil (n=8, light grey), i.p. 
injection of 76.2 mg/kg body weight LiCl (striped) and in gastric bypass rats after oral gavage with 
sterile isotonic saline (n=8, black) and corn oil (n=8, dark grey); B Saccharine intake expressed as 
percentage of total fluid intake in sham-operated rats after oral gavage with sterile isotonic saline 
(n=8, white), corn oil (n=8, light grey), i.p. injection of 76.2 mg/kg body weight LiCl (striped) and in 
gastric bypass rats after oral gavage with sterile isotonic saline (n=8, black) and corn oil (n=8, dark 
grey). C Water and saccharine intake in rats after intraperitoneal administration of sterile isotonic 
saline (n=7), amylin (20 µg/kg, n=8), lithium chloride (76.2 mg/kg, n=7) and exendin-4 (2 µg/kg, n=7). 
Data are shown as mean values ± SEM (** = p<0.01, *** = p<0.001; saccharine versus water). 
 
Tissue dopamine assay 
 
As shown in Figure 22, dopamine concentrations in the striatal tissue and in the 
nucleus accumbens did not substantially differ between gastric bypass rats and 
sham-operated counterparts when both groups were fed ad libitum with normal chow 
(striatum: sham: 22.0±5 pmol/g vs. bypass: 19.7±2.3 pmol/g, p=0.65 and nucleus 
accumbens: sham: 15.5±5.6 pmol/g vs. bypass: 9.5±0.9 pmol/g, p=0.21).  
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 Figure 22: Tissue dopamine levels in the Striatum and Nucleus Accumbens (NAcc) of gastric bypass 
and sham-operated rats when being ad libitum fed. Data are shown as mean values ± SEM. 
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Discussion 
 
I demonstrated a reduced preference of rats for concentrations of Intralipid® of 0.5% 
and above when offered during a two bottle preference test, but not in a brief access 
test. Because rats ingest significantly more Intralipid® during the two bottle 
preference test than during the brief access test where postingestive effects are 
minimal, I concluded that possible mechanisms may include postingestive factors 
such as the induction of an aversive effect. I further investigated this possibility and 
found that gastric bypass rats treated with 1ml of corn oil by gastric gavage showed 
a marked reduction in their preference for saccharine solution that is normally highly 
preferred by rats. Interestingly, the conditioned taste aversion seen after gavage of a 
small volume of corn oil in our study was of a similar magnitude compared with the 
conditioned taste aversion produced by peripheral administration of the GLP-1 
receptor agonist exendin-4. Thus, it seems plausible to suggest that alterations in fat 
preference after gastric bypass may result in part from the induction of an aversive 
response mediated by increased levels of GLP-1.  
My data in the rat gastric bypass model are consistent with previous human findings 
that gastric bypass does not only reduce food intake (Korner, Bessler, Cirilo, 
Conwell, Daud, Restuccia, & Wardlaw 2005;le Roux, Aylwin, Batterham, Borg, 
Coyle, Prasad, Shurey, Ghatei, Patel, & Bloom 2006a;le Roux, Welbourn, Werling, 
Osborne, Kokkinos, Laurenius, Lonroth, Fandriks, Ghatei, Bloom, & Olbers 2007), 
but also preference for food high in fat (Brolin, Robertson, Kenler, & Cody 
1994;Brown, Settle, & Van Rij 1982;Halmi, Mason, Falk, & Stunkard 1981;Olbers, 
Bjorkman, Lindroos, Maleckas, Lonn, Sjostrom, & Lonroth 2006). 
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In conclusion, gastric bypass in rats reduces preference for high fat food and high 
concentrations of Intralipid® solution. Postingestive effects and conditioned taste 
aversion may partly explain my findings. By elucidating the mechanisms by which 
obesity surgery reduces consumption of high fat foods, new surgical and non-
surgical therapies could be developed that mimic these mechanisms and so promote 
safe and effective weight loss. 
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Chapter 7: Analysis of Sweet Taste Sensitivity and Hedonic rating of 
sucrose after Roux-en-Y Gastric Bypass in humans 
 
Introduction 
 
Patients after gastric bypass often report idiosyncratic changes in taste perception 
that involve “sweet” taste and a selective reduction in food with high carbohydrate 
content (Brolin, Robertson, Kenler, & Cody 1994;Brown, Settle, & Van Rij 
1982;Halmi, Mason, Falk, & Stunkard 1981;Olbers, Fagevik-Olsen, Maleckas, & 
Lonroth 2005;Scruggs, Buffington, & Cowan, Jr. 1994;Tichansky et al. 2006). The 
gustatory system is a prime candidate as a contributor to the observed effects. It 
remains unclear, however, whether such changes in preferences, even if taste-
related, are attributable to changes in the intensity of the sensory signals generated 
by food or by their altered evaluation in so called “reward” circuits in the brain, or 
both (Hajnal et al. 2010a;Shin et al. 2010;Tichansky et al. 2011;Zheng et al. 2009).  
Against this background I hypothesized that gastric bypass surgery alters sweet 
taste function associated with sweeteners and affects the preference for sucrose in 
humans. I therefore examined oral-sensory sucrose taste detection thresholds of 
patients and controls before and after gastric bypass by asking patients to taste, but 
not to swallow sucrose solutions. Taste detection thresholds can be considered as 
an effective way to assess the functional status of oral-sensory receptors and the 
sensitivity of downstream gustatory circuits (Hajnal, Kovacs, Ahmed, Meirelles, 
Lynch, & Cooney 2010a;Spector 2000;Spector & Glendinning 2009). Although taste 
sensitivity has been shown to vary as a function of genetics (Lyall et al. 2004), 
pharmacological treatment (Spector et al. 1996a), and neural manipulations 
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(Pittman, Crawley, Corbin, & Smith 2007), it does not necessarily directly relate to 
perceived suprathreshold insensitivity or hedonic responsiveness (Bartoshuk 
1978;Spector 2000). I therefore used a hedonic visual analogue scale (VAS) to test 
what sucrose concentrations gastric bypass patients find “just about right” when they 
don’t swallow the solution (Conner and Booth 1988;Drewnowski et al. 1985;Frijters 
and Rasmussen-Conrad 1982). 
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Material and Methods 
 
Subjects 
 
All human studies were performed according to the principles of the Declaration of 
Helsinki. The Research and Ethics committee at Charing Cross Hospital, London, 
approved the study (REC reference number: 08/H0711/122). Exclusion criteria 
included presence of type 2 diabetes mellitus, pregnancy, breast feeding, substance 
abuse, more than three alcoholic drinks per day, psychiatric illness and chronic 
medical conditions that would make it unsafe to have a general anaesthetic. Written 
informed consent was obtained from all participants. Nine obese subjects were 
investigated for sucrose sensitivity one week before and six weeks after gastric 
bypass surgery. Nine lean control subjects were also tested at similar time intervals.  
 
Surgery 
 
Laparoscopic Roux-en-Y gastric bypass was performed as described before (Olbers, 
Lonroth, Fagevik-Olsen, & Lundell 2003). Briefly, the patients were positioned in 
supine position with extended legs placed on a footrest with head up tilt. The 
surgeon stood on the patient’s right side and the assistant on the left. Seven ports 
were positioned and the left liver lobe was lifted with a self-retraining retractor, and a 
30° angle laparoscope was used. The dissection started with incision of the 
phrenico-gastric peritoneal reflection at the angle of His. Starting 4 cm from the 
gastroesophageal junction at the lesser curvature, dissection was performed medial 
to the nerve of Latarjet to reach the bursa omentalis. Repeated firing of a 45-60 mm 
linear cutting stapler made an oblique partition of the stomach from the lesser 
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curvature up to the angle of His. This created a gastric pouch with an estimated size 
of 15-25 ml. All patients have been operated upon with an antecolic and antegastric 
Roux-en-Y loop, with the greater omentum and gastro-colic ligament completely 
divided caudo-cranially using ultrasound scissors, to shorten the distance for jejunum 
to gastric pouch. 
The anastomotic technique was as follows: 
1. The gastro-jejunostomy was created by stapling the jejunum to the posterior wall 
of the gastric pouch using a 45 mm 3.5-mm-staple linear cutting stapler. The 
remaining defect was sutured with two running resorbable 3/0 sutures anchored at 
both staple-line edges. 
2. The entero-entero-anastomosis was created in a similar manner as a side-to-side 
anastomosis with 45-60 mm 3.5-mm stapler. The length of the Roux limb was 
selectively chosen to be between 60 and 150 cm. 
3. To complete the Roux-en-Y construction, the loop was divided with a linear cutting 
stapler between the anastomosis 
 
Sucrose detection sensitivity 
 
Nine obese subjects (8 female, 1 male) were investigated for sucrose sensitivity one 
week before and two months after gastric bypass surgery. Nine normal weight 
control subjects (7 female, 2 male) were also tested at similar time intervals. 
Detection tests for sucrose were all performed in the morning after an overnight fast 
starting before 23:00. Room temperature was kept constant at 21°C for all test 
sessions. All solutions were prepared daily using the same still natural mineral water 
(Caledonian Still Natural Mineral Water, Sainsbury's Supermarkets Ltd., London, UK: 
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pH 7.4, Calcium 27 mg/l, Chloride 6.4 mg/l, Bicarbonate 103 mg/l, Magnesium 6.9 
mg/l, Sodium 6.6 mg/l, Sulfates 10.6 mg/l) and presented at room temperature. 
Seven sucrose (Sigma Aldrich, Dorset, UK) concentrations were used in this study: 
2.1, 6.25, 12.5, 25, 50, 100 and 300 mM. Concentrations were tested in eight blocks 
with each block consisting of seven sucrose and seven water stimuli. Sucrose and 
water stimuli were presented in random order without replacement. Thus, each of the 
seven sucrose concentrations was presented once within a block. Water and 
sucrose stimuli (15 ml) were offered in polystyrene cups that were filled immediately 
before the test began. The subjects were given a period of five seconds to sample 
the stimulus in the mouth.  Subjects then expectorated the sample and were given 
another five seconds to indicate whether the stimulus was water or not. If a subject 
reported that the stimulus was not water they were asked to describe the quality of 
the taste as sweet, sour, salty or bitter. Each stimulus was followed by a thorough 
ten second water rinse (30 ml) which was expelled before the next stimulus was 
offered. After four blocks, the assessment was interrupted with a 10 minutes rest 
period. To help ensure maintained vigilance, the patients were rewarded for correct 
responses with the presentation of a token and penalized by loss of a token for 
incorrect responses.     
 
Hedonic visual analogue scale to test the concentration reported as “just 
about right”  
 
Ten obese subjects (8 female, 2 male) were investigated with a VAS to test the 
concentration of sucrose that was “just about right” one week before and two months 
after gastric bypass surgery. Nine lean control subjects (7 female, 2 male) meeting 
the same exclusion criteria were also tested at similar time intervals. All tests were 
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performed in the morning after an overnight fast starting before 23.00 h. Room 
temperature was kept constant at 21°C for all test sessions. All solutions were 
prepared daily using the same still natural mineral water as in the detection study 
and presented at room temperature. Seven sucrose (Sigma Aldrich, Dorset, UK) 
concentrations were used in this study: 0, 12.5, 25, 50, 100, 200 and 400 mM. 
Concentrations were tested in three blocks with each block consisting of seven 
sucrose samples presented in random order without replacement. Sucrose samples 
(15 ml) were offered in polystyrene cups that were filled immediately before the test 
began. Between sucrose concentrations subjects rinsed their oral cavity with 15 ml 
water. Subjects were given a period of five seconds to sample the stimulus in the 
mouth. Subjects then expectorated the sample and were given another five seconds 
to indicate the acceptability of the sample on the VAS which was a bipolar scale, 200 
mm long with the ends anchored by the phrases “Far too sweet – I would never drink 
it” and “Far too little sweet- I would never drink it” whilst the midpoint anchoring was 
“Just About Right – My ideal sweetness in a soft drink”.  
 
Statistical analysis 
 
A hit was defined as when the subject correctly reported that the stimulus was 
different from water.  A false alarm (FA) was defined as when the subject incorrectly 
reported that the stimulus was different from water.  The hit rate for a given sucrose 
concentration was adjusted for the false alarm rate to derive a corrected hit rate 
using equation 1: 
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P(hit) - P(FA) 
Corrected Hit Rate  =  
1.0 - P(FA)  
       Equation 1 
where P(hit) = the proportion of trials of a given concentration that were hits, P(FA) = 
the proportion of water trials that were false alarms.  Thus, when the uncorrected hit 
rate is equal to the false alarm rate, the corrected hit rate = 0.  The corrected hit rate 
values were subjected to various two-way analyses of variance (ANOVAs).  Because 
there was very little or no variance around the sample means for the highest three 
concentrations for the groups both preoperatively and postoperatively, only the 
scores for the lower 4 concentrations, representing the dynamic range of 
performance, were used in the ANOVAs.  In addition, concentration-response curves 
were fit to the corrected hit rate values for each subject preoperatively and 
postoperatively to derive a family of individual psychometric functions using equation 
2: 
)*))(((log10101
)( bcx
axf   
       Equation 2       
                                                                                                                                                           
where log10(x) =  log10 concentration, a = the upper asymptote of performance, b = 
slope, and c = the log10 concentration at 1/2a performance (i.e. EC50).  We defined 
the c-parameter as the threshold because it represents the inflection point of the 
psychometric function and is thus optimally represents lateral shifts in sensitivity. The 
shifts in c-parameters were analyzed in a one-way ANOVA.  Although all control 
subjects and patients were included in the analyses of corrected hit rate described 
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above, one control subject and two patients had to be discarded from the c-value 
analysis because either their preoperative or postoperative curve fits accounted for 
only 77% or less of the variance.  All other subjects had curve fits that accounted for 
at least 85% of the variance (mean = 96.7%, se = ±0.7%).  A p-value below 0.05 was 
considered statistically significant. 
 
The ratings on the “Just About Right” Scale were analyzed with a two-way group 
(between subjects) x concentration (within subjects) analysis of variance (ANOVA). 
A p-value ≤0.05 was considered statistically significant.  
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Results 
 
Demographic data 
 
Table 1 shows the demographics for the nine obese patients (8 female, 1 male) and 
the nine lean control subjects (7 female, 2 male).  
    preop Postop 
No Initials Sex Operation 
Weight 
[kg] 
BMI 
[kg/m2] Weight [kg] BMI [kg/m2] 
Pat1 JHM F Gastric bypass 132.7 49.3 106.1 39.4 
Pat2 BM M Gastric bypass 132.1 35.8 102.2 27.7 
Pat3 JO F Gastric bypass 132.7 51.2 115.6 44.6 
Pat5 JL F Gastric bypass 123.8 46.6 107.9 40.6 
Pat6 VG F Gastric bypass 92.0 36.9 85.2 34.0 
Pat7 AL F Gastric bypass 132.7 47.0 106.1 37.6 
Pat8 AG F Gastric bypass 128.3 46.6 111.1 40.3 
Pat9 AS F Gastric bypass 96.7 43.0 90.2 40.1 
Pat10 VQ F Gastric bypass 114 46.8 101.1 41.5 
Average    120.6 44.8 102.8 33.8 
SEM    5.4 1.8 3.3 4.5 
        
Co1 MG F none 59.0 19.9 59.1 19.9 
Co2 MB M none 91.0 24.7 92.2 25.0 
Co3 SK F none 49.5 19.8 49.5 19.8 
Co4 KoD F none 70.0 23.9 70.4 23.9 
Co5 CleR M none 96.0 27.7 96.1 27.7 
Co8 LC F none 54.6 18.2 54.6 18.2 
Co9 KF F none 56.0 22.7 56.3 22.7 
Co10 SB F none 57.0 21.2 57.8 21.2 
Co11 DoR F none 65.0 22.2 65.3 22.2 
Average    66.5 22.3 66.6 22.3 
SEM    5.5 1.0 5.6 1.0 
        
p-value    <0.0001 <0.0001 <0.0001 <0.0001 
 
Table 1: Demographic data of obese patients (n=9) and lean control subjects (n=9). 
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Body weight  
 
The nine patients after gastric bypass reduced their mean body weight from 
120.6±5.4 kg to 102.8±3.3 kg within six weeks (p<0.001) resulting in a BMI reduction 
from 44.8±1.8 to 38.4±1.6 kg/m2 (p<0.001). In contrast, the nine normal weight 
controls with a BMI of 22.0±1.0 kg/m2 kept a stable body weight (66.5±5.5 kg vs. 
66.6±5.6 kg, p=0.99). For the visual analogue scaling study, the ten patients after 
gastric bypass had a mean body weight reduction from 117.4±7.2 kg to 103.4±6.5 kg 
(p<0.001) between the two test time points resulting in a BMI reduction from 
42.7±1.7 to 37.7±1.7 kg/m2 (p<0.001). In contrast, the nine normal weight controls 
with a BMI of 22.4±0.9 kg/m2 had a similar body weight at the two tests (65.5±4.6 kg 
vs. 65.8±4.8 kg, p=0.33).  
 
Corrected Hit Rate Analysis for sucrose taste detection  
 
The mean corrected hit rates (proportion of sucrose trials correctly adjusted for false 
alarm rate) for control subjects and patients pre- and postoperatively are displayed in 
Figure 23. Table 2 summarizes the two-way ANOVA values for comparison of 
corrected hit rates pre- and postoperatively between controls and patients. 
Preoperatively, there was a significant main effect of concentration (p<0.001), but no 
significant difference in corrected hit rates between controls and patients (p=0.71). 
There was also no statistically significant interaction between surgical group and 
concentration (p=0.28).  Postoperatively, gastric bypass patients had significantly 
higher corrected hit rates to the lowest 4 sucrose concentrations compared with 
controls (p=0.046).  There was also a significant main effect of concentration 
(p<0.001), but no significant group x concentration interaction (p=0.37).  
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 Two-way ANOVA values of a within group comparison of performance as a function 
of concentration and time are shown in Table 3.  Postoperatively, patients performed 
significantly better than preoperatively (p=0.048).  There was also a significant main 
effect of concentration (p<0.001), but the interaction was not significant (p=0.64).  In 
contrast, the performance of controls, did not change postoperatively compared with 
the preoperative values (p=0.33).  There was a main effect of concentration 
(p<0.001), but no significant interaction (p=0.73). 
 
 
 
Concentration Surgical group 
Concentration  
X Surgical group 
preoperative F(3,48)=59.5, p<0.001 F(1,16)=0.14, p=0.71 F(3,48)=1.31, p=0.28 
postoperative F(3,48)=60.3, p<0.001 F(1,16)=4.679, p=0.046 F(3,48)=1.07, p=0.37 
 
Table 2: Two-way ANOVA values for comparison of corrected hit rates pre- and postoperatively 
between controls and patients as a function of concentration and surgical group 
 
 
 
Concentration Time 
Concentration  
X time 
controls F(3,24)=188.5, p<0.001 F(1,8)=1.07, p=0.33 F(3,24)=0.442, p=0.73 
patients F(3,24)=44.43, p<0.001 F(1,8)=5.42, p=0.048 F(3,24)=0.56, p=0.64 
 
Table 3: Two-way ANOVA values for comparison of corrected hit rates for controls and patients as a 
function of concentration and time 
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Figure 23: Mean (±se) corrected hit rate for patients (filled circles) and controls (open circles) 
preoperatively (top) and postoperatively (bottom) as a function of sucrose concentration.  Curves 
were fit to the mean data points using equation 2 in text.  The EC50 was derived from the c-parameter 
in the curve fit and represents the concentration at which the corrected hit rate is ½ of the maximum 
asymptote. X-axes are displayed on a log10 scale. 
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C-Parameter Analysis 
 
Preoperatively, curves fit to the mean corrected hit rates for controls and patients 
produced remarkably similar c-values (EC50) of 10.8 mM sucrose for controls and 
11.0 mM sucrose for patients. Postoperatively, the c-values based on the curve fits 
for the mean corrected hit rates were: controls = 14.0 mM sucrose and gastric 
bypass patients = 7.8 mM, suggesting that controls had ”thresholds” that were 1.8-
times higher than patients. The c-value of the curve fit of the mean corrected hit rate 
measured before surgery decreased (indicating greater sensitivity) by 1.4 times after 
surgery.   
 
The preoperative to postoperative shift in the c-values representing the EC50 of the 
individual curve fits for the subjects who had fits that accounted for at least 85% of 
the variance was compared between the two groups (Figure 24).  Although the 0.21 
log10 increase in the EC50 in controls (F((1,7)=5.014, p=0.061) and the 0.194 
decrease in the EC50 in patients (F(1,6)=5.54, p=0.057) relative to their preoperative 
values just missed the statistical rejection criterion, there was a clear difference 
between the relative shifts in the EC50 between the two groups (F(1,13)=10.15, 
p=0.007). 
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 Figure 24: Shifts in the EC50 preoperatively vs. postoperatively for individual patients (black) and 
control subjects (gray) and their respective means (±se).  Bars going up represent rightward shifts in 
the detectability function indicating a decrease in sensitivity.  Bars going down represent leftward 
shifts in the detectability function indicating an increase in sensitivity.  Asterisk represents significant 
difference compared with control shift (p=0.007). 
 
Hedonic visual analogue scale to determine the sucrose concentration which 
was “just about right” 
 
The taste acceptability ratings for control subjects and patients pre- and 
postoperatively are displayed in Figure 25. Table 4 summarizes the two-way ANOVA 
values for the hedonic ratings pre- and postoperatively between controls and 
patients as a function of surgical group and concentration. Before surgery, there was 
a significant main effect of concentration (p<0.001), but no significant difference in 
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hedonic ratings between controls and patients (Figure 28 top) (p=0.63). There was 
also no statistically significant interaction between surgical group and concentration 
(p=0.93).  After surgery, there was also a significant main effect of sucrose 
concentration (p<0.001), but no difference in hedonic ratings between controls and 
patients (p=0.59).  There was also no significant interaction between surgical group 
and concentration (p=0.81).   
 
Two-way ANOVA values of a within group comparison of hedonic ratings as a 
function of concentration and time are shown in Table 5. Patients showed no 
difference in their taste acceptability ratings of the seven sucrose concentrations pre- 
and postoperatively (p=0.20). There was a significant main effect of sucrose 
concentration (p<0.001), but no significant time x concentration interaction (p=0.85).  
Hedonic ratings did also not differ between the two assessments of the normal 
weight group confirming the reliability of the visual analogue scale (Figure 25 bottom) 
(p=0.06).  Here, there was a significant main effect of sucrose concentration 
(p<0.001), but no significant time x concentration interaction (p=0.99).  
 
 
 
Concentration Surgical group 
Concentration  
X Surgical group 
preoperative F(6,102)=78.11; p<0.001 F(1,102)=0.24; p=0.63 F(6,102)=0.32; p=0.93 
postoperative F(6,102)=105.3; p<0.001 F(1,102)=0.30; p=0.59 F(6,102)=0.49; p=0.81 
 
Table 4: Two-way ANOVA values for comparison of hedonic ratings pre- and postoperatively for 
patients and controls as a function of concentration and surgical group. 
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Concentration Time 
Concentration  
X time 
controls F(6,56)=39.21; p<0.001 F(1,56)=3.74; p=0.06 F(6,56)=0.10; p=0.99 
patients F(6,63)=41.60; p<0.001 F(1,63)=1.69; p=0.20 F(6,63)=0.44; p=0.85 
 
Table 5: Two-way ANOVA values for comparison of hedonic ratings for patients and controls between 
as a function of concentration and time. 
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Figure 25: Ratings on a hedonic visual analogue scale to determine the sucrose concentration 
which was considered “Just-about-Right” for patients (filled circles, n=10) and controls (open 
circles, n=9) preoperatively (top) and postoperatively (bottom) as a function of sucrose 
concentration. The ideal sweet concentration was defined as the point at which the plotted line 
intersects the x axis. X-axes are displayed on a log10 scale. Water ratings were as follows: 
Preoperative: patients: -59.7±10.6 mm vs. controls: -55.6±10.7 mm, p=0.78; patients: -49.1±11.1 
mm vs. controls: -53.1±10.7 mm, p=0.80).  
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Discussion 
 
I demonstrated that gastric bypass patients can detect lower concentrations of 
sucrose when compared to normal weight controls. This has been reported before 
(Brolin, Robertson, Kenler, & Cody 1994;Brown, Settle, & Van Rij 1982;Halmi, 
Mason, Falk, & Stunkard 1981), but in contrast to previous experiments I used the 
method of constant stimuli in which taste stimuli are presented randomly and 
performance is assessed across a set of concentrations allowing for the derivation of 
a psychometric function. Threshold measures do not necessarily correlate with 
suprathreshold sensitivity (Bartoshuk 1978) and thus may not accurately reflect the 
hedonic evaluation of higher concentrations of taste stimuli. Accordingly, I 
complemented our measures of sucrose taste sensitivity with a visual analogue 
scale that is designed to estimate the sucrose concentration that is “just about right” 
(Conner & Booth 1988;Drewnowski, Brunzell, Sande, Iverius, & Greenwood 
1985;Frijters & Rasmussen-Conrad 1982). Despite an increased sensitivity to detect 
sucrose in lower concentrations, surprisingly I found that there was no difference in 
the hedonic ratings of sucrose solutions by patients before compared with after 
gastric bypass. This discrepancy could be due to a potential lack of correspondence 
between sucrose detection thresholds on one hand and the perceived intensity of 
suprathreshold sucrose concentrations on the other hand (Bartoshuk 1978). I also 
cannot dismiss the possibility that other scaling procedures for measuring the 
hedonic value of taste stimuli might reveal effects of gastric bypass on sucrose 
acceptability (Bartoshuk et al. 2006), but at least with the scale employed here there 
was no evidence of a postoperative change.  While this deserves further attention in 
future experiments, my results suggest that the changes in food preference observed 
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after gastric bypass might not represent a fundamental shift in the hedonic 
evaluation of the food, but may be more related to other factors such as 
postingestive events and learning.  
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Chapter 8: Analysis of Sucrose Preference and Sweet Taste after Roux-
en-Y Gastric Bypass in rats 
 
Introduction 
 
Potential mechanisms to explain an altered sweet preference, regardless of whether 
central or peripheral in origin, include changes in the T1R2 and T1R3 taste 
receptors, which bind with natural and artifical sweeteners, in the gut (Stearns et al. 
2010) and/or the gut hormones associated with gastric bypass such as glucagon-
like-peptide 1 (GLP-1) and peptide YY (PYY), which can potentially influence 
appetite (Lenard and Berthoud 2008). Mice lacking the GLP-1 receptor show 
decreased behavioural responsiveness to sucrose (Shin, Martin, Golden, Dotson, 
Maudsley, Kim, Jang, Mattson, Drucker, Egan, & Munger 2008), but it remains to be 
fully elucidated whether circulating GLP-1 modulates peripheral (e.g., taste buds) or 
central (brain) gustatory function (Jang, Kokrashvili, Theodorakis, Carlson, Kim, 
Zhou, Kim, Xu, Chan, Juhaszova, Bernier, Mosinger, Margolskee, & Egan 2007). 
However, PYY and GLP-1 administration in rodents has been shown to induce 
conditioned taste aversion by activation of brainstem neurons that mediate effects of 
aversive stimuli (Halatchev and Cone 2005;Seeley et al. 2000;Thiele et al. 1997). 
There is also electrophysiological and behavioral evidence demonstrating that leptin 
decreases responsiveness specifically to sweeteners (Horio et al. 2010;Jyotaki et al. 
2010;Shigemura et al. 2004). Given that gastric bypass surgery dramatically 
decreases adipose mass and, in turn, circulating levels of leptin (Beckman et al. 
2010), selective increases in taste sensitivity to sweeteners would be expected.  
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Against this background we hypothesized that gastric bypass surgery alters sweet 
taste function associated with sweeteners and affects the preference for sucrose in 
rats. We used a rat model to specifically assess the 24h preference in a standard 
two-bottle preference test to investigate how gastric bypass rats treat different taste 
stimuli in the context of natural feeding and drinking; this test allowed us greater 
latitude in behavioural, endocrine, and molecular measurements while providing a 
logical bridge with reports of changes in human taste acceptability following surgery 
(Spector & Glendinning 2009). In this study we used taste compounds representing 
four of the commonly accepted taste qualities, sucrose (sweet), sodium chloride 
(salty), quinine hydrochloride (bitter) and citric acid (sour). However, a possible 
confounding factor is that rats tend to consume less of a novel food or flavour than of 
familiar food, a phenomenon called neophobia (Barker et al. 1977). Moreover, it has 
been shown that neophobia can be enhanced in the context of recent visceral 
malaise (Barker, Best, & Domjan 1977). We therefore investigated the potential 
relevance of preoperative sucrose experience for a postoperatively reduced sucrose 
preference and tested sucrose preference in rats before and after gastric bypass 
surgery.  
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Material and Methods 
 
Animals 
 
Diet-induced obese male Wistar rats were individually housed in polycarbonate 
cages in a room with automatically controlled temperature of 21 ± 2 ºC and a 12h / 
12h light-dark cycle. Water and standard chow (RM1 diet, Special Diet Services Ltd, 
UK) were available ad libitum, unless otherwise stated.  All experiments were 
performed under a license issued by the Home Office UK (PL 70-6669).   
 
Surgery  
 
Surgery was performed according to an established protocol with preservation of the 
vagal fibres in the para-oesophageal bundle as previously described (page 35).  
 
Two bottle preference test  
 
Two groups of ten sham-operated controls and ten RYGB rats were subjected to 
standard two-bottle preference tests as described below. The first group was tested 
initially for sucrose and then for sodium chloride, the second group was tested first 
for quinine hydrochloride and then for citric acid.  Another group of seven sham-
operated rats and seven RYGB rats were subjected to a two-bottle preference test 
for sucrose before and after surgery. All two-bottle preference tests were started 10 
days after surgery when the weight loss had plateaued. Food (g) and fluid (ml) intake 
and solution preference (%) were measured daily. For the two-bottle test involving 
sucrose, we calculated total energy intake as the sum of calories consumed as 
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normal chow (3.5 kcal/g) and sucrose solution (4.1 kcal/g). All solutions were 
prepared daily with deionized water and presented at room temperature. Test stimuli 
consisted of seven concentrations of sucrose (1, 3, 10, 30, 100, 300, 1000 mM), 
sodium chloride (15, 35, 73, 150, 300, 600, 1200 mM), quinine hydrochloride (0.003, 
0.01, 0.03, 0.1, 0.3, 1, 3 mM) and citric acid (0.1, 0.3, 1, 10, 30, 100 mM; all Sigma 
Aldrich, Dorset, UK). The rats were presented with two pre-weighed bottles, one of 
which contained deionized water and the other of which contained the test solutions 
in ascending concentrations. Positions and content of the bottles were changed one 
hour after the start of the light phase and bottles were then weighed 24 hours 
thereafter. Rats were given access to the same concentration for two days and the 
positions of the bottles were switched each day to preclude the development of a 
side preference.  
 
Preference was defined as: [intake of test solution (in ml) ⁄ total fluid intake (ml)] x 
100.  With this type of preference experiment, a score of 50% conventionally 
represents indifference between the two stimulus options (water and sucrose or 
sodium chloride or quinine hydrochloride or citric acid).   
 
Preference, acceptance, food intake and energy intake during the two-bottle 
preference tests were analyzed with a two-way group (between subjects) x 
concentration (within subjects) analysis of variance (ANOVA). Post-hoc Bonferroni 
tests for each concentration were applied when there was a significant group x 
concentration interaction. The conventional p≤0.05 was used as the statistical 
rejection criterion. 
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Blood collection and Hormone assay 
 
Blood from nine ad libitum fed gastric bypass rats and nine sham-operated controls 
was collected on postoperative day 60 and plasma GLP-1 and PYY were measured 
as described before (Kreymann et al. 1987;le Roux et al. 2006b).  
 
Measurement of T1R2 and T1R3 mRNA and protein expression in the small 
intestine brush-border membrane (BBM) of rats  
 
Intestinal segments were opened longitudinally, and the mucosa scraped off using 
glass slides and the resulting mucosa snap-frozen and stored at -80°C.  Intestinal 
BBM vesicles were subsequently prepared as previously described (Marks et al. 
2006). RNA was extracted from tissue, using Trizol, according to manufacturer’s 
instructions (Invitrogen, Paisley, UK).  RNA was reverse transcribed and T1R 
transcripts were measured as previously described (Marks, Srai, Biber, Murer, 
Unwin, & Debnam 2006), with β-actin (GenBank accession number NM031144; 
forward position 937–955, reverse position 1223–1208) used as the house-keeping 
gene.  Expression of the Tasr2 and Tasr3, the protein products of which form a 
functional hetrodimer binding with sweetener compounds, was measured, using 
specific intron-spanning primers designed from the published sequences from rat; 
T1R2 (GenBank accession number XM_00107479.1; forward primer position 3759-
3778, reverse position 3923-3904) and T1R3 (GenBank accession number 
NM_130818.1; forward primer position 2107-2126, reverse position 2327-2308).   
 
The concentration of protein in the BBM vesicles was determined using the Bradford 
method (Bradford 1976). For Western blotting, BBM samples (20-30 µg of protein) 
134 
 
were prepared as previously described (Marks, Srai, Biber, Murer, Unwin, & Debnam 
2006), using Rabbit polyclonal antibodies against T1R2 and 3 (Santa Cruz 
Biotechnology, USA).  Mouse mAb for β-actin were used as a loading control 
(Abcam, Cambridge, UK). The comparative delta Ct method was used to calculate 
the gene expression, relative to β-actin, using Kruskal-Wallis. T1R2 and T1R3 
protein expression values were calculated relative to β-actin and expressed as a 
ratio of control average (%), using Student’s unpaired t test with p considered 
significant at ≤ 0.05.  
 
Statistical analysis 
 
Data were normally distributed and expressed as mean  SEM. Preference, 
acceptance, food intake and energy intake in the two bottle preference tests were 
analyzed with a two-way group (between subjects) x concentration (within subjects) 
analysis of variance (ANOVA). A one-way ANOVA followed by Bonferroni post hoc 
tests for each concentration was applied when there was a significant group x 
concentration interaction. Student’s t-test for independent samples was used to test 
for significant differences. A p-value <0.05 was considered statistically significant. 
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Results 
 
Body weight and food intake 
 
Data for body weight development and average daily food intake after surgery were 
pooled for all groups of rats, because data did not differ between the groups. Figure 
26A shows that the preoperative body weight of all gastric bypass rats (441±8 g) and 
sham-operated rats (425± 9 g) was similar (p=0.17). After postoperative day 15 the 
body weight (381±8 g) of the gastric bypass rats was significantly lower than that of 
the sham-operated group (426±8 g) (p<0.001). After a short period of post-surgical 
weight loss, subsequent weight gain was constant and similar among sham-operated 
rats. After postoperative day 15 until the end of the experiment on day 60 there was 
a difference in body weight between the two groups (day 60: sham: 476±10 g vs. 
bypass: 372±11 g, p<0.001) that was associated with a lower food intake for gastric 
bypass (21.7±0.5 g) rats relative to sham-operated rats (28.2± 0.2 g, p<0.001) 
(Figure 26B).  
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Figure 26: (A) Body weight change for all gastric bypass (-o-) (n=20) and sham-operated rats (-■-) 
(n=20) throughout the complete observation period of 60 days. (B) Average daily food intake of sham-
operated rats (n=20, white) and gastric bypass rats (n=20, black) throughout the entire observation 
period of 60 days. (C) GLP-1 and PYY level for nine sham-operated rats (white) and nine gastric 
bypass rats (black). Data are shown as mean values ± SEM (*** = p<0.001). 
 
Postprandial plasma levels of active GLP-1 and PYY 
 
Figure 26C demonstrates that gastric bypass rats had higher levels of plasma GLP-1 
(p<0.001) and PYY (p<0.001) in comparison to sham-operated controls. 
 
Two-bottle preference test in naïve rats after gastric bypass 
 
Preference 
 
Twenty-four hour preferences for all four test solutions are shown in the left column 
of Figure 27. The values of the two-way ANOVAs for preference for all four taste 
stimuli are summarized in Table 6. There was a significant main effect of sucrose 
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concentration (p<0.001) and of surgical group (p<0.001) as well as a significant 
group x concentration interaction (p<0.001).  Sham-operated rats showed an 
increase in 24h preference ((sucrose intake / total intake)*100) for sucrose at 
concentrations above 10 mM. In contrast, gastric bypass rats showed a much lower 
preference for sucrose concentrations above 10 mM (Figure 27A). There was no 
difference in 24h preference or intake for sodium chloride (Figure 27C), for quinine 
hydrochloride (Figure 27E) and for citric acid (Figure 27G and Table 6). 
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Concentration Surgical group 
Concentration  
X Surgical group 
Sucrose F(6,276)=10.28; p<0.001 F(1,276)=62.10; p<0.001 F(6,276)=6.65; p<0.001 
Sodium Chloride F(6,266)=100.45; p<0.001 F(1,266)=0.12; p=0.73 F(6,266)=0.31; p=0.93 
Quinine hydrochloride F(6,251)=49.08; p<0.001 F(1,251)=2.05; p=0.15 F(6,251)=0.35; p=0.91 
Citric Acid F(6,236)=18.77; p<0.001 F(1,236)=0.11; p=0.74 F(6;236)=1.94; p=0.08 
 
Table 6: Two-way ANOVA values for preference during the two-bottle preference tests in naïve rats 
as a function of concentration and surgical group for all four taste stimuli 
 
Intake 
 
Twenty-four hour intakes for all four test solutions are shown in right column of figure 
27. The values of the two-way ANOVAs for intake for all four taste stimuli are 
summarized in Table 7. There was a significant main effect of sucrose concentration 
(p<0.001) and of surgical group (p<0.001) as well as a significant group x 
concentration interaction (p<0.001). However, sham-operated and gastric bypass 
rats significantly increased their sucrose intake (in ml) within the 24h period at 
concentrations above 10 mM (Repeated Measures ANOVA: p<0.001 and p=0.036, 
respectively; Figure 27B).  There were no differences in intake between sham-
operated rats and gastric bypass rats for sodium chloride (Figure 27D), for quinine 
hydrochloride (Figure 27F) and for citric acid (Figure 27H and Table 7).  
 
Overall caloric intake was only analysed for rats that were in the sucrose study, as 
neither sodium chloride nor quinine hydrochloride nor citric acid contain calories. 
There was a significant main effect of sucrose concentration (F(6,276)=14.11; 
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p<0.001) and of surgical group (F(1,276)=347.07; p<0.001) as well as a significant 
interaction (F(6,276)=16.12; p<0.001) for total caloric intake, which represented the 
sum of calories consumed as food (3.5 kcal/g) and sucrose (energy content of a 
1000 mM sucrose solution: 1.4 kcal/ml). Despite a decrease in chow intake, the 
sham-operated rats increased their total caloric intake when exposed to 
concentrations of the sucrose solutions above 30 mM. In contrast, gastric bypass 
rats showed no significant change in total energy intake which is accounted for by 
their relatively low sucrose intake (One-way ANOVA: p=0.34; data not shown, p < 
0.05). 
 
 
 
Concentration Surgical group 
Concentration  
X Surgical group 
Sucrose F(6,276)=38.06; p<0.001 F(1,276)=189.05; p<0.001 F(6,276)=18.59; p<0.001 
Sodium Chloride F(6,266)=43.78; p<0.001 F(1,266)=1.89; p=0.17 F(6,266)=0.54; p=0.78 
Quinine hydrochloride F(6,251)=34.50; p<0.001 F(1,251)=0.97; p=0.33 F(6,251)=1.31; p=0.26 
Citric Acid F(6,236)=35.22; p<0.001 F(1,236)=1.89; p=0.17 F(6;236)=1.62; p=0.14 
 
Table 7: Two-way ANOVA values for intake during the two-bottle preference tests in naïve rats as a 
function of concentration and surgical group for all four taste stimuli 
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Figure 27: Two-bottle preference test in gastric bypass rats (n=10, -■-) and sham-operated rats 
(n=11, -□-); (A) 24 hour sucrose preference and (B) intake; (C) 24 hour sodium chloride preference 
and (D) intake; (E) 24 hour quinine hydrochloride preference and (F) intake; (G) 24 hour citric acid 
preference and (H) intake. Data are shown as mean values ± SEM with differences between gastric 
bypass rats and sham-operated rats. When two-way ANOVA revealed a significant group x 
concentration interaction , post-hoc Bonferroni test was used for concentration to concentration 
analysis between the two groups (** = p<0.01, *** = p<0.001). X-axes are displayed on a log10 scale. 
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Two-bottle preference test for sucrose in gastric bypass rats with preoperative 
sucrose experience    
 
Preference 
 
Twenty-four hour preferences for sucrose before and after gastric bypass and sham-
operation are shown in the left column of figure 28 and two-way ANOVA values for 
sucrose preference pre- and postoperatively are summarized in table 8. 
Preoperatively, there was no difference in sucrose preference between the two 
surgical groups (p=0.73; Figure 28A). After surgery, there was a significant main 
effect of surgical group (p=0.039) and a significant group x concentration interaction 
(p=0.011). However, there was no main effect for sucrose concentration (p=0.061; 
Figure 28C).  A repeated measures ANOVA for each group showed that there was a 
significant sucrose concentration effect for gastric bypass rats (p=0.002), but not for 
sham-operated rats (p=0.21).    
 
 
Concentration Surgical group 
Concentration  
X Surgical group 
Preoperative F(6,168)=38.58; p<0.001 F(1,168)=0.12; p=0.73 F(6,168)=0.41; p=0.87 
Postoperative F(6,144)=2.07; p=0.06 F(1,144)=4.77; p=0.039 F(6,144)=2.54; p=0.011 
 
Table 8: Two-way ANOVA values for pre- and postoperative sucrose preference during the two-bottle 
preference tests as a function of concentration and surgical group  
 
Intake 
 
Twenty-four hour sucrose intakes are shown in the right column of Figure 28 before 
and after gastric bypass and sham-operations. Table 9 summarizes the two-way 
ANOVA values for sucrose intake pre- and postoperatively. Preoperatively, there 
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was no difference in sucrose intake between the two surgical groups (p=0.27; Figure 
28B). Postoperatively, the two-way ANOVA indicated a significant main effect of 
surgical group (p<0.001) as well as for sucrose concentration (p<0.001). There was 
also a significant group x concentration interaction (p<0.001; Figure 28D). 
 
 
 
Concentration Surgical group 
Concentration  
X Surgical group 
preoperative F(6,168)=45.99; p<0.001 F(1,168)=1.28; p=0.27 F(6,168)=0.49; p=0.82 
postoperative F(6,144)=17.11 p<0.001 F(1,144)=28.90; p<0.001 F(6,144)=6.82; p<0.001 
 
Table 9: Two-way ANOVA values for pre- and postoperative sucrose intake during the two-bottle 
preference tests as a function of concentration and surgical group  
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Figure 28: Two-bottle preference test in gastric bypass rats (n=7, -■-) and sham-operated rats (n=7, -
□-) before and after gastric bypass and sham surgery; (A) preoperative 24 hour sucrose preference 
and (B) intake; (C) postoperative 24 hour sucrose preference and (D) intake; Data are shown as 
mean values ± SEM with differences between gastric bypass rats and sham-operated rats. When two-
way ANOVA revealed a significant group x concentration interaction, post-hoc Bonferroni test was 
used for concentration to concentration analysis between the two groups (** = p<0.01, *** = p<0.001). 
X-axes are displayed on a log10 scale. 
 
 
Intestinal mRNA and brush-border membrane protein levels of sweet taste 
receptor subunits T1R2 and T1R3   
 
Figure 29 shows the mucosal levels of mRNA (A-C) and protein (D-F) for the two 
taste receptor proteins, T1R2 and T1R3, in the corresponding duodenal, jejunal and 
ileal segments of sham- and bypass-operated rats. T1R2 mRNA expression was 
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significantly lower in the biliopancreatic limb after gastric bypass in comparison with 
the duodenum of sham-operated rats (p<0.001). In contrast, there was no difference 
in T1R2 mRNA expression in the alimentary limb and common channel of bypass 
rats compared with the proximal jejunum and terminal ileum in sham-operated rats. 
T1R3 mRNA expression was similar in gastric bypass rats and sham-operated rats 
in all examined parts of the small intestine. Consistent with the mRNA expression, 
there was a significant decrease in brush-border membrane protein expression of 
T1R2 in the biliopancreatic limb after gastric bypass when compared with the 
duodenum of sham-operated rats. Furthermore, there was a significant decrease in 
both T1R2 and T1R3 protein levels in the alimentary limb after gastric bypass.  
There was no difference in T1R2/3 protein levels between the common channel of 
bypass rats and the ileum of sham-operated rats.    
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 Figure 29: T1R2 and T1R3 mRNA expression (A-C) and brush-border membrane protein levels (D-F) 
in the biliopancreatic (Bilio), alimentary (Alim) and common channel (Co) of gastric bypass rats 
(black) in comparison with correspondent section of duodenum (Duo), jejunum (Jej) and ileum (Ileum) 
of sham-operated rats (white) (n=4-6 per group). Relative gene expression is represented as delta 
delta Ct mean values ± SEM (*** = p<0.001). 
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Discussion 
 
I demonstrated that gastric bypass reduces the preference for sucrose in rats, 
although preoperative sucrose exposure attenuated this effect. I confirmed that 
gastric bypass in rats leads to increased postprandial levels of the satiety gut 
hormones GLP-1 and PYY (Bueter et al. 2010a;le Roux, Aylwin, Batterham, Borg, 
Coyle, Prasad, Shurey, Ghatei, Patel, & Bloom 2006a;le Roux, Welbourn, Werling, 
Osborne, Kokkinos, Laurenius, Lonroth, Fandriks, Ghatei, Bloom, & Olbers 2007). 
The changes in both mRNA and tissue protein levels of the taste receptor proteins 
T1R2 and T1R3, which form a heterodimer that binds with sweeteners, in the small 
bowel may contribute to the postingestive effects that could influence sucrose 
preference.  
Several potential mechanisms that could underlie the selective effects of gastric 
bypass on sucrose preference in rats and these are not necessarily mutually 
exclusive. For example my observations might be explined by alterations in 
peripheral or central gustatory processes, Another possibility is that the lower 
preference of gastric bypass rats for higher sucrose solutions may be induced by 
postingestive consequences producing visceral malaise (Kyriazakis et al. 1999). 
Learning processes affecting sucrose preference and intake after gastric bypass 
may also have contributed to the observed effects. 
It will be important for future work to examine whether gastric bypass alters taste 
detection thresholds in the rat model, which allows for more systematic and targeted 
manipulations aimed at revealing mechanisms. Further elucidation of the 
mechanisms by which gastric bypass reduces consumption of high-caloric foods 
may help in the development of novel surgical and non-surgical therapeutic 
interventions that will promote safer and more effective weight loss. 
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Chapter 9: Final Discussion 
 
Role of the vagus for body weight loss in rodent model of Roux-en-Y gastric bypass 
 
My data in the rat model for gastric bypass are consistent with previous findings that 
gastric bypass surgery can effectively induce food intake and body weight reduction 
(Adams, Gress, Smith, Halverson, Simper, Rosamond, Lamonte, Stroup, & Hunt 
2007;Korner, Bessler, Cirilo, Conwell, Daud, Restuccia, & Wardlaw 2005;le Roux, 
Aylwin, Batterham, Borg, Coyle, Prasad, Shurey, Ghatei, Patel, & Bloom 2006a). In 
this randomized study the weight loss and food intake outcome of gastric bypass 
surgery was dependent on whether vagal fibres were preserved or not during the 
formation of the gastric pouch. Rats in which the para-oesophageal bundle including 
the vagal fibres was completely ligated started to regain body weight up to 
preoperative levels and showed no difference in average daily energy intake 
compared to their sham-operated counterparts. In contrast, rats in which the para-
esophageal bundle including the vagal fibres was preserved and in which the left 
gastric vessels were selectively ligated, maintained the reduced body weight and ate 
significantly less than the sham-operated controls throughout the entire study period.  
Gastric bypass rats had higher postprandial GLP-1 and PYY levels compared to 
sham-operated controls, but there were no differences in GLP-1 and PYY levels 
between gastric bypass rats with our without preserved vagal fibres. Furthermore, 
differences in food intake and body weight were not related to the size of the gastro-
jejunostomy in gastric bypass rats and there were no signs of malabsorption or 
inflammation after gastric bypass in any of the groups. 
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My data confirm previous findings that gastric bypass in rats increases postprandial 
levels of peptide YY (PYY) and glucagon-like peptide-1 (GLP-1), which are satiation 
inducing gut hormones and hence favour an anorectic state and facilitate body 
weight loss (Borg, le Roux, Ghatei, Bloom, Patel, & Aylwin 2006;Korner, Bessler, 
Cirilo, Conwell, Daud, Restuccia, & Wardlaw 2005). Both hormones are thought to 
activate anorectic neurons in the hypothalamic arcuate nucleus (ARC) which 
promote weight loss (Batterham, Cowley, Small, Herzog, Cohen, Dakin, Wren, 
Brynes, Low, Ghatei, Cone, & Bloom 2002;Batterham, Cohen, Ellis, le Roux, 
Withers, Frost, Ghatei, & Bloom 2003;Cone et al. 2001;Larsen, Tang-Christensen, & 
Jessop 1997). Gut hormones released from enteroendocrine cells in the distal ileum 
like GLP-1 and PYY can inform the brain either through the circulation or via afferent 
vagal neurons or both, and there is considerable controversy about the relative 
importance of these routes (Berthoud 2008). It is possible that a given hormone 
could use different routes to produce different physiological effects such as changes 
in eating behavior (Berthoud 2008).  
In this study body weight and food intake after gastric bypass were related to 
whether the vagal fibres within the para-oesophageal bundle were preserved or not 
while there were no differences in levels of GLP-1 and PYY between these two 
groups. This finding highlights the important role of the vagal nerve for mediating the 
inhibitory effects of gut hormones such as PYY and GLP-1 on food intake and body 
weight after gastric bypass surgery in rats. It is further supported by previous reports 
describing that ablation of the vagal-brainstem-hypothalamic pathway attenuates the 
inhibitory effects of PYY and GLP-1 on food intake (Abbott, Monteiro, Small, Sajedi, 
Smith, Parkinson, Ghatei, & Bloom 2005). This is an important observation as only a 
few reports examined whether vagal preservation is effective or necessary in weight 
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control after bariatric surgery (Perathoner, Weiss, Santner, Brandacher, Laimer, 
Holler, Aigner, & Klaus 2009;Sundbom, Holdstock, Engstrom, & Karlsson 
2007;Wang & Liu 2009).  
In contrast to my observation, Wang et al. described a greater weight loss after total 
vagal dissection along with a gastric bypass operation in rats (Wang & Liu 2009). 
This effect was only present 20 days after surgery and there was no difference in 
food intake and body weight between bypass rats with or without vagal dissection on 
postoperative day 100.  In this study the bypassed jejunum was about 10 cm in 
length which is much less in comparison to our technique as described above. This 
variation in length of the bypassed jejunum may result in differences in postprandial 
GLP-1 and PYY levels which may result in altered long-term body weight loss.  
However, the comparability of both studies is limited as Wang et al. used the bypass 
operation to prevent obesity in rats weighing 180-200g while I performed surgery to 
treat obesity in obese rats (Wang & Liu 2009). 
Weight loss after a gastric bypass operation might also be due to nutrient 
malabsorption or postoperative inflammation. However, I found no evidence for an 
increase in either fecal mass or fecal calorie content in the gastric bypass animals 
with or without vagal preservation. Moreover I did not detect any evidence of 
increased inflammation in animals with or without vagal ligation post surgery. 
The size of the gastric pouch and the lengths of the different limbs used in this study 
have been proven to effectively induce weight loss (Bueter, Lowenstein, Olbers, 
Wang, Cluny, Bloom, Sharkey, Lutz, & le Roux 2009c). An increasing body of 
evidence in humans indicates that up to certain limits the size of the gastric pouch 
and length of the different limbs is of less importance for the outcome of gastric 
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bypass (Muller, Rader, Wildi, Hauser, Clavien, & Weber 2008). In support of this 
observation, I demonstrated that the level of restriction measured by the size of the 
gastro-jejunostomy has no impact on different levels of weight loss and food intake 
after gastric bypass in rats.  
There are three major limitations of my study. Firstly, I cannot exclude the possibility 
that the ligation of the paraoesophageal bundle is functionally equivalent only to a 
partial dissection of the vagal nerve. In addition, I did not perform a secretin test or 
histological analysis to collect further informations on vagal function to confirm 
whether the complete ligation of the para-esophageal bundle produced a total or 
partial vagotomy. Secondly, greater body weight loss after gastric bypass might also 
be due to a greater total surgical trauma as bypass operations took longer and might 
have been more stressful for the rats. Finally, it remains unclear whether my results 
can be translated into humans. Most bariatric surgeons usually aim to preserve the 
anterior and posterior vagal trunk during formation of the gastric pouch, although 
there is a lack of supporting data indicating that this approach has beneficial effects. 
In a recent study, Perathoner et al investigate 40 morbidly obese patients 
undergoing gastric bypass dividing them into two groups according to vagal nerve 
preservation (Group 1, n = 25) or vagal nerve dissection (Group 2, n = 22) and found 
that the dissection of the anterior vagal trunk during pouch formation had no effect 
on clinical, functional and laboratory results of a gastric bypass operation 
(Perathoner, Weiss, Santner, Brandacher, Laimer, Holler, Aigner, & Klaus 2009).  
In conclusion, my gastric bypass technique induces reliable weight loss in rats with 
an acceptable mortality. I propose that vagal nerve fibres should be preserved during 
gastric bypass in rats. Restriction at the gastro-jejunal anastomosis does not seem to 
be critical for the weight loss. Although the mechanisms have not yet been fully 
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elucidated, vagal preservation may play an important role in inducing and 
maintaining weight loss after gastric bypass in humans and rats.  
 
Changes in energy expenditure after Roux-en-Y gastric bypass in rats 
 
I confirmed that body weight loss after gastric bypass was associated with a 
significant loss of fat mass and to a lesser degree of non-adipose body mass 
(Guijarro et al. 2007;Stenstrom et al. 2006). Food intake was reduced in gastric 
bypass rats which may be partly explained by hormonally mediated mechanisms 
(Atkinson and Brent 1982;Korner, Bessler, Cirilo, Conwell, Daud, Restuccia, & 
Wardlaw 2005;le Roux, Welbourn, Werling, Osborne, Kokkinos, Laurenius, Lonroth, 
Fandriks, Ghatei, Bloom, & Olbers 2007). Importantly, the lower food intake after 
gastric bypass compared with sham-operated ad libitum fed rats only partly explains 
body weight loss, because the sham-operated body weight-matched group required 
on average 40% less food than the bypass group to maintain the same level of body 
weight. Consequently, reduced calorie consumption is important but not the sole 
cause of weight loss after gastric bypass. I found no increased fecal mass, fecal 
calorie content or inflammation in the gastric bypass animals; therefore nutrient 
malabsorption or inflammation are unlikely to play a major role in this weight loss (le 
Roux, Aylwin, Batterham, Borg, Coyle, Prasad, Shurey, Ghatei, Patel, & Bloom 
2006a).  
I demonstrate a higher total energy expenditure in rats after gastric bypass 
compared to ad libitum fed and body weight-matched sham groups which is in 
accordance with some, but not all previous reports of energy expenditure in humans 
(Carrasco, Papapietro, Csendes, Salazar, Echenique, Lisboa, Diaz, & Rojas 
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2007;Das, Roberts, McCrory, Hsu, Shikora, Kehayias, Dallal, & Saltzman 
2003;Flancbaum, Choban, Bradley, & Burge 1997).   Differences in energy 
expenditure were mainly due to changes during the light phase when physical 
activity is typically low. Gastric bypass surgery did not only prevent the expected 
decrease in energy expenditure subsequent to body weight loss, but actually 
increased 24 hour and in particular light phase energy expenditure in comparison to 
the control groups.  
Higher energy expenditure after gastric bypass was associated with lower respiratory 
quotients suggesting that fat rather than carbohydrates was burnt to sustain higher 
energy expenditure. However, food restricted body weight-matched controls showed 
similar respiratory quotient levels to the gastric bypass group suggesting that body 
weight loss rather than a specific effect by the gastric bypass procedure was an 
important determinant for the observed decrease in respiratory quotient.  
As higher levels of total energy expenditure usually result either from greater heat 
generation or increased physical activity (Lowell & Spiegelman 2000), some of our 
findings remain unexplained. Firstly, bypass rats were not more physically active 
than the control groups. The bypass rats showed no difference in spontaneous 
activity during the light phase to indicate reduced sleep time, but I have not formally 
evaluated sleep patterns. In fact, at least during the dark phase, when spontaneous 
activity is usually high, physical activity was lower in the bypass rats than in the 
sham controls. As gastric bypass induces an increase in postprandial levels of PYY 
and GLP-1 (Borg, le Roux, Ghatei, Bloom, Patel, & Aylwin 2006) which reduce food 
intake, the reduced dark phase physical activity may possibly indicate reduced 
appetite and hence less foraging or food seeking behaviour. The second unexpected 
finding was the lower body temperature in gastric bypass rats compared to ad libitum 
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fed sham controls. This was observed throughout the light-dark cycle. However, 
during the light phase the body temperature of the gastric bypass rats was higher 
than in the body weight-matched controls despite no difference in physical activity. It 
must be emphasized that during the light phase gastric bypass rats continued to 
consume some food, whilst the body weight-matched shams consumed all food 
during the first half of the dark cycle. Thus, differences in light phase body 
temperature might be related to food intake and subsequently diet-induced 
thermogenesis (Shibata and Bukowiecki 1987;Sims and Danforth E Jr 1987).  
After a 5 g test meal gastric bypass rats had greater diet-induced thermogenesis 
than body weight-matched controls, but no difference was observed between gastric 
bypass rats and the ad libitum fed sham group.   
My data suggest that gastric bypass induces profound changes in food intake, 
energy expenditure and the mechanisms by which the body controls energy 
expenditure. As gastric bypass significantly rearranges the gastrointestinal anatomy, 
I suggest that gastrointestinal and central neuroendocrine signaling contribute to 
increased energy expenditure (Lowell & Spiegelman 2000). Neurons in the 
hypothalamic arcuate nucleus (ARC) co-express neuropeptide Y (NPY) and agouti-
related peptide, which stimulate food intake and weight gain (Schwartz et al. 2000). 
Another population of ARC neurons co-express pro-opiomelanocortin (POMC) and 
cocaine-and-amphetamine-regulated transcript (CART), which both promote weight 
loss (Cone, Cowley, Butler, Fan, Marks, & Low 2001). The balance between NPY 
and POMC is critical for the maintenance of body weight (Cone, Cowley, Butler, Fan, 
Marks, & Low 2001;Flier 2004;Schwartz, Woods, Porte, Jr., Seeley, & Baskin 2000). 
Gastric bypass increases postprandial levels of PYY and GLP-1 (Korner, Bessler, 
Cirilo, Conwell, Daud, Restuccia, & Wardlaw 2005;le Roux, Aylwin, Batterham, Borg, 
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Coyle, Prasad, Shurey, Ghatei, Patel, & Bloom 2006a), which are satiating inducing 
gut hormones and hence favour an anorectic state and facilitate body weight loss 
through modulation of the hypothalamus and brainstem (Abbott, Monteiro, Small, 
Sajedi, Smith, Parkinson, Ghatei, & Bloom 2005;Larsen, Tang-Christensen, & 
Jessop 1997), also being involved  in the control of energy expenditure (Murphy & 
Bloom 2006). In fact, PYY has been shown to activate anorectic POMC expressing 
neurons in the ARC (Batterham, Cowley, Small, Herzog, Cohen, Dakin, Wren, 
Brynes, Low, Ghatei, Cone, & Bloom 2002) and to inhibit NPY neurons (cuna-
Goycolea & van den Pol 2005), suggesting a potential to increase energy 
expenditure.   
Gastrointestinal effects of GLP-1 and PYY can be resolved by ablation of vagus–
brainstem–hypothalamus pathways (Abbott, Monteiro, Small, Sajedi, Smith, 
Parkinson, Ghatei, & Bloom 2005) indicating a role for the vagus in mediating effects 
on food intake and potentially energy expenditure. However, it was beyond the 
scope of this study to assess the potential role of vagal or visceral neural afferent 
information to the central nervous system. 
GLP-1 increases endogenous amylin levels (Lutz 2006). Amylin may be another 
potential candidate decreasing food intake and increasing energy expenditure 
(Wielinga, Alder, & Lutz 2007). Of note, the reduced food intake after amylin is 
independent of GLP-1 and vice versa (Lutz TA, unpublished data). Nonetheless, 
chronic amylin administration reduces food intake (Osto et al. 2007) and it prevents 
the decrease in energy expenditure that would typically result from lower food intake 
and body weight loss (Mack et al. 2007b;Roth et al. 2006) (Lutz TA, unpublished 
data).  
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The increase in total energy expenditure might also represent a higher energy 
requirement after bypass surgery. I also demonstrated significant morphometric 
changes of the small intestine after gastric bypass surgery (Borg, le Roux, Ghatei, 
Bloom, Patel, & Aylwin 2006;Nadreau, Baraboi, Samson, Blouin, Hould, Marceau, 
Biron, & Richard 2006).  The observed increase in muscle thickness and mucosal 
mass after gastric bypass resulted in a 72% increase of the total small bowel weight.  
The gut is metabolically very active and the mean in vitro rates of oxygen 
consumption in gastrointestinal tissues in rats have been reported to be 15-22% of 
total oxygen consumption (Cant et al. 1996;Pine et al. 1994). Thus, gut hypertrophy 
may at least in part explain the higher maintenance energy requirement that 
contribute to body weight loss.   
Postoperative inflammation secondary to infection can lead to a higher energy 
demands, but I found no evidence of an inflammatory response in my study. Other 
mechanisms that should be considered but may be less likely include decreased 
leptin after gastric bypass. Usually high leptin and not low leptin contributes to 
increased energy expenditure (Trakhtenbroit et al. 2009). Although low leptin levels 
may explain the lower body temperature in bypass rats than in ad libitum fed 
controls, it does not explain the observed difference in body temperature between 
bypass and body weight-matched rats.  
This study does not explain why average body temperature was reduced while total 
energy expenditure was higher after gastric bypass. One possible explanation is that 
more heat was dissipated to the immediate environment of the rats especially since 
gastric bypass rats had significantly less body fat and hence less thermal isolation. I 
did not assess cutaneous vasodilation to further explore potential mechanisms. 
Another explanation may be an up regulated activity of brown adipose tissue, but the 
156 
 
measuring system did not allow the separate assessment of brown adipose tissue 
and tail temperature. 
In summary, not only did gastric bypass surgery prevent the expected decrease in 
energy expenditure subsequent to body weight loss in this diet-induced obese rat 
model, but 24 hour and in particular light phase energy expenditure were higher than 
in sham controls. Diet-induced thermogenesis was also higher after gastric bypass 
surgery compared to body weight-matched controls. Increased energy expenditure 
may offer an additional explanation why gastric bypass surgery is superior to dieting 
for successfully maintaining long-term body weight loss.  
 
 
Sodium and water handling after gastric bypass surgery in a rat model 
 
Both central and peripheral abnormalities account for the development and 
maintenance of high arterial pressure in obesity (Hall 2003). Visceral obesity is 
considered an important risk factor for hypertension and cardiovascular disease 
(Sironi et al. 2004); it is linked to hyperinsulinemia, hyperleptinemia and increased 
levels of aldosterone, and so-called aldosterone releasing factors, all of which lead to 
activation of the sympathetic and renin-angiotensin-aldosterone systems (El-Atat et 
al. 2004;Rahmouni et al. 2003;Rahmouni et al. 2004). In addition, increased 
aldosterone levels might also be the result of an increased intra-abdominal pressure 
activating the renin-angiotensin-aldosterone system, leading to increased sodium 
and water reabsorption (Bloomfield et al. 1997;Sugerman, Windsor, Bessos, & Wolfe 
1997). 
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The beneficial effect of gastric bypass surgery on arterial hypertension is well 
documented (Adams, Gress, Smith, Halverson, Simper, Rosamond, Lamonte, 
Stroup, & Hunt 2007;Buchwald 2005). The reduction of visceral fat mass, and 
subsequent decrease in sympathetic activation and sodium retention, is not 
immediate and does not explain the early reduction in blood pressure observed after 
gastric bypass described by Ahmed at al (Ahmed, Rickards, Coniglio, Xia, Johnson, 
Boss, & O'Malley 2008). Thus, I reasoned that other mechanisms might be involved 
in the early resolution of hypertension after gastric bypass, and that alteration of 
renal sodium and water handling could be one of them.  
I have demonstrated a significant increase in urine output, water intake and sodium 
excretion after gastric bypass surgery compared with pre-operative measurements. 
Sham-operated animals show no changes in water intake, urine production or 
sodium excretion after surgery.  
In many groups of patients with hypertension there is disturbed sodium balance 
(Postnov 1990) attributed to impaired renal sodium excretion. However, only a few 
studies have focused on the possible role of the gastrointestinal tract in the control of 
sodium balance, and thus systemic blood pressure. The concept that dietary intake 
and composition can affect renal function is perhaps self-evident, but a detailed 
characterization of this relationship is still lacking. Several physiological mechanisms 
are involved in controlling sodium balance, in particular the hormones aldosterone, 
angiotensin II (Bouhnik et al. 1992), and atrial natriuretic peptide (Sterzel et al. 
1987); but there is some evidence supporting involvement of the gastrointestinal 
tract. Analogous to the ‘incretin effect’, characterized by an exaggerated plasma 
insulin response to an oral glucose load compared with the same amount of glucose 
given intravenously, oral ingestion of sodium chloride has a greater natriuretic effect 
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than when the same amount is given intravenously to subjects on a low sodium diet 
(Lennane et al. 1975). This effect has been shown to be independent of changes in 
aldosterone and atrial natriuretic peptide (Lennane, Carey, Goodwin, & Peart 1975). 
In the case of insulin release, the important incretin gut hormone has been shown to 
be GLP-1, which has since been developed into a successful treatment for type 2 
diabetes (Baggio & Drucker 2007). Although the mechanism for the analogous effect 
on sodium excretion, and potentially blood pressure control, has yet to be identified; 
the GLP-1 response after bypass remains a candidate, as it is a known natriuretic 
(Gutzwiller, Tschopp, Bock, Zehnder, Huber, Kreyenbuehl, Gutmann, Drewe, 
Henzen, Goeke, & Beglinger 2004;Holst 2004).  
Animal studies provide some evidence that the gastrointestinal tract can exert a 
direct influence on renal function. Morgan et al observed that salt-sensitive Harlan 
Sprague Dawley (HSD) rats (SS/Jr) with transplanted kidneys from salt-resistant 
HSD rats (SR/Jr) developed significant salt-induced hypertension, suggesting that 
extra-renal factors also contribute to hypertension in this model of hypertension 
(Morgan et al. 1990). These findings were not accounted for by any changes in 
established hormones known to control renal sodium excretion, including 
aldosterone, renin and angiotensin II (Bouhnik, Richoux, Huang, Savoie, Baussant, 
henc-Gelas, & Corvol 1992), or atrial natriuretic peptide (Sterzel, Luft, Gao, Lang, 
Ruskoaho, & Ganten 1987). Hence, the presence of an intestinal natriuretic factor 
renal sodium excretion was proposed (Morgan, DiBona, & Mark 1990).  
My data suggest that gastric bypass induces profound changes in sodium and water 
handling. As gastric bypass significantly rearranges the gastrointestinal anatomy, I 
suggest that gastrointestinal and central neuroendocrine signaling contribute to 
increased sodium and water excretion (Lowell & Spiegelman 2000). Potential 
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mediators between the gut and the kidney include both, Peptide YY (PYY) (Playford, 
Mehta, Upton, Rentch, Moss, Calam, Bloom, Payne, Ghatei, Edwards, & . 1995) and 
glucagon-like peptide (GLP)-1, which have been shown to have diuretic and 
natriuretic properties (Michell, Debnam, & Unwin 2008). Thus, it is reasonable to 
speculate that GLP-1 and PYY could mediate a link between the gastrointestinal 
tract and kidney in terms of sodium and water excretion (Gutzwiller, Tschopp, Bock, 
Zehnder, Huber, Kreyenbuehl, Gutmann, Drewe, Henzen, Goeke, & Beglinger 
2004;Gutzwiller, Hruz, Huber, Hamel, Zehnder, Drewe, Gutmann, Stanga, Vogel, & 
Beglinger 2006;Michell, Debnam, & Unwin 2008). 
However, this study cannot distinguish between a direct effect of hypertonic saline to 
stimulate thirst, and increase water intake after gastric bypass, and an indirect effect 
of increased renal sodium excretion to stimulate thirst and offset salt and water loss. 
Also, a non hypertensive rat strain was used, and blood pressure was not measured 
to determine if the observed increase in sodium excretion lead to any change in 
blood pressure.  
In conclusion, gastric bypass surgery in humans, and in the rat, provides us with a 
valuable model in which to explore the role of the gastrointestinal tract in sodium and 
water homeostasis, and other electrolytes, and perhaps also in salt-sensitive 
hypertension. Gastric bypass results in a greater urine output, water intake and 
sodium excretion in salt-restricted rats following an oral sodium load. This 
observation may provide an insight into the mechanism of the early improvement in 
arterial hypertension seen in patients after gastric bypass surgery. 
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Fat Preference after Roux-en-Y Gastric Bypass 
 
Patients randomised to gastric bypass six years earlier decreased their liking for fat 
compared to pre surgery, but the same is not the case after vertical-banded 
gastroplasty. The results of my rat experiments after gastric bypass show a shift 
away from solid high fat to solid low fat food. We confirmed previous findings 
demonstrating that gastric bypass leads to increased postprandial levels of plasma 
GLP-1 and PYY when compared to sham-operated control rats (Korner, Bessler, 
Cirilo, Conwell, Daud, Restuccia, & Wardlaw 2005;le Roux, Aylwin, Batterham, Borg, 
Coyle, Prasad, Shurey, Ghatei, Patel, & Bloom 2006a). We also demonstrated a 
reduced preference of rats for concentrations of Intralipid® of 0.5% and above when 
offered during a two bottle preference test, but not in a brief access test. Because 
rats ingest significantly more Intralipid® during the two bottle preference test than 
during the brief access test where postingestive effects are minimal, I concluded that 
possible mechanisms may include postingestive factors such as the induction of an 
aversive effect. In line with this I observed that exogenous administration of the GLP-
1 receptor agonist exendin-4 induced a conditioned taste aversion of similar 
magnitude as an oral gavage of a small volume of corn oil; this suggests that 
exaggerated postprandial GLP-1 responses might play a role in mediating the 
decreased fat preference after gastric bypass. 
In humans a long-term reduction in dietary fat following gastric bypass was found to 
be the single most pronounced differing factor in the dietary composition between 
the two groups six years after the operation. As part of general lifestyle advice 
(Blundell & MacDiarmid 1997) to achieve adequate and sustained weight loss a 
reduction in total energy intake by reducing dietary fat is recommended.  
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My findings add to previous reports in humans which have shown a reduced dietary 
fat intake one year after gastric bypass surgery (Olbers, Bjorkman, Lindroos, 
Maleckas, Lonn, Sjostrom, & Lonroth 2006) ; this set the stage for use of the rat as 
an animal model to pursue the physiological, endocrine, and molecular mechanisms 
underlying the effects of gastric bypass surgery on food preference. In this regard, I 
demonstrated that rats after gastric bypass decrease their total energy intake from 
pelleted food by 37%, and specifically decrease their preference for high fat, while 
actually increasing low fat chow consumption. The relative contribution of normal 
chow to energy intake increased four-fold, while the contribution of high fat chow 
decreased by 11% after gastric bypass; this reflects the direction of the preference 
shift from high toward low fat chow. Nevertheless, it should be noted that in this 
model, rats still ingested more calories from high fat than from low fat chow.   
Rats after gastric bypass when given a choice over 48 hours between distilled water 
and Intralipid® solutions had a lower preference for the higher Intralipid® 
concentrations compared to sham-operated rats; the latter showed a clear 
preference for high concentrations (above 0.1%) of Intralipid®. Sham-operated rats 
consumed up to 100 ml per day of Intralipid® – a volume equivalent to 20% of their 
body weight. After bypass, the reduced preference for Intralipid® was present early 
and persisted for at least 200 days.  
In contrast, I observed no difference in the preference for Intralipid® between bypass 
and control rats in a brief access test which is specifically designed for rats to ingest 
only very small amounts of Intralipid® during the 30 minute test sessions; hence, the 
total amount of Intralipid® ingested is much smaller than during the 48 hours of 
exposure in the two bottle preference tests (Smith 2001;Spector & Glendinning 
2009). Consequently, associations of particular Intralipid® concentrations with 
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postingestive effects such as satiety or visceral malaise are minimized in the brief 
access test (Smith 2001;Spector & Glendinning 2009).  
I therefore concluded that the reduced preference for high fat food seen in rats after 
gastric bypass may in part be due to negative postingestive effects including 
conditioned taste aversion against high concentrations of fat. I further investigated 
this possibility and found that gastric bypass rats treated with 1ml of corn oil by 
gastric gavage showed a marked reduction in their preference for saccharine 
solution that is normally highly preferred by rats. However, the taste aversion was 
not as strong as in the case of the positive control lithium chloride because gastric 
bypass rats continued to consume at least 50% (versus about 5% in lithium chloride 
treated rats) of their fluid intake as saccharine solution; further, in the two bottle tests 
comparing Intralipid® and distilled water intake, Intralipid still made up about 50% of 
total liquid intake.  The lithium chloride group was simply included as a basic positive 
control in the taste aversion experiment, without having a priori knowledge of 
whether corn oil would serve as an effective unconditioned stimulus; hence I did not 
make an effort to match the aversive potency of the treatments.  Accordingly, this 
can potentially explain the disparity in the magnitude of the aversion between the two 
groups.   
Interestingly, the conditioned taste aversion seen after gavage of a small volume of 
corn oil in our study was of a similar magnitude compared with the conditioned taste 
aversion produced by peripheral administration of the GLP-1 receptor agonist 
exendin-4. Thus, it seems plausible to suggest that alterations in fat preference after 
gastric bypass may result in part from the induction of an aversive response 
mediated by increased levels of GLP-1, but it was beyond the scope of my studies to 
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assess neuronal activity in specific brain areas like the area postrema or the solitary 
tract.  
Whether gastric bypass also induces an aversion against the ingestion of highly 
concentrated sugar solutions is unknown. Comparing fat aversion after gastric 
bypass to aversion to sucrose or a combination of fat and sucrose may yield more 
insight.  Smith et al. reported that rats conditioned with corn oil show a more 
profound aversion to the sucrose/corn oil mixture than rats conditioned with sucrose, 
suggesting that the salient feature of the sucrose/corn oil mixture is the oil (Smith et 
al. 2000). It would be instructive to compare the relative effectiveness of corn oil 
versus mineral oil infusions to induce a conditioned taste aversion to determine 
whether it is the nutritive or non nutritive properties of the fluid that are critical. 
My data in the rat gastric bypass model are consistent with previous human findings 
that gastric bypass does not only reduce food intake (Korner, Bessler, Cirilo, 
Conwell, Daud, Restuccia, & Wardlaw 2005;le Roux, Aylwin, Batterham, Borg, 
Coyle, Prasad, Shurey, Ghatei, Patel, & Bloom 2006a;le Roux, Welbourn, Werling, 
Osborne, Kokkinos, Laurenius, Lonroth, Fandriks, Ghatei, Bloom, & Olbers 2007), 
but also preference for food high in fat (Brolin, Robertson, Kenler, & Cody 
1994;Brown, Settle, & Van Rij 1982;Halmi, Mason, Falk, & Stunkard 1981;Olbers, 
Bjorkman, Lindroos, Maleckas, Lonn, Sjostrom, & Lonroth 2006). The reduced 
preference for fat was absent or at least less pronounced in patients six years after 
vertical-banded gastroplasty in which the anatomical rearrangement of the small 
bowel is not part of the operation and which is known not to induce changes in 
postprandial gut hormone levels (Valverde, Puente, Martin-Duce, Molina, Lozano, 
Sancho, Malaisse, & Villanueva-Penacarrillo 2005). However, gastric bypass rats still 
showed a substantial preference for the solid high fat diet which made up 86% of 
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total energy intake. In contrast, preference for the liquid Intralipid® concentrations 
was reduced up to 50%.  
Gastric bypass leads to reduced hunger (Borg, le Roux, Ghatei, Bloom, Patel, & 
Aylwin 2006), increased satiation (Borg, le Roux, Ghatei, Bloom, Patel, & Aylwin 
2006) and increased energy expenditure (Bueter et al. 2010b;Stylopoulos, Hoppin, & 
Kaplan 2009), all of which are at least partly mediated by alterations in 
gastrointestinal and central neuroendocrine signalling (Korner, Bessler, Cirilo, 
Conwell, Daud, Restuccia, & Wardlaw 2005;le Roux, Aylwin, Batterham, Borg, 
Coyle, Prasad, Shurey, Ghatei, Patel, & Bloom 2006a;Stylopoulos, Hoppin, & Kaplan 
2009). Indeed, I confirmed previous findings demonstrating that gastric bypass leads 
to increased postprandial levels of GLP-1 and PYY when compared to sham-
operated control rats (Korner, Bessler, Cirilo, Conwell, Daud, Restuccia, & Wardlaw 
2005;le Roux, Aylwin, Batterham, Borg, Coyle, Prasad, Shurey, Ghatei, Patel, & 
Bloom 2006a),(Baggio & Drucker 2007;Karra et al. 2009). In addition, GLP-1 or PYY 
may also influence fatty acid detection or perception and there may be parallels with 
the recognition of sweet stimuli. Mice lacking the GLP-1 receptor show decreased 
behavioural responsiveness to sucrose.  This receptor has been shown to be 
expressed on taste afferent fibers, and GLP-1 is expressed in taste buds cells (Feng, 
Liu, Zhou, Wang, & Liu 2008;Shin, Martin, Golden, Dotson, Maudsley, Kim, Jang, 
Mattson, Drucker, Egan, & Munger 2008).  
 
Part of the lower preference for high fat food may be induced by postingestive 
consequences that produce visceral illness. This is supported by our observation 
that rats did not show a reduced preference for concentrations of Intralipid® of 0.5% 
or higher when they were only allowed to ingest very small amounts during a brief 
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access test. Consistent with my previous finding, the conditioned taste aversion 
experiment showed that corn oil administered by gavage (thus excluding a direct 
effect of corn oil within the oral cavity) produced signs of conditioned taste aversion, 
although the effects were less intense than after lithium chloride. This is consistent 
with my findings that gastric bypass rats still ingested half of their total fluid intake 
from Intralipid® during the two bottle preference test. Hence, postingestive aversive 
consequences may be one, but not the only factor to explain reduced fat preference 
after gastric bypass. 
In conclusion, gastric bypass in humans and rats reduces preference for high fat 
food and high concentrations of Intralipid® solution. Postingestive effects and 
conditioned taste aversion may partly explain my findings. By elucidating the 
mechanisms by which obesity surgery reduces consumption of high fat foods, new 
surgical and non-surgical therapies could be developed that mimic these 
mechanisms and so promote safe and effective weight loss. 
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Sweet taste and preference after gastric bypass 
 
I demonstrated that gastric bypass reduces the preference for sucrose in rats, 
although preoperative sucrose exposure attenuated this effect.  In contrast, there 
was no change in salt, bitter and sour preferences after gastric bypass. My findings 
are consistent with previous reports in humans (Olbers, Bjorkman, Lindroos, 
Maleckas, Lonn, Sjostrom, & Lonroth 2006) suggesting the rat model is reliable to 
pursue the physiological, endocrine, and molecular mechanisms underlying the 
effects of gastric bypass on taste and food preference. In this regard, I confirmed 
that gastric bypass in rats, as in humans, leads to increased postprandial levels of 
the satiety gut hormones GLP-1 and PYY (Bueter, Lowenstein, Ashrafian, 
Hillebrand, Bloom, Olbers, Lutz, & le Roux 2010a;le Roux, Aylwin, Batterham, Borg, 
Coyle, Prasad, Shurey, Ghatei, Patel, & Bloom 2006a;le Roux, Welbourn, Werling, 
Osborne, Kokkinos, Laurenius, Lonroth, Fandriks, Ghatei, Bloom, & Olbers 2007). 
The changes in both mRNA and tissue protein levels of the taste receptor proteins 
T1R2 and T1R3, which form a heterodimer that binds with sweeteners, in the small 
bowel may contribute to the postingestive effects that could influence sucrose 
preference.  
I also investigated changes in sucrose taste detection thresholds in humans as one 
basic aspect of taste function in general and found that gastric bypass patients can 
detect lower concentrations of sucrose when compared to normal weight controls. 
This has been reported before (Brolin, Robertson, Kenler, & Cody 1994;Brown, 
Settle, & Van Rij 1982;Halmi, Mason, Falk, & Stunkard 1981), but in contrast to 
previous experiments I used the method of constant stimuli in which taste stimuli are 
presented randomly and performance is assessed across a set of concentrations 
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allowing for the derivation of a psychometric function. Moreover, subjects obtained 
feedback by receiving tokens for correct responses and losing tokens for incorrect 
responses which appeared to keep subjects vigilant and motivated in this game-like 
competitive setting. Using this novel approach, I confirmed that patients, after gastric 
bypass, can detect lower sucrose concentrations compared with both their 
preoperative performance and that of lean control subjects.  
I confirmed that gastric bypass increases postprandial plasma levels of the L-cell 
hormones GLP-1 and PYY which have been shown to reduce hunger and enhance 
satiety (Baggio & Drucker 2007;Batterham, Cohen, Ellis, le Roux, Withers, Frost, 
Ghatei, & Bloom 2003). In addition, increased plasma GLP-1 levels may be 
consistent with my observation of a reduction in sucrose taste thresholds after 
gastric bypass. GLP-1 is expressed in murine taste bud cells and is considered as a 
potential paracrine modulator of the peripheral gustatory apparatus, as GLP-1 
receptors are found on intragemmal taste afferent nerve fibers (Feng, Liu, Zhou, 
Wang, & Liu 2008;Shin, Martin, Golden, Dotson, Maudsley, Kim, Jang, Mattson, 
Drucker, Egan, & Munger 2008). Sufficiently high plasma levels of GLP-1 may affect 
peripheral taste signalling. Reception and transduction of sweet-tasting compounds 
has been shown to involve, in part, α-gustducin and the sugar binding receptor 
subunit T1R3 (Kokrashvili et al. 2009a;Kokrashvili, Mosinger, & Margolskee 
2009b;Zhao, Zhang, Hoon, Chandrashekar, Erlenbach, Ryba, & Zuker 2003), but 
these proteins also partly mediate the glucose-dependent GLP-1 secretion from 
enteroendocrine L cells of the gut (Jang, Kokrashvili, Theodorakis, Carlson, Kim, 
Zhou, Kim, Xu, Chan, Juhaszova, Bernier, Mosinger, Margolskee, & Egan 2007). 
The close cellular and functional relationship of GLP-1, T1R3, and α-gustducin may 
allow the elevated levels of GLP-1 seen after gastric bypass to influence the taste 
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signal pathways at multiple levels.  The decreased detection thresholds seen after 
gastric bypass are consistent with this possibility. 
 A reduction in sweet taste sensitivity is also in agreement with recent findings 
demonstrating that some taste receptor cells are target of the adipose-derived 
hormone leptin. Kawai et al. showed that intraperitoneal leptin injections in lean mice 
suppressed responses of peripheral taste nerves to sucrose and saccharine without 
affecting other taste qualities (Kawai et al. 2000). This effect was absent in db/db 
mice which have no leptin receptors (Kawai, Sugimoto, Nakashima, Miura, & 
Ninomiya 2000). Furthermore, taste bud cells of lean mice expressed mRNA of the 
leptin receptor (Shigemura et al. 2003) suggesting that leptin may not only be a 
regulator of food intake and energy expenditure, but also a modulator of taste 
sensing of sweeteners (Shigemura, Ohta, Kusakabe, Miura, Hino, Koyano, 
Nakashima, & Ninomiya 2004). As gastric bypass dramatically decreases white 
adipose tissue, the main source of leptin (Beckman, Beckman, & Earthman 2010), 
one would expect selective increases in taste sensitivity to sweeteners after this type 
of operation, which I found here. 
Threshold measures do not necessarily correlate with suprathreshold sensitivity 
(Bartoshuk 1978) and thus may not accurately reflect the hedonic evaluation of 
higher concentrations of taste stimuli. Accordingly, I complemented our measures of 
sucrose taste sensitivity with a visual analogue scale that is designed to estimate the 
sucrose concentration that is “just about right” (Conner & Booth 1988;Drewnowski, 
Brunzell, Sande, Iverius, & Greenwood 1985;Frijters & Rasmussen-Conrad 1982). 
This scale allowed us to assess the relative taste acceptability of a wide range of 
suprathreshold sucrose concentrations, while keeping potential confounding 
postingestive factors to a minimum as all samples only contacted the oral cavity and 
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were not swallowed. The “just about right” VAS has been used extensively in 
sensory consumer testing and marketing research because it effectively links taste 
compound concentration with acceptance and thus provides information on the 
affective value of the stimulus (Conner & Booth 1988;Drewnowski, Brunzell, Sande, 
Iverius, & Greenwood 1985;Frijters & Rasmussen-Conrad 1982). Despite an 
increased sensitivity to detect sucrose in lower concentrations, surprisingly I found 
that there was no difference in the hedonic ratings of sucrose solutions by patients 
before compared with after gastric bypass. This discrepancy could be due to a 
potential lack of correspondence between sucrose detection thresholds on one hand 
and the perceived intensity of suprathreshold sucrose concentrations on the other 
hand (Bartoshuk 1978). I also cannot dismiss the possibility that other scaling 
procedures for measuring the hedonic value of taste stimuli might reveal effects of 
gastric bypass on sucrose acceptability (Bartoshuk, Duffy, Hayes, Moskowitz, & 
Snyder 2006), but at least with the scale employed here there was no evidence of a 
postoperative change.  While this deserves further attention in future experiments, 
my results suggest that the changes in food preference observed after gastric 
bypass might not represent a fundamental shift in the hedonic evaluation of the food, 
but may be more related to other factors such as postingestive events and learning.  
The rats in our study displayed a decreased sucrose preference after gastric bypass, 
although this effect was attenuated in rats that had preoperative sucrose experience. 
In contrast, there was no change in NaCl, quinine, and citric acid preferences after 
gastric bypass. This is in line with findings of Hajnal et al showing decreased taste 
preference for 0.3 and 1.0 M sucrose solutions following gastric bypass in obese 
CCK-1 receptor deficient OLETF rats compared with intact controls (Hajnal et al. 
2010b).  
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There are several potential mechanisms that could underlie the selective effects of 
gastric bypass on sucrose preference in obese rats and these are not necessarily 
mutually exclusive. First, the reduced sucrose preference after gastric bypass could 
be related to alterations in peripheral or central gustatory processes. For example, 
Hajnal et al (Hajnal, Kovacs, Ahmed, Meirelles, Lynch, & Cooney 2010b) performed 
extracellular single neuron recordings in the pontine parabrachial nucleus (PBN), 
which is the second central relay in the ascending gustatory system of rodents 
(Norgren and Pfaffmann 1975). Obese CCK-1 receptor-deficient OLETF rats had 
neural concentration-response functions to oral sucrose stimulation that were shifted 
to the right compared with lean controls, but this was reversed by gastric bypass 
such that the curves between the two groups were similar. Although the origin of this 
effect could still be peripheral, these results demonstrate that the consequences of 
gastric bypass can be seen in a critical nucleus of the central taste pathway. (Hajnal, 
Kovacs, Ahmed, Meirelles, Lynch, & Cooney 2010b).  The data from my human 
experiments suggest that sucrose taste sensitivity is enhanced after gastric bypass, 
but I did not explicitly measure this in rats.  Nevertheless, even if the changes in 
threshold translated into more intense sensations at higher sucrose concentrations, it 
is unclear why this would result in decreased preference.  In fact, one would expect 
to see a greater preference for the lower sucrose concentrations and this did not 
occur. Thus, despite the fact that the perceived taste intensity of sucrose might 
actually be greater in gastric bypass rats, it appears likely that additional factors are 
at play.  Another possibility is that the lower preference of gastric bypass rats for 
higher sucrose solutions may be induced by postingestive consequences producing 
visceral malaise (Kyriazakis, Tolkamp, & Emmans 1999). Such negative 
postingestive effects might be mediated by increased postprandial levels of GLP-1 
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and PYY as both hormones activate neurons in the area postrema (AP) and the 
intermediate nucleus tractus solitarius (NTS) (Halatchev & Cone 2005); brainstem 
areas that are known to mediate effects of certain aversive stimuli (Halatchev & 
Cone 2005). In addition, peripheral administration of PYY (Halatchev & Cone 2005) 
and at least central administration of GLP-1 (Seeley, Blake, Rushing, Benoit, Eng, 
Woods, & D'Alessio 2000;Thiele, Van, Campfield, Smith, Burn, Woods, Bernstein, & 
Seeley 1997) have been shown to cause conditioned taste aversion in mice and rats, 
respectively. However, it was beyond the scope of my study to assess neuronal 
activity in specific brain areas like the AP and the NTS.  Nevertheless, gastric bypass 
rats with no preoperative sucrose experience still ingested approximately half of their 
total fluid intake from sucrose when exposed to the highest concentration and 
presurgical sucrose exposure appeared to attenuate this effect. Thus, severely 
aversive consequences cannot be the sole explanation for the reduced sucrose 
preference after gastric bypass. Alternatively, perhaps the normal satiating potency 
of sucrose is enhanced by gastric bypass.  It is tempting to speculate that the altered 
expression of intestinal T1R2 and T1R3 receptor proteins after gastric bypass 
affected nutrient sensing in the gut with associated consequences on satiety 
processes. However, the role of intestinal T1R2 and T1R3 receptor proteins in sugar 
preference remains debatable. For example, one recent study reported that T1R3 
knockout mice develop strong preferences for flavors paired with intragastric sugar 
infusions suggesting that sugar binding gut receptors do not directly influence sugar 
intake and preference (Sclafani et al. 2010).   
Finally, the potential contribution of learning processes affecting sucrose preference 
and intake after gastric bypass should not be ignored. In my study, the rats that had 
presurgical sucrose experience appeared to be somewhat refractory to the 
172 
 
suppressive effects of gastric bypass on preferences for low and midrange 
concentrations of sucrose in a two bottle test suggesting that some form of learning 
may have influenced the behaviour. It has been shown that rats and other animals 
can initially display reduced intake of and preference for novel tasting foods and 
fluids. This phenomenon is referred to as neophobia (BARNETT 1958). Neophobia 
can also be enhanced if the rat has encountered a recent experience of visceral 
malaise (Domjan 1974). In addition to neophobia, it is well documented that rats can 
learn, in a single trial, to avoid consumption of novel tasting foods and fluids when 
ingestion is followed by certain types of visceral distress such as that caused by 
administration of agents known to elicit nausea in humans (Barker, Best, & Domjan 
1977;Garcia et al. 1955).  This can occur even when there is up to a 12 hour delay 
between the ingestion and the illness and in many cases requires only a single 
pairing (Barker, Best, & Domjan 1977;Carroll and Smith 1974).  However, taste 
novelty is a key component; it is much more difficult to condition a taste aversion to 
familiar tasting substances (Barker, Best, & Domjan 1977;Siegel 1974).  The 
adaptive significance of these processes requires little defence especially in a 
species such as the rat which is incapable of vomiting (BORISON and WANG 1953).  
Given that taste novelty is a critical feature in the demonstration of neophobia and 
conditioned taste aversion, it is possible that either of these processes, or even both, 
underlie the differences in the effects of gastric bypass on sucrose preference seen 
in animals with vs. without presurgical experience with this taste stimulus (Barker, 
Best, & Domjan 1977). My results do however caution against some of the initial 
conclusions regarding sucrose preferences in recent publications (Hajnal, Kovacs, 
Ahmed, Meirelles, Lynch, & Cooney 2010b), especially as very few humans would 
be naïve to the taste of sucrose. 
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In conclusion, gastric bypass increases the oral sensitivity to detect sucrose in 
humans and reduces sucrose preference in rats. These findings are associated with 
changes in sugar-binding taste receptors in the gut and increased levels of GLP-1 
after gastric bypass. Postingestive factors together with increased sensitivity to 
detect lower concentrations of sucrose in the mouth as well as learning may explain 
the changes in food preference seen after gastric bypass. It will be important for 
future work to examine whether gastric bypass alters taste detection thresholds in 
the rat model, which allows for more systematic and targeted manipulations aimed at 
revealing mechanisms.  Further elucidation of the mechanisms by which gastric 
bypass reduces consumption of high-caloric foods may help in the development of 
novel surgical and non-surgical therapeutic interventions that will promote safer and 
more effective weight loss. 
174 
 
Chapter 10: Summary  
 
Patients after gastric bypass reported a lack of desire to consume fatty food as they 
no longer found it enjoyable (Halmi, Mason, Falk, & Stunkard 1981). Total fat intake 
is lower after gastric bypass, because of a reported disinterest in sweets or deserts 
after surgery (Brolin, Robertson, Kenler, & Cody 1994;Brown, Settle, & Van Rij 
1982;Olbers, Bjorkman, Lindroos, Maleckas, Lonn, Sjostrom, & Lonroth 2006). The 
gustatory system is a prime candidate to contribute to the observed effects after 
gastric bypass and changes might be mediated by altered gut hormone levels (Shin, 
Martin, Golden, Dotson, Maudsley, Kim, Jang, Mattson, Drucker, Egan, & Munger 
2008). It remains however unclear, whether such changes in preferences, even if 
taste-related, are attributable to changes in the intensity of the sensory signals 
generated by food (stimulus identification) or by their altered evaluation in so called 
“reward” circuits in the brain (ingestive motivation), or both. Finally, gastric bypass 
may also induce negative postingestive consequences via cephalic phase reflexes 
that lead to changes in food preference (digestive preparation).  
 
In conclusion, I have demonstrated that gastric bypass in humans and rats reduces 
the preference for high fat food and high concentrations of Intralipid® solution. 
Postingestive effects and conditioned taste aversion may partly explain my findings.  
Furthermore, gastric bypass increases the oral sensitivity to detect sucrose in 
humans and reduces sucrose preference in rats. My findings are associated with 
changes in sugar-binding taste receptors in the gut and increased levels of GLP-1 
after gastric bypass. Postingestive factors together with increased sensitivity to 
detect lower concentrations of sucrose in the mouth as well as learning may explain 
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the changes in food preference seen after gastric bypass. It will be important for 
future work to examine whether gastric bypass alters taste detection thresholds in 
the rat model, which allows for more systematic and targeted manipulations aimed at 
revealing mechanisms.   
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Abstract
Background The aim of this study was to evaluate whether
gastric bypass with or without vagal preservation resulted
in a different outcome.
Methods Body weight, food intake and postprandial pep-
tide YY (PYY) and glucagon-like peptide (GLP-1) levels
were compared between gastric bypass (n=55) and sham-
operated rats (n=27) in three groups. In group 1 (n=17),
the vagal nerve was not preserved, while in group 2 the
vagal nerve was preserved during gastric bypass (n=10). In
group 3, gastric bypass rats (n=28) were randomised for
either one of the two techniques.
Results Rats in which the vagal nerve was preserved during
gastric bypass showed a lower body weight (p<0.001) and
reduced food intake (p<0.001) compared to rats in which the
vagal nerve was not preserved during the gastric bypass
operation. Levels of PYY and GLP-1 were significantly
increased after gastric bypass compared to sham-operated
controls (p<0.05), but there was no difference between gastric
bypass rats with and without vagal preservation. Differences
in food intake and body weight were not related to the size of
the gastro-jejunostomy in gastric bypass rats. There were no
signs of malabsorption or inflammation after gastric bypass.
Conclusion We propose that the vagal nerve should be
preserved during the gastric bypass operation as this might
play an important role for the mechanisms that induce weight
loss and reduce food intake in rats. In contrast, the gastro-
jejunal stoma size was found to be of minor relevance.
Keywords Gastric bypass . Rats . Para-oesophageal bundle .
Vagal nerve . Left gastric vessels .Weight loss
Introduction
Bariatric surgery has been proven to be the most effective
treatment for severe obesity and its inherent co-morbidities
resulting in significant and sustained weight loss with a proven
mortality benefit [1, 2]. At present, the Roux-en-Y gastric
bypass procedure (gastric bypass) provides reliable and
sustainable weight loss. Given the rapid increase in gastric
bypass procedures, it is important to understand the underlying
mechanisms by which gastric bypass induces and sustains
weight loss [3, 4]. The use of animal models for gastric bypass
surgery is a valuable tool and has been shown to be a valid
model to mimic human weight loss after gastric bypass [5–7].
However, there is significant variation in techniques used in
humans and rodent models. The results for weight loss, food
intake and mortality rates are heterogeneous [5–15].
The vagal nerve is thought to have an important role in
the regulation of food intake and body weight, but only a
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few reports examined whether vagal preservation is
effective or necessary in weight control after bariatric
surgery [15–17]. Gut hormones released from enteroendo-
crine cells in the distal ileum like glucagon-like peptide
(GLP-1) and peptide YY (PYY) can signal either through
the circulation or via afferent vagal fibres [18].
In this study, we describe variations in the technique for
gastric bypass surgery in rats in the area of the gastro-
jejunostomy. Here, the para-oesophageal bundle can be
found which contains the left gastric vessels and the dorsal
vagal trunk that contains 4/5 of the right vagal fibres and a
1/5 of the left vagal fibres [19]. The aim of our study was to
assess whether preservation of the vagal fibres in the para-
oesophageal bundle impacts on body weight and food
intake after gastric bypass in rats.
Material and Methods
Animals
Male Wistar rats used were individually housed under a
12/12 h light–dark cycle and at a room temperature of
21±2°C. Water and standard chow were available ad
libitum, unless otherwise stated. All experiments were
performed under a licence issued by the Home Office UK
(PL 70-5569) or approved by the Veterinary Office of the
Canton Zurich, Switzerland. Body weight and food intake
were measured daily in groups 1 and 2 for a postoperative
period of 60 days and in group 3 for 75 days.
Surgery
All operations reported in this study were performed by one
surgeon (MB). After 1 week of acclimatisation, rats were
randomised to gastric bypass or sham operation. Rats were
food deprived for 12 h overnight, but water was available
ad libitum. Before surgery, rats were weighed, and then
anaesthetised with isofluorane (4% for induction, 3% for
maintenance). Preoperatively, gentamicin 8 mg/kg and
carprofen 0.01 ml were administered intraperitoneally (ip)
as prophylaxis for postoperative infection and pain relief.
Surgery was performed on a heating pad to avoid decrease
of body temperature during the procedure. Prior to a
midline laparotomy, the abdomen was shaved and dis-
infected with surgical scrub. In the sham group, a 7 mm
gastrotomy on the anterior wall of the stomach with
subsequent closure (interrupted prolene 5-0 sutures) and a
7 mm jejunotomy with subsequent closure (running prolene
6-0 suture) was performed. In the gastric bypass group, the
proximal jejunum was divided 15 cm distal to the pylorus to
create a biliopancreatic limb. After identification of the
caecum, the ileum was then followed proximally to create a
common channel of 25 cm. Here, a 7 mm side-to-side jejuno-
jejunostomy (running prolene 7-0 suture) between the
biliopancreatic limb and the common channel was performed.
The two techniques described below in this paper relate
to how the stomach was transected close to the gastro-
oesophageal junction to create a small gastric pouch with
no more than 3 mm of gastric mucosa left. The gastric
pouch and alimentary limb was anastomosed end-to-side
using a running prolene 7-0 suture. The gastric remnant was
closed with interrupted prolene 5-0 sutures. The complete
bypass procedure lasted approximately 60 min and the
abdominal wall was closed in layers using 4-0 and 5-0
prolene sutures. Approximately 20 min before the antici-
pated end of general anaesthesia, all rats were injected with
0.1 ml of 0.3% buprenorphine subcutaneously to minimise
postoperative discomfort. Immediately after abdominal
closure, all rats were injected subcutaneously with 5 ml of
normal saline to compensate for intraoperative fluid loss.
After 24 h of wet diet (normal chow soaked in tap water),
regular chow was offered on postoperative day 2.
Experimental Design
The vagal fibres in the para-oesophageal bundle in the area
of the gastric pouch were subjected to two different
techniques. All groups were operated in chronological
order. In a first group, 25 obese rats (body weight (BW)
348±3.9 g) were randomised for gastric bypass (n=17) or
sham operation (n=8). In this group the vagal fibres were
not preserved in the gastric bypass rats as the para-
oesophageal neurovascular bundle was completely ligated
(group 1). In a subsequent group, 18 obese rats (332±2.4 g)
were randomised to gastric bypass (n=10) or sham
operation (n=8). Here, the vagal fibres were preserved as
the left gastric vessels were separated and selectively
ligated in all gastric bypass rats (group 2). Significant
differences in body weight and energy intake were
observed in these two groups. As it was unclear whether
these differences were related to the different techniques of
vagal preservation, a third group (group 3) of 39 obese rats
(471±4.3 g) was randomised for gastric bypass without
vagal preservation (n=14) or gastric bypass with vagal
preservation (n=14) or sham operation (n=11).
Hormone Assay
Animals from group 3 were fasted for 12 h from the
beginning of the light cycle. At the onset of the dark cycle
animals were offered 5 g of standard chow all of which was
consumed within half an hour by the animals. Blood was
then obtained by puncture of a sublingual vein under brief
isoflurane anaesthesia from sham-operated controls, gastric
bypass with and without vagal preservation (each n=6).
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Blood was collected into EDTA-rinsed tubes and, immedi-
ately centrifuged at 3,000 rpm for 10 min at 4°C. The
supernatant was stored at −80°C until further analysis.
Concentrations of active GLP-1 and PYY were analysed
using a rat endocrine lincoplex kit (RENDO-85 K, Labodia
SA, Yens, Switzerland).
Measurement of Size of the Gastro-Jejunostomy
To exclude that the differences in body weight between
bypass rats were due to different levels of restriction and
subsequent differences in food intake, sizes of the gastro-
jejunostomy were measured during necropsy in all gastric
bypass rats of group 3.
CRP Analysis
Blood was obtained from all animals of group 3 by
puncture of a sublingual vein under brief isoflurane
anaesthesia. Blood was collected into EDTA-rinsed tubes
and immediately centrifuged at 3,000 rpm for 10 min at
4°C. Plasma was stored at −80°C before analysis for C-
reactive protein (Abbott, UK) to assess inflammation.
Faecal Analysis
To evaluate nutrient malabsorption, faeces were collected over
24 h on postoperative days 15 and 59 from all animals in group
3. Faeces were dried in an oven and weighed; calorie content
was measured using a ballistic bomb calorimeter [20].
Statistics
All data were normally distributed and are expressed as
mean ± SEM. Student’s t test for independent samples and
one-way ANOVA with repeated measures and post-hoc
Bonferroni test for each time point were used to test for
significant differences. p<0.05 was considered significant.
Results
Mortality
Overall surgical mortality was 13.4% (11/82). Gastric
bypass-related mortality was 14.5% (8/55), while mortality
after sham operation was 11.1% (3/27, p=0.668). There
was no mortality difference between bypass rats with
complete ligation and with preservation of the para-
oesophageal bundle. All eight bypass rats showed signs of
respiratory distress along with hypersalivation and dyspha-
gia within the first two postoperative days after the
operation and were euthanized immediately after onset of
symptoms. Necropsy revealed that these symptoms origi-
nated at the level of the gastro-jejunostomy where food did
not pass through and was retained in the oesophagus.
Whether this was due to inflammatory swelling following
anastomotic leakage or due to anastomotic constriction
remains unclear. The three sham-operated rats died without
prior noticeable symptoms. Necropsy revealed in two cases
a small bowel ileus presumably due to a volvulus after
inappropriate repositioning of the viscera into the abdom-
inal cavity at the end of the operation. In one case, a leak at
the site of the gastrotomy was found.
Energy Intake
In group 1, there was no difference in average daily energy
intake between gastric bypass rats and sham-operated rats
over a period of 60 days (sham, 97.4±2.5 kcal vs. bypass,
89.3±4.7 kcal, p=0.3). In contrast, gastric bypass rats of
group 2 ate significantly less than the sham-operated rats
(sham, 76.7±2.2 kcal vs. bypass, 52.5±4.8 kcal, p<0.001).
In group 3, there was no difference in average energy intake
between bypass rats without vagal preservation and sham-
operated rats over a period of 75 days, while bypass rats
with vagal preservation ate significantly less than sham-
operated rats and rats without vagal preservation (sham,
118.7±3.9 kcal vs. bypass with vagal preservation, 84.4±
3.3 kcal vs. bypass without vagal preservation, 102.8±
7.5 kcal, p<0.001). The average daily energy intake is
shown for all three groups in Fig. 1.
Body Weight
In all three groups gastric bypass rats had a significant
lower body weight than sham-operated rats from day 5 after
surgery throughout the rest of the observation period. After
a short period of post-surgical weight loss, sham-operated
rats of all three groups constantly gained weight for the rest
of the study. In group 1, gastric bypass rats started to regain
weight around postoperative day 25 and there was no
difference between their body weight before surgery and
after surgery at the end of the observation period (day 0,
457.0±7.4 g vs. day 60, 468.0±9.3 g, p=0.36). In group 2,
gastric bypass animals lost about 20% of their preoperative
weight by postoperative day 25 and their body weight then
plateaued around 260 g (day 0, 330.8±5.8 g vs. day 60,
259.1±16.3 g, p=0.001). In group 3, there was no
difference in body weight between bypass rats without
vagal preservation and bypass rats with vagal preservation
until postoperative day 40 (day 40: bypass with vagal
preservation, 408.3±11.2 g vs. bypass without vagal
preservation, 414.4±11.2 g, p=0.70). However, thereafter
bypass rats without vagal preservation started to regain
weight for the rest of the observation period, while bypass
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rats with preserved vagal fibres maintained their low body
weight (day 75: bypass with selective ligation, 365.8±
14.6 g vs. bypass with complete ligation, 468.0±9.3 g, p<
0.001). The development of body weight after surgery is
shown for all groups in Fig. 2.
Postprandial Plasma Levels of PYY and Active GLP-1
One-way ANOVA revealed significant differences for
levels of PYY and active GLP-1 in the gastric bypass
groups in comparison to sham-operated controls (PYY:
sham, 29.5±7.1 pg/ml vs. bypass with vagal preservation,
70.4±8.8 pg/ml vs. bypass without vagal preservation, 83.2±
14.3 pg/ml, p<0.01; GLP-1: sham, 85.8±2.1 pg/ml vs.
bypass with vagal preservation, 146.9±23.7 pg/ml vs. bypass
without vagal preservation, 155.4±24.1 pg/ml, p<0.05).
However, post-hoc Bonferroni testing showed no significant
Fig. 2 a Body weight change in group 1 for the gastric bypass
(unfilled circle; n=14) and sham-operated rats (filled square; n=7).
Data are shown as mean values ± SEM (*p<0.05). b Body weight
change in group 2 for the gastric bypass (unfilled circle; n=8) and
sham-operated rats (filled square; n=8). Data are shown as mean
values ± SEM (*p<0.05). c Body weight change in group 3 for the
gastric bypass rats without vagal preservation (unfilled circle; n=10)
and gastric bypass rats with vagal preservation (filled circle; n=11)
and sham-operated rats (filled square; n=10). Data are shown as mean
values ± SEM (*p<0.05 for sham vs. bypass; #p<0.05 for bypass
without vagal preservation vs. bypass with vagal preservation)
Fig. 1 a Average daily energy intake (group 1) over 60 days for
sham-operated ad libitum fed rats (n=7, white column) and for gastric
bypass rats (n=14, black column). Data are shown as mean values ±
SEM. b Average daily energy intake (group 2) over 60 days for sham-
operated ad libitum fed rats (n=8, white column) and for gastric
bypass rats (n=8, black column). Data are shown as mean values ±
SEM (***p<0.001). c Average daily energy intake (group 3) over
75 days for sham-operated ad libitum fed rats (n=10, white column)
and for gastric bypass rats with vagal preservation (n=11, dark grey)
or without vagal preservation (n=10, light grey). Data are shown as
mean values ± SEM. Post-hoc differences between the three groups
are indicated (***p<0.001 and *p<0.05)
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difference for PYY and GLP-1 levels between gastric bypass
rats with or without vagal preservation (Fig. 3).
Size of the Gastro-Jejunostomy
There was no gastrogastric fistula in any of the gastric
bypass rats of group 3. The overall size of the gastro-
jejunostomy in all gastric bypass rats was 15.4±0.4 mm.
There was no difference in size of the anastomosis between
rats in which the complete para-oesophageal bundle was
ligated and rats in which the left gastric vessels were
separated and selectively ligated (bypass with selective
ligation, 15.2±0.4 mm vs. 15.6±0.7 mm, p=0.69).
CRP Analysis
C-reactive protein levels were below 2 mg/L in all animals
of group 3 indicating that there was no postsurgical
infection or inflammation 28 days after surgery.
Faecal Analysis
There was no increase in either fresh faecal mass (sham,
8.4±0.5 g vs. bypass with vagal preservation, 7.5±0.6 g vs.
bypass without vagal preservation, 7.2±0.6 g, p=0.3) or
faecal calorie content (sham, 3.56±0.04 kcal vs. bypass
with vagal preservation, 3.43±0.05 kcal vs. bypass without
vagal preservation, 3.65±0.06 kcal, p=0.24) in the gastric
bypass animals compared to the sham-operated rats in
group 3.
Discussion
Our data in the rat model for gastric bypass are consistent
with previous findings that gastric bypass surgery can
effectively induce food intake and body weight reduction
[1, 21, 22]. In this randomised study, the weight loss and
food intake outcome of gastric bypass surgery was
dependent on whether vagal fibres were preserved or not
during the formation of the gastric pouch. Rats in which the
para-oesophageal bundle including the vagal fibres was
completely ligated started to regain body weight up to
preoperative levels and showed no difference in average daily
energy intake compared to their sham-operated counterparts.
In contrast, rats in which the para-oesophageal bundle
including the vagal fibres was preserved and in which the
left gastric vessels were selectively ligated, maintained the
reduced body weight and ate significantly less than the sham-
operated controls throughout the entire study period. Gastric
bypass rats had higher postprandial GLP-1 and PYY levels
compared to sham-operated controls, but there were no
differences in GLP-1 and PYY levels between gastric bypass
rats with our without preserved vagal fibres. Furthermore,
differences in food intake and body weight were not related to
the size of the gastro-jejunostomy in gastric bypass rats and
there were no signs of malabsorption or inflammation after
gastric bypass in any of the groups.
Our data confirm previous findings that gastric bypass in
rats increases postprandial levels of peptide YY and
glucagon-like peptide-1, which are satiation-inducing gut
hormones and hence favour an anorectic state and facilitate
body weight loss [5, 21]. Both hormones are thought to
activate anorectic neurons in the hypothalamic arcuate
nucleus which promote weight loss [23–26]. Gut hormones
released from enteroendocrine cells in the distal ileum like
GLP-1 and PYY can signal either through the circulation or
via afferent vagal neurons [18].
In this study body weight and food intake after gastric
bypass were related to whether the vagal fibres within the
para-oesophageal bundle were preserved or not, while there
were no differences in levels of GLP-1 and PYY between
these two groups. This finding highlights the potential role
of the vagal nerve for mediating the inhibitory effects of gut
hormones such as PYY and GLP-1 on food intake and body
weight after gastric bypass surgery in rats. Our findings are
consistent with previous reports showing that the ablation
Fig. 3 Levels of active GLP-1 (a) and PYY (b) for sham-operated ad
libitum fed rats (n=6, white column) and for gastric bypass rats with
vagal preservation (n=6, dark grey) or without vagal preservation (n=
6, light grey). Data are shown as mean values ± SEM. Post-hoc
differences between the three groups are indicated (**p<0.01 and
*p<0.05)
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of the vagal–brainstem–hypothalamic pathway attenuates
the inhibitory effects of PYY and GLP-1 on food intake
[27]. Vagal preservation may thus be necessary for
optimum weight loss after bariatric surgery [15–17].
In contrast to our observation, Wang and Liu [15]
described greater weight loss after gastric bypass and total
vagotomy in rats. The difference was only present at
20 days after surgery, but the difference in food intake
and body weight between bypass rats with or without vagal
dissection was lost thereafter. Another difference to our
study is that Wang and Liu [15] used the bypass operation
to prevent obesity in rats weighing 180–200 g while we
performed surgery to cause weight loss in obese rats.
Weight loss after a gastric bypass operation might also be
due to nutrient malabsorption or postoperative inflamma-
tion. However, we found no evidence for an increase in
either faecal mass or faecal calorie content in the gastric
bypass animals with or without vagal preservation. More-
over, we did not detect any evidence of increased inflamma-
tion in animals with or without vagal ligation post-surgery.
The size of the gastric pouch and the lengths of the
different limbs used in this study have been proven to
effectively induce weight loss [6]. An increasing body of
evidence in humans indicates that up to certain limits the
size of the gastric pouch and length of the different limbs is
of less importance for the outcome of gastric bypass [28].
In support of this observation, we demonstrated that the
level of restriction measured by the size of the gastro-
jejunostomy has no impact on different levels of weight
loss and food intake after gastric bypass in rats.
There are two major limitations of our study. Firstly, we
cannot exclude the possibility that the ligation of the para-
oesophageal bundle is functionally equivalent only to a
partial dissection of the vagal nerve. In addition, we did not
perform a secretin test or histological analysis to collect
further informations on vagal function to confirm whether
the complete ligation of the para-oesophageal bundle
produced a total or partial vagotomy. Secondly, it remains
unclear whether our results can be translated into humans.
Most bariatric surgeons usually aim to preserve the anterior
and posterior vagal trunk during formation of the gastric
pouch, although there is a lack of supporting data indicating
that this approach has beneficial effects. Recently, the
dissection of the anterior vagal trunk during pouch
formation has been reported to have no effect on clinical,
functional and laboratory results of a gastric bypass
operation [16].
In conclusion, our gastric bypass technique induces
reliable weight loss in rats with an acceptable mortality.
We propose that vagal nerve fibres should be preserved
during gastric bypass in rats. Restriction at the gastro-
jejunal anastomosis does not seem to be critical for the
weight loss. Although the mechanisms have not yet been
fully elucidated, vagal preservation may play an important
role in inducing and maintaining weight loss after gastric
bypass in humans and rats.
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TACKGROUND&AIMS:Mechanisms underlying weight
ossmaintenance after gastric bypass are poorly understood.
ur aim was to examine the effects of gastric bypass on
nergy expenditure in rats. METHODS: Thirty diet-in-
uced obese male Wistar rats underwent either gastric by-
ass (n  14), sham-operation ad libitum fed (n  8), or
ham-operation body weight-matched (n  8). Energy ex-
enditure was measured in an open circuit calorimetry
ystem. RESULTS: Twenty-four-hour energy expenditure
as increased after gastric bypass (4.50  0.04 kcal/kg/h)
ompared with sham-operated, ad libitum fed (4.29  0.08
cal/kg/h) and sham-operated, body weight-matched con-
rols (3.98  0.10 kcal/kg/h, P  .001). Gastric bypass
ats showed higher energy expenditure during the light
hase than sham-operated control groups (sham-oper-
ted, ad libitum fed: 3.63  0.04 kcal/kg/h vs sham-
perated, body weight-matched: 3.42 0.05 kcal/kg/h vs
ypass: 4.12  0.03 kcal/kg/h, P  .001). Diet-induced
hermogenesis was elevated after gastric bypass compared
ith sham-operated, body weight-matched controls 3
ours after a test meal (0.41%  1.9% vs 10.5%  2.0%,
espectively, P  .05). The small bowel of gastric bypass
ats was 72.1% heavier because of hypertrophy compared
ith sham-operated, ad libitum fed rats (P  .0001).
ONCLUSIONS: Gastric bypass in rats prevented the
ecrease in energy expenditure after weight loss. Diet-
nduced thermogenesis was higher after gastric by-
ass compared with body weight-matched controls.
aised energy expenditure may be a mechanism ex-
laining the physiologic basis of weight loss after
astric bypass.
eywords:Weight Loss; Diet-Induced Thermogenesis; Gut
ypertrophy.
he obesity epidemic is a major health concern that is
associated with increased morbidity and mortality1
s well as negative personal, social, and economic conse-
uences.2,3 Roux-en-Y gastric bypass (gastric bypass) is
he most effective therapeutic option currently available
or sustained weight loss with a proven mortality bene-
t.4,5 Gastric bypass procedures are increasing rapidly,6ut underlying mechanisms by which gastric bypass in-uces and sustains weight loss are poorly understood.
nitially, it was speculated that weight loss after gastric
ypass was due to mechanical restriction and malabsorp-
ion.7 Experimental and clinical studies, however, have
uggested that other mechanisms contribute to weight
oss after gastric bypass.8–13 The absence of a compensa-
ory increase in appetite after gastric bypass-induced
eight loss has been intriguing because nonsurgical in-
entional body weight loss is usually followed by body
eight regain through increased appetite.14
A proposed mechanisms for reduced food intake after
ypass surgery is the secretory stimulus to L-cells in the
istal gut, resulting in increased levels of gastrointestinal
atiation hormones such as peptide YY (PYY) and pep-
ides of the enteroglucagon family.9,11,15–17 These hor-
ones stimulate anorectic pathways in the hypothala-
us and brain stem leading to reduced food intake18 and
ay also influence energy expenditure.19
Gastric bypass surgery has been successfully modeled
n rat experiments. The body weight loss after gastric
ypass in rats is not only due to decreased food intake
ecause sham-operated, pair-fed controls weigh more
han gastric bypass rats.10,11,20–22 Possible explanations
uch as malabsorption and inflammation have been ex-
luded,10 thus the weight difference despite similar food
ntake raises the possibility of enhanced energy expendi-
ure10 as previously speculated.23,24 We therefore tested
he hypothesis that energy expenditure would be higher
fter bypass surgery.
Materials and Methods
Animals and Housing
Thirty adult diet-induced obese male Wistar rats
eighing 480–500 g were used for energy expenditure
xperiments, and 16 adult male Wistar rats weighing
30–350 g were used for morphometric gut analysis. All
nimals were individually housed under artificial 12-
our/12-hour light-dark cycle and at a room temperature
Abbreviations used in this paper: ARC, arcuate nucleus; NPY, neu-
opeptide Y; POMC, pro-opiomelanocortin; PYY, peptide YY.
© 2010 by the AGA Institute
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ARTICLE IN PRESSf 21°C  2°C unless otherwise stated. Water and stan-
ard chow were available ad libitum. All experiments
ere performed under a license issued by the Home
ffice United Kingdom (PL70-6669) or were approved by
he Veterinary Office of the Canton Zurich, Zurich, Swit-
erland.
Surgery
Surgery was performed according to an estab-
ished protocol as described in the Supplementary Mate-
ials and Methods.10 Figure 1 shows a schematic illustra-
ion of the pre- and postoperative anatomy.
Indirect Calorimetry
Measurements were conducted in an open circuit
alorimetry system (AccuScan Inc, Columbus, OH) as
escribed in the Supplementary Materials and Meth-
ds.25
Experimental Design
The 30 diet-induced obese rats used in the energy
xpenditure experiments were randomized to gastric by-
ass (n  14) or sham operation (n  16). After a
ecovery period of 7 days, sham-operated animals were
andomly divided into 2 groups of 8 rats each: shams
ith no dietary manipulation (ad libitum fed, sham-
igure 1. Diagrammatic representation of the gastrointestinal anat-
my before (A) and after (B) the gastric bypass operation. Letter A within
igure part B represents biliopancreatic limb (10 cm), B represents
limentary limb (50 cm), C represents common channel (25 cm), andcrepresents cecum.perated rats weighing 488.8  3.9 g) and food-re-
tricted, sham-operated rats whose postoperative weight
as matched to the weight of bypass animals (body
eight-matched, sham-operated rats weighing 474.3 
.2 g). Starting on day 7 after gastric bypass surgery, the
ody weight-matched, sham-operated rats received as
uch food daily as was necessary for them to maintain a
imilar body weight to the bypass rats. Based on experi-
nces from previous studies, rats were given 10 g of
tandard chow in the beginning of food restriction. This
mount of food was offered at dark onset and readjusted
very third day depending on the body weight. Sixteen
etabolic cages were used, and measurements were con-
ucted in the following order on 3 consecutive days:
ypass (n  8) vs sham-operated, ad libitum fed (n  8)
40 days after surgery) rats and bypass (n  6) vs sham-
perated, body weight-matched (n  8) (75 days after
urgery) rats. Diet-induced thermogenesis was measured
n rats that were fasted for 12 hours from the beginning
f the light cycle and received a 5-g meal at subsequent
ark onset. Diet-induced thermogenesis was calculated as
he cumulative increase in energy expenditure after a 5-g
est meal compared with fasting values before the test
eal (expressed as percentage of the energy content of
he test meal: 17.6 kcal). Methods for fecal and blood
nalysis are described in the Supplementary Materials
nd Methods.
Measurement of Body Composition
Adipose tissue mass was measured using a rodent
omputerized tomography scanner (Latheta, Aloka, Ja-
an). Rats were anesthetized with isoflurane, and the area
etween vertebrae L1 and L5 was scanned using an x-ray
ource tube voltage of 50 kV, current of 1 mA, pitch size
f 2 mm, and a speed of 4.5 seconds per image (roughly
5 images per rat). Aloka software (Zug, Switzerland) was
sed to estimate volumes of adipose tissue and nonadi-
ose tissue using differences in x-ray density. Adipose
issue weights were computed using the density factor of
.92 g/cm3. Scanning was undertaken 70 days after sur-
ery.
Gut Morphometry
For the study of gut morphometry, 16 male
istar rats were randomized to gastric bypass (n  8) or
ham operation (n  8). All rats were ad libitum fed
hroughout the complete observation period of 60 days.
ats were fasted for 24 hours before being killed to
nsure the small bowel was free of chow residue. The
ntire small bowel from the duodenum to the ileocecal
alve was collected. Total wet weight and length of the
mall bowel were measured in the sham-operated rats,
hereas, in gastric bypass rats, the weight and length of
he 3 limbs (alimentary, biliopancreatic, and common
hannel) were measured separately and then added. Sup-
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ARTICLE IN PRESSlementary Materials and Methods describes gut tissue
rocessing and analysis.
Statistical Analysis
All data were normally distributed and are ex-
ressed as mean  standard error of mean. Student t test
or independent samples and 1-way analysis of variance
ith repeated measures and post hoc Bonferroni test for
ach time point were used to test for significant differ-
nces. P .05 was considered significant. For all analyses,
ata from the 2 gastric bypass groups were pooled be-
ause data did not differ between the 2 time points (day
0 and day 75 after surgery).
Results
Body Weight
Figure 2 shows the body weight changes for both
roups. For the energy expenditure experiments (Figure
A), body weight was significantly lower in gastric bypass
ats compared with the sham-operated, ad libitum fed
roup from day 5 after surgery. On postoperative day 70,
he difference in weight was almost 200 g (sham-oper-
ted, ad libitum fed: 603.2  6.6 g vs bypass: 414.3 
3.8 g, P  .0001). After a short period of postsurgical
eight loss, sham-operated, ad libitum fed rats fed con-
tantly gained weight for the rest of the study. In con-
rast, gastric bypass animals lost 11.2%  1.4% of their
reoperative weight by postoperative day 10; body weight
hen plateaued around 415 g.
Food restriction started 1 week after surgery for the
ody weight-matched, sham-operated (n  8) rats. There
as no significant difference in body weight between the
astric bypass group and the food-restricted body weight-
atched rats on and after day 55 (sham-operated, body
eight-matched: 412.2  3.0 g vs bypass: 408.7  9.4 g,
 .78).
There was no increase in either fresh fecal mass (sham-
perated, ad libitum fed: 8.4  0.5 g vs sham-operated,
ody weight-matched: 6.6  0.6 g vs bypass: 7.3  0.4 g,
 ns) or fecal calorie content (sham-operated, ad libi-
um fed: 3.56  0.04 kcal/g vs sham-operated, body
igure 2. Body weight change
or the gastric bypass (-Œ-) (n 
4) and sham-operated rats ad
ibitum fed (--) (n  8) and
ham-operated body weight
atched (--) (n  8) used for
nergy expenditure measure-
ents (A) and for gastric bypass
-Œ-) (n 8) and sham-operated
ats ad libitum fed (--) (n  8)
sed for gut morphometry anal-
sis (B). Data are shown as
ean values  SEM.eight-matched: 3.51  0.04 kcal/g vs bypass: 3.65 
.04 kcal/g, P  ns) in the gastric bypass animals com-
ared with the control groups. C-reactive protein levels
ere below the detection limit of the assay (2 mg/L) in
ll animals, suggesting no postsurgical infection or in-
ammation 28 days after surgery.
In the gut morphometry experiments, body weight was
ignificantly lower in gastric bypass rats compared with
he sham-operated group from day 5 after surgery (Fig-
re 2B); sham-operated rats gained weight for the rest of
he study, whereas gastric bypass animals lost 15.4% 
.1% of their preoperative weight by postoperative day 10
nd then plateaued around 260 g. The difference in body
eight on day 60 was 164 g (sham-operated, ad libitum
ed: 423.6  10.2 g vs bypass: 259.1  16.3 g, P  .0001).
Body Composition
Adipose tissue mass between vertebrae L1 and L5
n gastric bypass was lower than in sham-operated, ad
ibitum fed rats, but similar to body weight-matched
hams (sham-operated, ad libitum fed: 27.6  2.7 g vs
ham-operated, body weight matched: 5.3  0.9 g vs
ypass: 11.6  1.3 g, P  .001). Nonadipose tissue in
astric bypass was lower than in sham-operated, ad libi-
um fed rats but higher than in body weight-matched
hams (sham-operated, ad libitum fed: 107.1  2.9 g vs
ham-operated, body weight matched: 71.0  1.1 g vs
ypass: 80.9  2.4 g, P  .001).
Food Intake Outside Metabolic Cages
Food intake followed similar patterns as body
eight. Figure 3A shows the average daily food intake for
ats of the energy expenditure experiments (postoperative
ays 1–70). Daily food intake was consistently lower after
astric bypass (sham-operated, ad libitum fed: 34.0 
.2 g vs bypass: 27.5  0.8 g, P  .0001). Body weight-
atched, sham-operated animals required significantly
ess food than gastric bypass animals to maintain the
ame level of body weight (sham-operated, body weight-
atched: 16.2 0.5 g vs bypass: 27.5 0.8 g, P .0001).
astric bypass rats used for the analysis of gut mor-
hometry also ate significantly less than their sham-
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ARTICLE IN PRESSperated counterparts (sham-operated: 32.5  0.4 g vs
ypass: 26.0  0.5 g, P  .0001).
Food Intake in Metabolic Cages
Meal patterns were different among the 3 groups
n the energy expenditure experiment. In the dark phase,
astric bypass and sham-operated, ad libitum fed rats ate
ore than in the light phase. Dark phase food intake in
astric bypass rats was lower than in sham-operated, ad
ibitum fed rats (sham-operated, ad libitum fed: 26.6 
.1 g vs bypass: 17.0 1.5 g, P .0001), whereas they ate
ore during the light phase (sham-operated, ad libitum
ed: 2.7 0.5 g vs bypass: 4.5 0.7 g, P .05, Figure 3B).
ham-operated, body weight-matched rats consumed all
heir food during the first half of the dark phase and are
herefore not represented in Figure 3B.
Energy Expenditure
Twenty-four hour energy expenditure was in-
reased after gastric bypass compared with sham-oper-
ted, ad libitum fed rats and sham-operated, body
eight-matched controls (sham-operated, ad libitum fed:
.29  0.08 kcal/kg/h vs sham-operated, body weight
atched: 3.98  0.10 kcal/kg/h vs bypass: 4.50  0.04
cal/kg/h, P  .001). Sham-operated, body weight-
atched rats had lower total energy expenditure than
ham-operated, ad libitum fed rats (P  .05). When
nalyzing the 2 phases of the light/dark cycle separately,
t was obvious that, during the light phase, when overall
ctivity is typically low, energy expenditure in gastric
ypass rats was significantly higher than in sham-oper-
ted, ad libitum fed animals and body weight-matched
hams (sham-operated, ad libitum fed: 3.63  0.04 kcal/
g/h vs sham-operated, body weight-matched: 3.42 
.05 kcal/kg/h vs bypass: 4.12  0.03 kcal/kg/h, P 
001). In the dark phase, when overall activity is typically
igher, there was no difference in energy expenditure
etween gastric bypass and sham-operated, ad libitum
ed rats, but energy expenditure in bypass rats was higher
han in body weight-matched, sham-operated rats (sham- mperated, ad libitum fed: 4.81  0.06 kcal/kg/h vs sham-
perated, body weight matched: 4.46  0.15 kcal/kg/h vs
ypass: 4.81  0.04 kcal/kg/h, P  .01). Figure 4A shows
verage 24-hour light phase and dark phase energy ex-
enditure for all groups.
Respiratory Quotient
Respiratory quotient was examined during 12
ours of fasting and for the subsequent 6 hours after
ffering a fixed test meal of 5 g. Results are shown in
igure 4B. During fasting, gastric bypass rats had a lower
espiratory quotient than sham-operated, ad libitum fed
ats, but there was no difference in sham-operated, body
eight-matched rats. The pattern was similar for the 0- to
-hour observation period after the test meal for gastric
ypass; sham-operated, ad libitum fed; and sham-oper-
ted, body weight-matched rats (sham-operated, ad libi-
um fed: 0.89  0.01 vs sham-operated, body weight
atched: 0.78  0.01 vs bypass: 0.77  0.01, P  .001)
nd the 3- to 6-hour observation period after the test
eal (sham-operated, ad libitum fed: 0.95  0.01 vs
ham-operated, body weight matched 0.73  0.01 vs
ypass: 0.74  0.01, P  .001). Respiratory quotient
etween gastric bypass and sham-operated body weight-
atched rats was not different during fasting or the 6
ours after the test meal.
Body Temperature
Body temperature as measured during the light
nd dark phase is shown in Figure 4C. Body temperature
n gastric bypass rats was lower than in sham-operated,
d libitum fed rats but higher compared with body
eight-matched, sham-operated rats during the light
hase (sham-operated, ad libitum fed: 36.8°C  0.02°C
s sham-operated, body weight matched: 36.3°C 
.06°C vs bypass: 36.5°C  0.03°C, P  .001). During
he dark phase, average body temperature in gastric by-
ass rats was lower than in sham-operated, ad libitum fed
ats but no different compared with body weight-
Figure 3. (A) Average daily food
intake over 70 days for sham-
operated ad libitum fed rats (n
8, open column), for sham-oper-
ated body weight-matched rats
(n  8, shaded column), and for
gastric bypass rats (n 14, solid
column). Data are shown as
mean valuesSEM (***P .001).
(B) Average food intake during
dark and light phase for sham-op-
erated ad libitum fed (n 8, open
columns) and gastric bypass rats
(n  8, solid columns). Data are
shown as mean values  SEM
(*P .05, ***P .001).atched, sham-operated rats (sham-operated, ad libitum
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ARTICLE IN PRESSed: 37.7°C  0.02°C vs sham-operated, body weight
atched: 37.3°C  0.09°C vs bypass: 37.3°C  0.03°C,
 .001).
Physical Activity
A dissociation between total energy expenditure
nd body temperature was observed and, thus, physical
ctivity was analyzed (Figure 4D). No difference in activ-
ty over 24 hours or during the light phase was seen
mong all 3 groups. During the dark phase, however,
astric bypass rats were less active than sham-operated,
d libitum fed rats and sham-operated, body weight-
atched rats (sham-operated, ad libitum fed: 7.19  0.4
ctivity counts vs sham-operated body weight matched:
.70  0.8 activity counts vs bypass: 5.04  0.2 activity
ounts, P  .001).
Diet-Induced Thermogenesis
Diet-induced thermogenesis was measured over 3
ours after a 5-g standard test meal after a 12-hour fast.
he sham-operated, ad libitum fed and the sham-oper-
ted body weight-matched groups consumed all 5 g
ithin 20 minutes; the gastric bypass animals required 30
inutes. Figure 4E shows the diet-induced thermogene-
is for all groups for the first 3 hours after the test meal.
igure 4. Differences in maintenance energy expenditure (A), respirato
hermogenesis (E) for sham-operated ad libitum fed (n 8, open colum
or gastric bypass rats (n 14, solid columns). Whereas data for energy
ight and dark phase, respiratory quotients are shown during 12-hour fa
hermogenesis are expressed as a percentage of the energy content o
ith the test meal after a 12-hour fasting period. All data are shown ashree hours after the 5-g test meal, gastric bypass rats 8ad a significantly greater diet-induced thermogene-
is than the body weight-matched controls, but bypass
as not different from the sham-operated, ad libitum fed
ats (sham-operated, ad libitum fed: 5.2%  4.4% vs
ham-operated, body weight-matched: 0.41%  1.9% vs
ypass: 10.5%  2.0%, P  .05).
Gut Morphometry
Differences in gut morphometry are summarized
n Figure 5. There was no difference in total length of the
omplete small bowel between sham-operated and gastric
ypass rats (sham-operated, ad libitum fed: 108.6  1.7
m vs bypass: 110  2.2 cm, P  .8). In contrast, the wet
eight of the small bowel was 72.1% higher after gastric
ypass than after sham operations (sham-operated, ad
ibitum fed: 12.2  0.6 g vs bypass: 21.0  1.2 g, P 
001). Average weight of the alimentary limb was 10.6 
.8 g, of the biliopancreatic limb 2.7  0.2 g, and of the
ommon channel 7.8  0.6 g. Muscle thickness (sham-
perated, ad libitum fed: 95.0 8.7 m vs bypass: 247.9
2.5 m, P  .001), mucosal height (sham-operated, ad
ibitum fed: 530.8  19.1 m vs bypass: 969  58.2 m,
 .001), villus height (sham-operated, ad libitum fed:
90.4  21.7 m vs bypass: 673.6  63.8 m, P  .001),
nd crypt depth (sham-operated, ad libitum fed: 140.4 
tients (B), average body temperature (C), activity (D), and diet-induced
r sham-operated body weight matched (n 8, shaded columns), and
nditure, body temperature, and activity are shown during 24 hours, the
and within the first 6 hours after a 5-g test meal. Data for diet-induced
g test meal and shown at 1 hour, 2 hours, and 3 hours after refeeding
n values  SEM (*P  .05, **P  .01, ***P  .001).ry quo
ns), fo
expe
sting
f a 5-.0 m vs bypass: 295.4  20.6 m, P  .001) were
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ARTICLE IN PRESSignificantly increased in the alimentary limb after gastric
ypass in comparison with the corresponding section of
he jejunum of the sham-operated controls. Gastric by-
ass rats had a significantly greater villus height of the
ommon channel than sham-operated animals (sham-
perated, ad libitum fed: 287.1  18.1 m vs bypass:
64.6  73.9 m, P  .05). There was a trend toward an
ncrease in mucosal height (sham-operated, ad libitum
ed: 490.4  29.6 m vs bypass: 673.8  99.7 m, P 
09) and muscle thickness (sham-operated, ad libitum
ed: 490.4  29.6 m vs bypass: 673.8  99.8 m, P 
09) in the common channel.
Discussion
Our data in the rat gastric bypass model are con-
istent with previous findings that gastric bypass surgery
s effective to reduce body weight and especially to main-
ain body weight loss.4,9,10,12,16 We confirmed that body
eight loss after gastric bypass was associated with a
ignificant loss of fat mass and to a lesser degree of
onadipose body mass.26,27 Food intake was reduced in
astric bypass rats, which may be partly explained by
ormonally mediated mechanisms.9,16,28 Importantly, the
ower food intake after gastric bypass compared with
ham-operated, ad libitum fed rats only partly explains
ody weight loss because the sham-operated, body
igure 5. Length (A) and weight (B) of the entire small bowel and diffe
ham operation (n 8). Differences in muscle thickness (C), mucosal he
he biliopancreatic limb, and the common channel after gastric bypass in
fter sham operation, respectively. Data are shown as mean values eight-matched group required on average 40% less food nhan the bypass group to maintain the same level of body
eight. Consequently, reduced calorie consumption is
mportant but not the sole cause of weight loss after
astric bypass. We found no increased fecal mass, fecal
alorie content, or inflammation in the gastric bypass
nimals; therefore, nutrient malabsorption or inflamma-
ion are unlikely to play a major role in this weight loss.10
We demonstrate a higher total energy expenditure in rats
fter gastric bypass compared with ad libitum fed and body
eight-matched sham groups, which is in accordance with
ome but not all previous reports of energy expenditure in
umans.29–31 Our differences in energy expenditure were
ainly due to changes during the light phase when physical
ctivity is typically low. Gastric bypass surgery did not only
revent the expected decrease in energy expenditure subse-
uent to body weight loss but actually increased 24-hour
nd in particular light phase energy expenditure in compar-
son with the control groups.
Higher energy expenditure after gastric bypass was
ssociated with lower respiratory quotients, suggesting
hat fat rather than carbohydrates was burnt to sustain
igher energy expenditure. However, food-restricted,
ody weight-matched controls showed similar respira-
ory quotient levels to the gastric bypass group, suggest-
ng that body weight loss rather than a specific effect by
he gastric bypass procedure was an important determi-
s in gut morphometry in rats 60 days after gastric bypass (n  8) and
), villus height (E), and crypt depth (F) are shown for the alimentary limb,
parison with the corresponding parts of jejunum, duodenum, and ileum
(***P  .001, *P  .05).rence
ight (D
comant for the observed decrease in respiratory quotient.
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ARTICLE IN PRESSBecause higher levels of total energy expenditure usu-
lly result either from greater heat generation or in-
reased physical activity,32 some of our findings remain
nexplained. First, bypass rats were not more physically
ctive than the control groups. The bypass rats showed
o difference in spontaneous activity during the light
hase to indicate reduced sleep time, but we have not
ormally evaluated sleep patterns. In fact, at least during
he dark phase, when spontaneous activity is usually
igh, physical activity was lower in the bypass rats than in
he sham-operated controls. Because gastric bypass in-
uces an increase in postprandial levels of PYY and glu-
agon-like peptide-1 (GLP-1),15 which reduce food intake,
he reduced dark phase physical activity may possibly
ndicate reduced appetite and hence less foraging or
ood-seeking behavior. The second unexpected finding
as the lower body temperature in gastric bypass rats
ompared with ad libitum fed, sham-operated controls.
his was observed throughout the light-dark cycle. How-
ver, during the light phase, the body temperature of the
astric bypass rats was higher than in the body weight-
atched controls, despite no difference in physical activ-
ty. It must be emphasized that, during the light phase,
astric bypass rats continued to consume some food,
hereas the body weight-matched, sham-operated rats
onsumed all food during the first half of the dark cycle.
hus, differences in light phase body temperature might
e related to food intake and subsequently diet-induced
hermogenesis.33,34
After a 5-g test meal, gastric bypass rats had greater
iet-induced thermogenesis than body weight-matched
ontrols, but no difference was observed between gastric
ypass rats and the ad libitum fed, sham-operated group.
ur data suggest that gastric bypass induces profound
hanges in food intake, energy expenditure, and the
echanisms by which the body controls energy expendi-
ure. Because gastric bypass significantly rearranges the
astrointestinal anatomy, we suggest that gastrointesti-
al and central neuroendocrine signaling contribute to
ncreased energy expenditure.32 Neurons in the hypotha-
amic arcuate nucleus (ARC) coexpress neuropeptide Y
NPY) and agouti-related peptide, which stimulate food
ntake and weight gain.35 Another population of ARC
eurons coexpress pro-opiomelanocortin (POMC) and
ocaine-and-amphetamine-regulated transcript, which
oth promote weight loss.36 The balance between NPY
nd POMC is critical for the maintenance of body
eight.35–37 Gastric bypass increases postprandial levels
f PYY and GLP-1,9,10 which are satiating-inducing gut
ormones and hence favor an anorectic state and facili-
ate body weight loss through modulation of the hypo-
halamus and brain stem,38,39 also being involved in the
ontrol of energy expenditure.18 In fact, PYY has been
hown to activate anorectic POMC expressing neurons in
he ARC40 and to inhibit NPY neurons,41 suggesting a
otential to increase energy expenditure. eGastrointestinal effects of GLP-1 and PYY can be re-
olved by ablation of vagus/brain stem/hypothalamus
athways,38 indicating a role for the vagus in mediating
ffects on food intake and potentially energy expendi-
ure. However, it was beyond the scope of this study to
ssess the potential role of vagal or visceral neural affer-
nt information to the central nervous system.
GLP-1 increases endogenous amylin levels.42 Amylin
ay be another potential candidate decreasing food in-
ake and increasing energy expenditure.25 Of note, the
educed food intake after amylin is independent of
LP-1 and vice versa (Lutz TA, unpublished data). None-
heless, chronic amylin administration reduces food in-
ake,43 and it prevents the decrease in energy expenditure
hat would typically result from lower food intake and
ody weight loss44,45 (Lutz TA, unpublished data).
The increase in total energy expenditure might also
epresent a higher energy requirement after bypass sur-
ery. We also demonstrated significant morphometric
hanges of the small intestine after gastric bypass sur-
ery.11,15 The observed increase in muscle thickness and
ucosal mass after gastric bypass resulted in a 72%
ncrease of the total small bowel weight. The gut is
etabolically very active and the mean in vitro rates of
xygen consumption in gastrointestinal tissues in rats
ave been reported to be 15%–22% of total oxygen con-
umption.46,47 Thus, gut hypertrophy may at least in part
xplain the higher maintenance energy requirement that
ontributes to body weight loss.
Postoperative inflammation secondary to infection can
ead to a higher energy demands, but we found no evi-
ence of an inflammatory response in our study. Other
echanisms that should be considered but may be less
ikely include decreased leptin after gastric bypass. Usu-
lly high leptin and not low leptin contributes to in-
reased energy expenditure.48 Although low leptin levels
ay explain the lower body temperature in bypass rats
han in ad libitum fed controls, it does not explain the
bserved difference in body temperature between bypass
nd body weight-matched rats.
This study does not explain why average body temper-
ture was reduced while total energy expenditure was
igher after gastric bypass. One possible explanation is
hat more heat was dissipated to the immediate environ-
ent of the rats especially because gastric bypass rats had
ignificantly less body fat and hence less thermal isola-
ion. We did not assess cutaneous vasodilation to further
xplore potential mechanisms. Another explanation may
e an up-regulated activity of brown adipose tissue, but
ur measuring system did not allow the separate assess-
ent of brown adipose tissue and tail temperature.
In summary, not only did gastric bypass surgery pre-
ent the expected decrease in energy expenditure subse-
uent to body weight loss in this diet-induced obese rat
odel, but 24-hour and in particular light phase energy
xpenditure were higher than in sham controls. Diet-
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ARTICLE IN PRESSnduced thermogenesis was also higher after gastric bypass
urgery compared with body weight-matched controls. In-
reased energy expenditure may offer an additional expla-
ation why gastric bypass surgery is superior to dieting for
uccessfully maintaining long-term body weight loss.
Supplementary Material
Note: To access the supplementary material
ccompanying this article, visit the online version of
astroenterology at www.gastrojournal.org, and at doi:
0.1053/j.gastro.2009.11.012.
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ARTICLE IN PRESSSupplementary Materials and Methods
Surgery
At the beginning of the gastric bypass procedure,
he stomach was transected close to the gastro-oesopha-
eal junction to create a small gastric pouch. Subse-
uently, the pouch was anastomosed to a loop of jeju-
um 10 cm distal to the pylorus in an end-to-side
ashion. A 7-mm side-to-side small bowel anastomosis
as performed between the biliopancreatic and the ali-
entary limbs to create a common channel of 25 cm;
imilar to the technique in humans, the omega loop of
mall bowel was then divided. The sham operation con-
isted of a laparotomy, a 7-mm gastrotomy on the ante-
ior wall of the stomach with subsequent closure and a
-mm jejunotomy with subsequent closure. Preopera-
ively, gentamicin, 8 mg/kg, and carprofen, 5 mg/kg, were
dministered intraperitoneally as prophylaxis for postop-
rative infection and pain relief.
To assess changes of body temperature, intra-ab-
ominal temperature sensors were used during indi-
ect calorimetry. Under brief isoflurane anesthesia, a
emperature transmitter was implanted intraperitone-
lly (VM-FA disc; DataScience ART4.0 telemetry sys-
em; DataScience, St. Paul, MN). Animals were given at
east 1 week to recover before measurements in meta-
olic cages were started.
Indirect Calorimetry
Rats were individually housed in Plexiglas air-
ight metabolic cages (41  41  31 cm) on a layer of
ood shavings under the same light and temperature
onditions as described above. Water and standard pow-
er chow (GLP3433; Provimi Kliba Ag, Kaiseraugst, Swit-
erland) were available ad libitum, unless otherwise
tated. Food intake and water intake were measured
ontinuously. Physical activity was monitored by a 3-di-
ensional array of infrared light beams and sensors.
hus, the activity data provided represent a relative mea-
ure of locomotor activity of the rats. The activity data do
ot relate to an absolute measurement of distance moved
r to a spatial position. Measurements were conducted in
n open circuit calorimetry system (AccuScan Inc, Co-
umbus, OH).1 Energy expenditure was calculated for
ach 2-minute sample according to Weir2 using the fol-
owing equation: total energy expenditure (kcal/h)  3.9
V(O2)L/h 1.1 V(CO2)L/h. The respiratory quotient
as defined as the quotient of CO2 production and O2
onsumption.
Gut Morphometry
For analysis of gut morphometry, 2-cm segments
f the alimentary, biliopancreatic limb, and common
hannel from bypass operated rats and corresponding
egments of jejunum, duodenum, and ileum of sham-perated rats were opened on the mesenteric border and
xed overnight at 4°C in Zamboni’s fixative (2% parafor-
aldehyde, 15% picric acid, pH 7.4). Transverse segments
rom each segment were incubated in 20% sucrose in
hosphate-buffered saline overnight at 4°C and then
mbedded in optimum cutting temperature compound.
ections of intestine (12 m) were cut on a cryostat, thaw
ounted onto slides coated with poly-D-lysine, and
tored at 20°C until use. Sections were then processed
or H&E staining. Sections were washed 3 times at 10-
inute intervals in phosphate-buffered saline containing
.1% Triton X-100 and then rinsed in distilled water.
ections were immersed in Ehrlich’s Alum Hematoxylin
or 4 minutes and then rinsed in distilled water. Sections
ere then dipped 2 or 3 times in 0.5% acid alcohol and
insed in distilled water. Sections were soaked in Scott’s
lueing for 30 seconds before being rinsed in distilled
ater for 30 seconds. Next, the sections were dipped once
n Eosin Y acid, washed stain, and again rinsed in dis-
illed water. Slides were then coverslipped with bicarbon-
te-buffered glycerol, and sections were examined for
orphometric analysis. Muscle thickness (circular lon-
itudinal muscle), mucosal height (villus height  crypt
epth), villus height and crypt depth were measured in
ell-orientated sections under a Zeiss Axioplan (Zeiss,
ena, Switzerland) microscope fitted with an eyepiece
raticule by an observer blinded to the group. Three
easurements per tissue were taken, and an average was
btained.
Fecal Analysis
To evaluate nutrient absorption, feces were col-
ected over 24 hours on postoperative days 15 and 59
rom all animals. Feces were dried in an oven and
eighed; calorie content was measured using a ballistic
omb calorimeter.3
Blood Analysis
Blood was obtained by puncture of a sublingual
ein under brief isoflufrane anesthesia. Blood was col-
ected into EDTA-rinsed tubes and immediately centri-
uged at 3000 rpm for 10 minutes at 4°C. Plasma was
tored at 80°C before analysis. Measurements of C-re-
ctive protein (Abbott, Maidenhead, UK) were made to
ssess inflammation.
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Sodium and water handling after gastric bypass surgery in a rat model
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Abstract Background: To investigate the influence of gastric bypass on renal sodium and water handling at
a university hospital. The relationship between sodium and water absorption along the gastrointes-
tinal tract and their renal excretion is poorly understood. Beneficial effects on blood pressure have
been seen after bariatric surgery before significant weight loss has occurred.
Methods: Male Wistar rats (348  19 g) underwent either gastric bypass (n  14) or sham
operation (n  7) and were given a low-sodium diet with deionized water ad libitum. Before and
after surgery, the rats received an oral sodium load (1.5 mmol/kg) as hyperosmolar saline (616 mM),
and were then placed in individual metabolic cages so the urine volume, sodium content, and water
intake for 8 hours could be recorded. The urine sodium concentration was also measured.
Results: The rats that had undergone gastric bypass had a significantly lower body weight than the
sham-operated controls throughout the follow-up period (346  21 g versus 501.3  8.0 g at day
60; P  .0004). An oral sodium load after gastric bypass led to an increase in water intake (.07 
.01 mL/g versus .03  .01 mL/g; P  .023), urine output (.03  .01 mL/g versus .02  .002 mL/g;
P  .027), and sodium excretion (65.99  10.7 mol versus 31.71  8.7 mol; P  .020). No change
was seen in water intake, urine output, or sodium excretion after sham surgery.
Conclusion: Urine output, water intake, and sodium excretion are all increased after gastric
bypass surgery in rats given an oral sodium load compared with sham-operated controls. More
rapid excretion, and less retention, of a dietary sodium load could be a part of the mechanism
underlying the beneficial effect of bariatric surgery on blood pressure. (Surg Obes Relat Dis
2010;xx:xxx.) © 2010 Published by Elsevier Inc. on behalf of American Society for Metabolic
and Bariatric Surgery.
Keywords: Gastrointestinal tract; Hypertension; Sodium; Water
Gastric bypass surgery is currently the most effective
treatment of morbid obesity, and its beneficial effects on
obesity-related co-morbidities, such as diabetes and hyper-
tension, are now well documented [1]. In the Swedish
Obese Subjects study, the systolic blood pressure decreased
by approximately 11 mm Hg and the diastolic blood pres-
sure by approximately 7 mm Hg in the first 6 months after
bariatric surgery [2,3]. Several other studies have reported
similar findings [1,4–6]. The improvement in blood pres-
sure seen after bypass surgery was initially thought to be a
medium-term effect related to weight loss, with the first
documented reductions seen at 8 weeks postoperatively.
However, Ahmed et al. [7] observed significant reductions
in systolic (9 mm Hg) and diastolic (7 mm Hg) blood
pressure as early as 1 week after gastric bypass surgery,
before any significant change in weight. Furthermore, this
beneficial effect was maintained for 1 year after surgery,
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and the postoperative use of antihypertensive drugs was
reduced by one third [7].
Hypertension is associated with central adiposity and
insulin resistance [8–10], but the pathophysiologic mecha-
nism remains unclear. Several hypotheses are plausible,
including insulin resistance [11,12], aldosterone and so-
called aldosterone-releasing factors [13,14], and hyperlep-
tinemia [15,16], leading to sodium retention, increased
blood volume, and, finally, elevated blood pressure. Alter-
natively, it has been suggested that increased aldosterone
levels might be secondary to increased intra-abdominal
pressure [17,18]. A proposed mechanism is that the in-
creased intra-abdominal pressure raises the diaphragm,
which increases pleural pressure, decreasing venous return
to the heart. An increased intra-abdominal pressure would
also increase the inferior vena cava pressure, resulting in
increased renal venous pressure and decrease renal perfu-
sion. Both mechanisms would activate the renin-angioten-
sin-aldosterone system, leading to increased renal sodium
and water retention [17,18]. However, a reduction of the
visceral fat mass and decrease in sympathetic nerve activity
and/or sodium retention do not occur immediately after
gastric bypass surgery, and they do not explain the early
reductions in blood pressure reported by Ahmed et al. [7].
Therefore, we hypothesized that renal sodium and water
handling might be altered by bypass surgery and that this
might contribute to the early improvement in blood pressure
control that occurs.
Thus, our aim in the present study was to evaluate the
water intake, urine output, and renal sodium excretion in
rats before and shortly after gastric bypass surgery in re-
sponse to an acute oral sodium challenge.
Methods
Animals
A total of 21 male Wistar rats (body weight 348  19 g)
were randomized to undergo either gastric bypass (n  14)
or sham surgery (n  7). The study was performed under
U.K. Home Office license (PL 70-5569), and all rats were
kept in identical environmental conditions (temperature
24°C, humidity 60%, light cycle 7:00–7:00) with normal
chow (RM1 diet, Special Diet Services, Essex, UK) and tap
water ad libitum, unless otherwise stated. The body weight
was measured daily.
Metabolic cage experiments
The urine output, water intake, and sodium excretion
were measured at 3 different points. First, before surgery
and after an oral sodium load; second, after surgery, but
without an oral sodium load (baseline measurements); third,
after surgery and after an oral sodium load. Before each
experiment, the rats were maintained on a low-sodium diet
and given deionized water ad libitum for 1 week to establish
a stable urinary excretion rate for sodium and to enhance the
endogenous mechanisms for sodium retention [19]. The
low-sodium diet was identical to normal chow, except for its
sodium content (D02051701, Research Diets, New Bruns-
wick, NJ; sodium content 102.6 ppm). For the measure-
ments after an oral sodium load, sodium (1.5 mmol Na/kg
body weight) was given intragastrically by oral gavage for
10 seconds as a hyperosmolar NaCl solution (616 mM) at
the beginning of the light phase (7:00 AM). The rats were
then placed in individual metabolic cages for urine collec-
tion and to record the water intake for 8 hours. For the
baseline measurements, the rats were placed in metabolic
cages without having received the oral sodium load. In all
experiments, urine was collected in preweighed plastic
tubes. Water was given in preweighed plastic bottles that
were reweighed at the end of the experiment. The cages
were cleaned and rinsed with deionized water after each
experiment.
Surgery
Surgery was performed according to an established and
standardized protocol using isoflurane inhalation anesthesia
[20]. All operations were performed by 1 surgeon (M.B.).
The rats were fasted overnight but had access to tap water
ad libitum. During surgery, the stomach was transected
close to the gastroesophageal junction, which was subse-
quently anastomosed to a loop of jejunum 7 cm distal to the
ligament of Treitz in an end-to-side fashion. A 7-mm side-
to-side small bowel anastomosis was performed between
the biliopancreatic and the alimentary limbs to create a
common channel of 25 cm, and the omega loop of small
bowel was then divided. Figure 1 shows a diagrammatic
representation of the gastric bypass rodent model. The sham
operation consisted of laparotomy, a 7-mm gastrotomy on
the anterior wall of the stomach with subsequent closure,
and a 7-mm jejunotomy with subsequent closure. Preope-
ratively, gentamycin 8 mg/kg and carprofen .01 mL were
administered intraperitoneally as prophylaxis for postoper-
ative pain and infection.
Measurement of urinary sodium
The urine sodium concentration was measured with in-
tegrated chip technology using the Architect ci16200 (Ab-
bott Diagnostics, Abbott Park, IL). It obtains millivolt read-
ings and converts them to assay-specific analyte conversion
units. The measurement of the integrated chip technology
reference solution and integrated chip technology samples
were used to calculate the assay results.
Statistical analysis
The data are presented as the mean  standard error of
the mean. The data were compared using the 2-tailed, paired
Student t test (GraphPad Prism, GraphPad Software, La
Jolla, CA). P  .05 was considered significant.
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Results
Weight loss
The body weight was significantly lower in the gastric
bypass rats than in the sham-operated group from day 5
after surgery (sham 349.9  6.1 g versus bypass 313.6 
6.4 g; P  .01). The sham-operated rats gained weight for
the rest of the study. The difference in body weight on day
60 was 165 g (sham 501  8 g versus bypass 346  21 g;
P  .001). Figure 2 shows the percentage of initial body
weight for all bypass (n  14) and sham-operated (n  7)
rats.
Urine output (volume)
In the gastric bypass rats, sodium loading after surgery
led to a greater increase in urine output compared with the
urine output after the same sodium load before surgery
(preoperatively .015  .002 mL/g body weight versus post-
operatively .034  .007 mL/g body weight; P  .03). No
change was seen in the urine output in the sham-operated
group after the sodium load compared with their preop-
erative response after sodium loading (preoperatively
.011  .001 mL/g body weight versus postoperatively
.010  .002 mL/g body weight; P  .44). The gastric
bypass rats produced significantly more urine than the
sham-operated rats after sodium loading (sham .010  .002
versus bypass .034 .007 mL/g body weight; P.038). No
difference was seen in the baseline urine production be-
tween the 2 groups after surgery (sham .011  .001 mL/g
body weight versus bypass .015  .002 mL/g body weight;
P  .12). Figure 3 summarizes the data for urine output.
Water intake
The data for water intake are summarized in Fig. 4. The
gastric bypass rats consumed significantly more water after
the sodium load compared with before surgery (preopera-
tively .033 .006 mL/g body weight versus postoperatively
.065  .012 mL/g body weight; P  .02). No changes were
Fig. 2. Body weight (BW) change in group 1 for gastric bypass (circles;
n  14) and sham-operated rats (black squares; n  7). Data shown as
mean  standard error of mean. *P  .05. RYGB  Roux-en-Y gastric
bypass.
Fig. 1. Diagrammatic representation of gastrointestinal anatomy (A) before
and (B) after gastric bypass operation. A, biliopancreatic limb (10 cm);
B, alimentary limb (50 cm); C, common channel (25 cm); and D,
cecum.
Fig. 3. Urine production of bypass rats (black columns; n  14) and
sham-operated rats (white columns; n  7) after oral sodium loading (1.5
mmol Na/kg body weight of 616 mM NaCl solution) preoperatively and on
postoperative day 30. Baseline urine output measured without oral sodium
loading. Data shown as mean  standard error of mean. *P  .05 consid-
ered significant.
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observed for water intake before and after sham surgery
after the sodium load (preoperatively .029  .006 mL/g
body weight versus postoperatively .021  .002 mL/g body
weight; P  .3). The bypass rats also drank significantly
more water than did the sham-operated rats (sham .021 
.002 mL/g body weight versus bypass .065  .012 mL/g
body weight; P  .02) after the sodium load. No difference
was seen in the baseline water intake between the 2 groups
(sham .029 .006 mL/g body weight versus bypass .033
.006 mL/g body weight; P  .68).
Sodium excretion
Postoperative sodium loading led to a greater increase in
cumulative sodium excretion in the gastric bypass rats com-
pared with their preoperative response (preoperative 31.7 
8.7 mol versus postoperative 65.9 10.7 mol; P .02).
No changes in sodium excretion were observed before or
after sham surgery after the oral sodium load (preoperative
40.9  16.0 mol versus postoperative 36.2  10.7 mol;
P  .81). The gastric bypass rats had greater sodium ex-
cretion than their sham-operated counterparts after sodium
loading (sham 36.2 10.7 mol versus bypass 80.9 14.4
mol; P  .03). No significant difference was found be-
tween the baseline sodium excretion between the gastric
bypass rats and the sham-operated rats (sham 40.9  16.0
mol versus bypass 31.7  8.7 mol; P  .59). The data
are summarized in Fig. 5.
Discussion
Both central and peripheral abnormalities account for the
development and maintenance of high arterial pressure in
the presence of obesity [21]. Visceral obesity is considered
an important risk factor for hypertension and cardiovascular
disease [22]. It is linked to hyperinsulinemia, hyperleptine-
mia, and increased levels of aldosterone and so-called al-
dosterone-releasing factors, all of which lead to activation
of the sympathetic and renin-angiotensin-aldosterone sys-
tems [23–25]. In addition, increased aldosterone levels
might also result from increased intra-abdominal pressure
activating the renin-angiotensin-aldosterone system and
leading to increased sodium and water reabsorption [17].
The beneficial effect of gastric bypass surgery on arterial
hypertension has been well documented [26,27]. The reduc-
tion of visceral fat mass and the subsequent decrease in
sympathetic activation and sodium retention is not imme-
diate and does not explain the early reduction in blood
pressure observed after gastric bypass described by Ahmed
et al. [7]. Thus, we reasoned that other mechanisms might
be involved in the early resolution of hypertension after
gastric bypass and that alteration of renal sodium and water
handling could be 1 of them.
We have demonstrated a significant increase in urine
output, water intake, and sodium excretion after gastric
bypass surgery compared with preoperatively. The sham-
Fig. 5. Cumulative sodium excretion of bypass rats (black columns; n 
14) and sham-operated rats (white columns; n  7) after oral sodium
loading (1.5 mmol Na/kg body weight of 616 mM NaCl solution) preop-
eratively and on postoperative day 30. Baseline sodium excretion measured
without oral sodium loading. Data shown as mean  standard error of
mean. *P  .05 considered significant.
Fig. 4. Water intake of bypass rats (black columns; n  14) and sham-
operated rats (white columns; n  7) after oral sodium loading (1.5 mmol
Na/kg body weight of 616 mM NaCl solution) preoperatively and on
postoperative day 30. Baseline water intake measured without oral sodium
loading. Data shown as mean  standard error of mean. *P  .05 consid-
ered significant.
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operated rats showed no such changes in water intake, urine
production, or sodium excretion after surgery.
In many groups of patients with hypertension, the so-
dium balance is disturbed [28], attributed to impaired renal
sodium excretion. However, only a few studies have fo-
cused on the possible role of the gastrointestinal tract in the
control of the sodium balance and, thus, systemic blood
pressure. The concept that dietary intake and composition
can affect renal function is perhaps self-evident, but a de-
tailed characterization of this relationship is still lacking.
Several physiologic mechanisms are involved in controlling
the sodium balance, in particular, the hormones aldosterone,
angiotensin II [29], and atrial natriuretic peptide [30]; how-
ever, some evidence has supported involvement of the gas-
trointestinal tract. Analogous to the “incretin effect,” char-
acterized by an exaggerated plasma insulin response to an
oral glucose load compared with the same amount of glu-
cose given intravenously, the oral ingestion of sodium chlo-
ride has a greater natriuretic effect than when the same
amount has been given intravenously to subjects consuming
a low-sodium diet [31]. This effect has been shown to be
independent of changes in aldosterone and atrial natriuretic
peptide [31]. In the case of insulin release, the important
incretin gut hormone has been shown to be glucagon-like
peptide-1, which has since been developed into a successful
treatment for type 2 diabetes [32]. Although the mechanism
for the analogous effect on sodium excretion and, poten-
tially, blood pressure control, has yet to be identified, the
glucagon-like peptide-1 response after gastric bypass re-
mains a candidate, because it is a known natriuretic [33,34].
Animal studies have provided some evidence that the
gastrointestinal tract can exert a direct influence on renal
function. Morgan et al. [35] observed that salt-sensitive
Harlan Sprague-Dawley rats with transplanted kidneys from
salt-resistant Harlan Sprague-Dawley rats developed signif-
icant salt-induced hypertension, suggesting that extrarenal
factors also contribute to hypertension in this model of
hypertension [35]. These findings were not accounted for by
any changes in established hormones known to control renal
sodium excretion, including aldosterone, renin [29], angio-
tensin II [29], or atrial natriuretic peptide [30]. Hence, the
presence of an intestinal natriuretic factor for renal sodium
excretion was proposed [35].
Our data have suggested that gastric bypass induces
profound changes in sodium and water handling. Because
gastric bypass significantly rearranges the gastrointestinal
anatomy, we suggest that gastrointestinal and central neu-
roendocrine signaling contribute to the increased sodium
and water excretion [36]. Potential mediators between the
gut and the kidney include both peptide YY [37] and glu-
cagon-like peptide-1, which have been shown to have di-
uretic and natriuretic properties [38]. Thus, it is reasonable
to speculate that glucagon-like peptide-1 and peptide YY
could mediate a link between the gastrointestinal tract and
kidney in terms of sodium and water excretion [33,38,39].
However, our study could not distinguish between a
direct effect of hypertonic saline to stimulate thirst with an
increase in water intake after gastric bypass and an indirect
effect of increased renal sodium excretion to stimulate thirst
and offset salt and water loss. Also, a nonhypertensive rat
strain was used, and the blood pressure was not measured to
determine whether the observed increase in sodium excre-
tion led to any change in the blood pressure.
Conclusion
Gastric bypass surgery in humans and in the rat have
provide us with a valuable model in which to explore the
role of the gastrointestinal tract in sodium and water ho-
meostasis, other electrolytes, and perhaps also in salt-sen-
sitive hypertension. Gastric bypass resulted in a greater
urine output, water intake, and sodium excretion in salt-
restricted rats after an oral sodium load. This observation
could provide insight into the mechanism of the early im-
provement in arterial hypertension seen in patients after
gastric bypass surgery.
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Bariatric surgery as a model to study appetite control
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The obesity epidemic and its associated morbidity and mortality have led to major research
efforts to identify mechanisms that regulate appetite. Gut hormones have recently been found
to be an important element in appetite regulation as a result of the signals from the periphery to
the brain. Candidate hormones include ghrelin, peptide YY, glucagon-like peptide-1 and gastric
inhibitory polypeptide, all of which are currently being investigated as potential obesity treat-
ments. Bariatric surgery is currently the most effective therapy for substantial and sustained
weight loss. Understanding how levels of gut hormones are modulated by such procedures has
greatly contributed to the comprehension of the underlying mechanisms of appetite and obesity.
The present paper is a review of how appetite and levels of gastrointestinal hormones are
altered after bariatric surgery. Basic principles of common bariatric procedures and potential
mechanisms for appetite regulation by gut hormones are also addressed.
Bariatric surgery: Appetite control model: Gut hormones: Obesity
Obesity is a major health problem that is associated with
increased morbidity and mortality(1). Its personal, social
and economic consequences can be devastating(1–3). Sub-
stantial research efforts are being directed towards the
development of successful weight-loss therapies. Conse-
quently, the understanding of neuroendocrine regulation
of food intake and weight gain, especially in relation to the
role of gut hormones, has substantially increased over
recent years, but new therapies are still awaited(4–6). Cur-
rent anti-obesity drugs are moderately effective at achiev-
ing weight loss, but considerable adverse effects can occur.
Presently, the only effective treatment with a proven mor-
tality benefit is bariatric surgery(7,8). The mechanisms
underlying the effectiveness of these surgical techniques
are not completely understood but alterations in circulating
gut hormone levels have been shown to be an important
factor(9–11). The gut–brain axis refers in part to gut hor-
mones communicating information from the gastro-
intestinal tract to the appetite centres within the central
nervous system. Changes in these hormones following
bariatric surgery may partly explain the mechanism by
which surgery reduces appetite and sustains weight loss.
Bariatric surgery
Bariatric surgery, also known as weight-loss surgery, refers
to the various surgical procedures performed to treat obe-
sity by modification of the gastrointestinal tract in order to
reduce nutrient intake and/or absorption. Procedures for
surgical removal of body fat such as liposuction or abdo-
minoplasty are not considered bariatric surgical proce-
dures. Patients who have a BMI ‡ 35 kg/m2 with an
obesity-related comorbidity or patients with a BMI
‡ 40 kg/m2 who have instituted an adequate exercise and
diet programme (with or without adjunctive drug therapy)
that has failed meet the National Institute of Clinical
Excellence criteria for bariatric surgery(12). Surgical pro-
cedures can be grouped in two main categories: restrictive
procedures, e.g. gastric banding (Fig. 1); bypass proce-
dures, e.g. Roux-en-Y gastric bypass (Fig. 2). Restrictive
surgery works by reducing the volume of the stomach and
physically preventing excessive consumption of food(13).
However, the most common form of bariatric surgery
worldwide is Roux-en-Y gastric bypass surgery(14,15).
Here, a small stomach pouch is created with a stapler
Abbreviations: ARC, arcuate nucleus; GIP, gastric inhibitory polypeptide; GLP-1, glucagon-like peptide-1; PYY, peptide YY.
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device and connected to the distal small intestine. The
upper part of the small intestine is then re-attached in a
‘Y’-shaped configuration (Fig. 2). In general, the bypass
procedures lead to more weight loss than the restrictive
procedures(8). Typically, gastric banding results in a weight
loss of approximately 20%, whilst the Roux-en-Y gastric
bypass results in approximately 30% weight loss(16).
Weight loss after bypass-type procedures has been shown
to be a result of energy intake rather than malabsorp-
tion(17). Several recent studies have reported a dramatic
improvement in obesity-related comorbidities and a de-
crease in mortality after bariatric surgery(8,18,19). Adverse
effects after gastric bypass include dumping syndrome in
about 20% of patients, leaks at the surgical anastomosis
(12%), incisional hernia (7%), infections (6%), deep-vein
thrombosis (1–3%)(20), pulmonary embolism (2%)(21) and
pneumonia (4%)(22). To reduce the incidence of complica-
tions, patients should be cared for in high-volume centres
with clinicians experienced in bariatric surgery(23).
Appetite regulation via the gut–brain axis
The hypothalamus contains part of the central melano-
cortin system and plays a critical role in the regulation
of food intake. It has a number of nuclei, including the
arcuate nucleus (ARC), paraventricular nucleus, ven-
tromedial nucleus and the dorsomedial nucleus, all of
which are interconnected by circuits that regulate energy
homeostasis(24). The ARC receives and acts on circulating
appetite signals including the modulated release of several
key amino acid neurotransmitters(25,26). The neurons in the
medial ARC co-express neuropeptide Y and agouti-related
peptide, which stimulate food intake and weight gain by
increasing appetite(26). By contrast, the neurons in the late-
ral ARC co-express pro-opiomelanocortin (also known as
corticotrophin–lipotropin) and cocaine-and-amphetamine-
regulated transcript, which both promote weight loss by
decreasing appetite(25). Both the ARC and the brainstem
are ideally positioned to interact with circulating humoral
factors and to receive signals from the periphery(26). Thus,
gut hormones may act directly in the brain after being re-
leased into the circulation and entering through the circum-
ventricular organs. Neuropeptide Y can suppress appetite
and is a selective ligand for the Y4 receptor subtype, which
is expressed at the area postrema and the other appetite-
regulating areas of the melanocortin pathway(27,28). The
balance between the activities of neuropeptide Y–pro-
opiomelanocortin neuronal circuits is critical for the
maintenance of body weight(25,26,29). After food is ingested
sensory input to the central nervous system is forwarded by
vagal and somatosensory afferent fibres in the gastro-
intestinal tract that all end in the nucleus tractus solitarius
within the brainstem. Reciprocal pathways between the
hypothalamus and brainstem pass on information about
energy stores and recent food intake, influencing the per-
ception of satiety(26). These brain centres can respond
independently to peripheral signals when communication
with higher brain centres is surgically interrupted(30). Peri-
pheral feedback to the hypothalamus is complex. Many
circulating signals, including gut hormones, can have
direct access to the ARC(29). These neuronal interactions
through central melanocortin pathways therefore reveal the
critical role this system has in the regulation of hunger,
satiety and energy expenditure(31). However, the homeo-
static melanocortin system may protect against weight loss
more robustly than it does against weight gain(32). In case
of changes in body adiposity, the brain triggers physio-
logical mechanisms that resist weight change through
compensatory changes in appetite and metabolic rate(33,34).
Gut hormones
Ghrelin
Ghrelin is a twenty-eight-amino acid gut peptide derived
predominantly from the stomach and pituitary gland(35). So
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Fig. 1. Gastric banding, a restrictive procedure performed to treat
obesity.
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Fig. 2. Roux-en-Y gastric bypass, a bypass procedure performed to
treat obesity.
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far, it is the only gut hormone with an orexigenic action. It
acts via the growth hormone secretagogue receptor to in-
crease food intake in rodents(36) and also stimulate food
intake in human subjects(24). Clinical studies have thus
concentrated on its use as an orexigenic agent in conditions
characterized by anorexia and cachexia(37–39). Circulating
ghrelin levels peak in the fasting state and fall after a
meal(40). Energy intake seems to be the primary regulator
of plasma ghrelin levels(41). Ghrelin stimulates appetite and
food intake also in obese individuals(42). Ghrelin levels are
lower in weight-stable obese individuals and rise after diet-
induced weight loss(43). The postprandial decrease in
plasma ghrelin is absent or attenuated in the obese, which
suggests that ghrelin might be involved in the patho-
physiology of obesity(44,45).
Glucagon-like peptide-1
Glucagon-like peptide-1 (GLP-1) is a neuropeptide hor-
mone produced by post-translational processing of the pre-
proglucagon gene in the central nervous system and the
gastrointestinal tract(46). Preproglucagon is secreted in the
gastrointestinal tract by the endocrine L-cells that also
secrete peptide YY (PYY)(46). The GLP-1 receptor belongs
to the G-protein-coupled receptors(47). These receptors
have been identified in neurons of the nucleus tractus soli-
tarius, extending to regions of the hypothalamus that are
important for the regulation of food intake(48). Peripheral
as well as central GLP-1 administration activates neurons
in the ARC, the hypothalamic paraventricular nucleus,
the nucleus tractus solitarius and the area postrema, induc-
ing increased satiety and decreased hunger(47,49). Usually,
GLP-1 is released after energy intake, but differences have
been observed between normal-weight and obese indi-
viduals(50–52). GLP-1 is a potent incretin. It also suppresses
gastric acid secretion and delays gastric emptying(53,54).
These effects can be resolved by vagotomy, indicating an
important role of the vagus nerve in mediating the ano-
rectic effects of GLP-1(49). Peripheral GLP-1 infusions
have been found to cause a dose-dependent reduction in
food intake, while administration of exenatide (an agonist
of the GLP-1 receptor) markedly reduces food
intake(55,56). Central actions of GLP-1 might also lead to
increased energy expenditure by raising body tempera-
ture(57,58). GLP-1 has been shown to promote lipo-
lysis(59,60), although some studies have suggested a role in
lipogenesis(60). Glycaemic control in patients with type 2
diabetes mellitus improves after 3 weeks of treatment with
subcutaneous GLP-1(61), while the agonist exenatide im-
proves HbA1c in the long term(62). Furthermore, GLP-1
has been shown to up regulate the expression of pancreatic
b-cell genes, promoting b-cell proliferation and inhibiting
apoptosis(63). Exenatide enhances insulin secretion and sup-
presses glucagon release(64). In phase III clinical trials ex-
enatide has been found to reduce body weight by 3–4 kg,
although not all patients respond equally(64,65). Exenatide
is not currently approved as an obesity treatment but has
been approved for the treatment of type 2 diabetes melli-
tus. However, nausea is a common adverse effect of this
treatment and this effect may relate to reduced gastric
emptying or direct effects of the central nervous system(65).
Peptide YY
As a thirty-six-amino acid peptide PYY is a member of the
pancreatic polypeptide family(66). It is found throughout
the human small intestine, with highest levels in the colon
and rectum(67). PYY is released after a meal from the endo-
crine L-cells of the gastrointestinal tract, where it is co-
stored with GLP-1(67,68). PYY is secreted in proportion to
the amount of energy ingested and is independent of gastric
distension(67). PYY inhibits gastric, pancreatic and intes-
tinal secretion as well as gastrointestinal motility(69,70). The
major form of circulating PYY is the N-terminally truncated
PYY3–36, which has high affinity for the Y2 receptor and a
lesser affinity for Y1 and Y5 receptors(71). Although initi-
ally controversial, peripheral administration of PYY3–36 at
physiological doses has now been accepted to reduce food
intake in rodents, primates and human subjects in the short
term(72–75). PYY-knock-out mice are characterized by dys-
regulation of energy homeostasis(76). PYY3–36 activates
anorectic pro-opiomelanocortin-expressing neurons in the
ARC and direct intra-ARC administration of PYY3–36
reduces food intake in rats(77). Furthermore, it inhibits neuro-
peptide Y neurons, which might also contribute to its ano-
rectic effects(78). These effects of PYY3–36 can be blocked
by the administration of a specific Y2 antagonist. In addi-
tion, PYY3–36 does not reduce appetite in Y2-knock-out
mice(77,79). Similar to GLP-1, ablation of the vagus–brain-
stem–hypothalamus pathway leads to a moderation of the
anorectic effects, indicating a role of the vagus nerve in the
neuronal messaging of PYY(49). Obese individuals are sen-
sitive to the effects of PYY, as peripheral PYY administra-
tion in the obese reduces food intake to the same extent as in
normal-weight individuals(80), but circulating postprandial
PYY levels are lower in the obese(80). Exogenous adminis-
tration of PYY3–36 has attracted considerable interest as a
possible therapeutic strategy(81). Long-term augmentation
of dietary protein induces an increase in plasma PYY levels
in mice, leading to less food intake and reduced adipo-
sity(82). PYY3–36 administration in human subjects to
levels within the physiological range reduces food intake
without causing nausea(77,80), whereas higher pharmaco-
logical doses can result in nausea(73). Sensations of hunger,
satiety and nausea might all be points along the same
physiological spectrum(83), and nausea is associated with
all high-dose satiety-inducing gastrointestinal hormones,
including cholecystokinin(83), oxyntomodulin(63) and
GLP-1(84). Elevated fasting levels of PYY have also been
observed in several gastrointestinal diseases associated with
appetite loss, including inflammatory bowel disease, stea-
torrhoea as a result of small intestinal mucosal atrophy and
chronic destructive pancreatitis(85). Furthermore, in healthy
elderly individuals high cholecystokinin and PYY levels are
associated with delayed gastric emptying and reduced gall-
bladder contractility(86). These high cholecystokinin and
PYY levels facilitate long-lasting satiety and hunger sup-
pression after meals and can lead to restriction of energy
intake and malnutrition in the elderly(86).
Gastric inhibitory polypeptide
Gastric inhibitory polypeptide (GIP) is a forty-two-amino
acid incretin peptide, which is released from endocrine
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K-cells in the duodenum and proximal jejunum within
minutes after food ingestion(87). The main stimulus for GIP
secretion is the presence of glucose and fat(88). GIP pro-
motes energy storage by direct actions on adipose tissue.
The peptides exert several anabolic adipocyte actions(88,89)
as well as lipolytic effects. GIP-receptor-knock-out mice
have lower adipocyte mass and display a resistance to diet-
induced obesity(90). GIP on its own has no acute impact on
food intake(87), but acts in concert with GLP-1 to control
food intake and energy absorption. Similar to GLP-1, GIP
increases glucose-dependent insulin secretion, b-cell proli-
feration and resistance to apoptosis(91). GIP levels have
been found to be elevated in obese individuals(87).
Gut hormones and appetite after bariatric surgery
Changes in appetite are evident within days of bariatric sur-
gery(10). Postprandial levels of gastrointestinal hormones
that induce satiety, such as GLP-1 and PYY, are elevated
after gastric bypass surgery(92), but not after gastric band-
ing(93). It has been shown that hunger is reduced and sati-
ety is elevated if gastric bands are optimally inflated(13).
These changes in appetite appear independent of any gut
hormone alterations(93). Administration of octreotide,
which would inhibit gut hormone responses, does not
affect food intake after gastric banding(93). Thus, non-
hormonal mechanisms have been suggested(93). In contrast,
studies have demonstrated that postprandial PYY and
GLP-1 levels start rising as early as 2 d after gastric bypass
and can remain elevated for many months after sur-
gery(10,11). In patients with only 20% weight loss after
gastric-bypass operations the postprandial PYY and GLP-1
responses are attenuated compared with patients with 40%
post-operative weight loss(10). Moreover, inhibition of the
satiety gastrointestinal hormone response with octreotide
after gastric bypass increases appetite and food intake(10).
The proposed mechanism behind these findings is that
bariatric surgery gives a secretory stimulus to the distal
L-cells, resulting in an increased level of gastrointestinal
hormones such as PYY and the enteroglucagon family of
peptides(93). As a result, patients have long-term decreased
appetite after gastric bypass. The combined effect of exo-
genous elevation of PYY and GLP-1 reduces food intake
more than predicted by individual hormone infusions
alone(94). This combination of gastrointestinal hormone
responses might, therefore, contribute to the successful
weight loss and its maintenance after bariatric surgery.
On the other hand, changes in ghrelin levels after bari-
atric surgery are controversial. Ghrelin levels have been
reported to be markedly suppressed after gastric bypass,
while diet-induced weight loss is associated with increased
levels of plasma ghrelin(43). It was suggested that reduced
ghrelin contributes to the weight loss after gastric by-
pass(43). Other authors have published conflicting re-
sults(95–99). Thus, the role of ghrelin after gastric bypass
remains unclear. Ghrelin secretion might in fact be modi-
fied by other gastrointestinal hormones, the levels of which
change in response to the altered gastrointestinal anatomy.
However, since obesity is associated with lower levels of
ghrelin, it seems unlikely that reducing the level of ghrelin
would, by itself, induce weight loss(100).
Long-term follow-up data on the changes in gastro-
intestinal hormones after bariatric surgery are still awaited.
Surgery modulates a number of the gut hormones and
probably allows them to act in concert in such a way as to
affect appetite optimally. Understanding the contribution
each hormone makes to appetite control within the setting
of gastric-bypass surgery may be the stepping stone to
future anti-obesity treatments.
Conclusions
Gastrointestinal hormones have attracted a remarkable
amount of research interest in recent years because of their
physiological effects on energy balance and appetite
effects. Gastric bypass surgery is associated with elevated
satiety and satiety-inducing gut hormones. Blocking these
hormones reverses the satiety effects. Although surgery has
been shown to be beneficial for the time being, it carries a
risk for complications for patients. Bariatric surgery may
thus be used as a model to understand physiological weight
loss. This knowledge may help to guide future surgical and
non-surgical weight-loss treatments.
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